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Abstract and scope 
Abstract 
Cardiovascular disease (CVD) is a term used to describe a variety of diseases 
and events that impact the heart and circulatory system. CVD is the United 
Kingdom’s (UKs) biggest killer, causing more than 50,000 premature deaths 
each year. Early recognition of the potential for magnetic resonance imaging 
(MRI) to provide a versatile, non-ionising, non-invasive, technique for the 
assessment of CVD resulted in the modality becoming an area of intense 
interest in the research, radiology and cardiology communities. The first half of 
this thesis reviews some of the key developments in magnetic resonance 
hardware and software that have led to cardiac magnetic resonance imaging 
(CMRI) emerging as a reliable and reproducible tool, with a range of 
applications ideally suited for the evaluation of cardiac morphology, function, 
viability, valvular disease, perfusion, and congenital cardiomyopathies. In 
addition to this, the advantages and challenges of imaging at 3.0T in 
comparison to 1.5T are discussed. The second half of this thesis presents a 
number of investigations that were specifically designed to explore the 
capability of CMRI to accurately detect subtle age and disease related changes 
in the human heart.  Our investigations begin with a study at 1.5T that explores 
the clinical and scientific significance of the less frequently used measure of 
right ventricular function to test the hypothesis that the inclusion of this data 
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provides a more informative assessment of overall cardiac function. The focus 
then shifts to imaging at 3.0T and the challenges of optimising cardiac imaging 
at this field strength are discussed. Normal quantitative parameters of cardiac 
function are established at this field strength for the left ventricle and the left 
atrium of local volunteers. These values are used to investigate disease related 
changes in left ventricle and left atrium of distinct patient cohorts. This work 
concludes by investigating the impact of gadolinium-based contrast agents on 
the quantitative parameters of cardiac function.  
The Scope of the Thesis 
This thesis is concerned with studies regarding both the basic principles and 
clinical practice of CMRI when performed at 1.5T and 3.0T. Chapters 2–5 
provide the platform of knowledge necessary to appreciate the experimental 
work presented in 6–9 of this thesis.  
Chapter 1 begins with a brief introduction to the physics of magnetic resonance 
imaging before comparing the various cardiac imaging modalities routinely 
available in British hospitals today. 
Chapter 2 provides an overview of normal cardiac anatomy and function before 
discussing the cardiac disease-related changes that are relevant to chapters 6–9. 
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Chapter 3 is a literature review, which explores some of the key hardware and 
software developments that have led to a paradigm shift in CMRI over the past 
three decades. The overall impact of these developments on this research is laid 
into context. 
Chapter 4 starts with a brief comparison of the radio frequency and gradient 
fields of the 1.5T and 3.0T Siemens imaging systems utilised for the purpose of 
this research. This is followed by a discussion on the advantages and challenges 
of imaging at 3.0 Tesla in comparison to 1.5 Tesla.  
Chapter 5 defines a cardiac magnetic resonance imaging protocol and discussed 
two fast gradient echo sequences, both of which are fundamental to cardiac 
imaging. In addition to this, chapter 5 contains examples of the images obtained 
using these sequences together with a brief discussion of the clinical 
information that can be gained from some of these images. The chapter 
concludes with an introduction to image analysis and the important clinical 
parameters that are obtained from post-processing short-axis cine images. 
Chapters 6–8 investigate the clinical and scientific significance of novel or 
infrequently used measures of cardiac function with the hypothesis that the 
inclusion of this data may provide a more informative assessment of overall 
cardiac function. 
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Chapter 6 This chapter details a study that was designed to test inter-observer 
reproducibility between a novice and experienced observer. In conjunction to 
this, the quantitative right and left ventricular analysis of three distinct clinical 
cohorts were examined with the hypothesis that the inclusion of RV data may 
generate a more informative characterisation of cardiac function. 
Chapter 7 Begins with a discussion on the challenges faced in optimising ven-
tricular imaging at 3.0T. This is followed by a study designed to define subtle 
age-related functional changes in both male and female healthy volunteers in a 
bid to provide normal ranges of cardiac function at 3.0T for the local popula-
tion. Measures of ejection fraction, end-diastolic volume, end-systolic volume, 
and left ventricular mass for 100 volunteers are obtained and compared. This 
chapter concludes by using these normal ranges to determine if disease-related 
cardiac changes exist in a cohort of patients with Systemic Lupus Erythemato-
sus.  
Chapter 8 An optimised LA protocol is implemented to identify possible volu-
metric variations between healthy volunteers and patient cohorts with carefully 
defined clinical cardiac conditions. 
Gadolinium-based contrast agents are used in CMRI protocols to enhance 
imaging by shortening the inherent T1 values of tissue, effectively creating a 
contrast change.  
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Chapter 9 focuses on the effect of contrast agent delivery on important calculat-
ed cardiac variables, particularly on the value of LV mass. Significant differ-
ences are highlighted that may have important implications for the correct in-
terpretation of patient data in clinical studies. 
Chapter 10 concludes this thesis and consolidates the achievements of chapters 
6–9 before discussing the future of CMRI. This thesis is drawn to a close with an 
overview of present studies and future work. 
Appendix A: This appendix begins with a modification to the Bloch Equations 
to provide explicate forms for Mx, My and Mz.  This is followed by a valid 
solution to an incoherent steady-state imaging technique where the transverse 
magnetisation is essentially zero before the application of the excitation pulse 
(FLASH). The equitation describing the magnetisation from a coherent steady-
state technique (TrueFISP) is given without proof. 
Part two of this appendix describes an essential quality assurance test that is 
routinely performed on all of our MRI scanners to ensure that they are 
performing to the manufacturer’s specifications. Novel matlab code is 
presented that efficiently post-processes the images acquired during testing. 
Appendix B contains the MATLAB® code discussed in Appendix A of this 
thesis. 
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1. The Basics of MRI 
A healthy adult human heart expands and contracts an average of 100,000  
times a day, continuously pumping approximately 7,000 litres of blood  
through a system of veins, arteries and capillaries that is in excess of 96,000 
kilometres long [1]. This continuous flow of blood through the cardiovascular 
system is of paramount importance as it delivers nutrients, removes waste and 
is central to the production of energy and other materials necessary for life 
(metabolism). 
Cardiovascular diseases (CVDs) are a group of disorders that negatively  
impact the heart and blood vessels. It is estimated that CVDs will be responsible 
for almost 23.6 million deaths globally per annum by 2030, with men  
and women being almost equally effected [2]. Consequently, there is a  
move towards the early identification of cardiovascular disease risk,  
as proactive disease management may be effective in slowing disease 
progression [3]. This would have major financial benefits for our national  
health service (NHS), but more importantly, disease management has the 
potential to benefit the patient in terms of morbidity and mortality. For 
example, a patient’s long-term survival may be improved by revascularisation 
procedures, such as coronary artery bypass grafting, if it can be established  
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that there are viable heart muscle cells in the cardiac territory affected by  
the occluded vessel [4, 5] 
1.1 Diagnostic Imaging 
Diagnostic imaging plays a vital role in the identification of cardiac disease-
related changes. A number of well-established techniques are available for this 
purpose, all of which obtain images by measuring the interaction between 
energy and a biological tissue. This thesis focuses on the application of cardiac 
magnetic resonance imaging (CMRI), which is a comparatively new imaging 
modality. In particular, we investigate the ability of CMRI to detect age and 
disease related changes in the human heart. This chapter begins with a brief 
introduction to magnetic resonance imaging (MRI); however the interested 
reader is directed to the following books for a more thorough discussion of the 
science involved in this technique [6, 7]. 
1.2 Magnetic Resonance Imaging 
Paul Lauterbur produced the first primitive magnetic resonance image in 1973. 
Subsequent rapid developments in hardware and software lead to the 
introduction of the first clinical whole-body scanners less than 10 years later. 
Today MRI is established as an essential radiological tool with an estimated 60 
million MRI exams performed each year, worldwide [8]. 
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1.3 Nuclear Magnetic Resonance  
Magnetic resonance imaging is based on the principles of proton nuclear 
magnetic resonance (NMR). NMR is used to induce and detect a very weak 
radio frequency signal that is a manifestation of nuclear magnetism. NMR can 
only be performed on isotopes with a net spin angular momentum whose 
natural abundance is high enough to be detected.  
1.4 Spin Angular Momentum 
Nuclear spin angular momentum (J) is a fundamental property of nature that 
makes the nucleus a continuously rotating positive charge, and as a moving 
charge it has an associated magnetic field and magnetic dipole moment () 
(Figure 1.1).  
 
 
The magnetic dipole moment of a nucleus is directly proportional to the spin 
angular momentum:  
 J   (1.1) 
Where  is a proportionality constant, known as the gyromagnetic ratio.  
 
 
Figure 1.1 Spin angular momentum makes the proton a continuously rotating positive charge. 
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1.4.1 Gyromagnetic Ratio  
The gyromagnetic ratio () relates the nuclear rotating frequency to the strength 
of the magnetic field and is commonly expressed in terms of Mega-Hertz per 
Tesla (MHz/T) in MRI. Every nucleus suitable for MRI has its own specific 
gyromagnetic value. For example, hydrogen nuclei (1H) have a gyromagnetic 
ratio of: 
The magnitude of the nuclear spin angular momentum is given by: 
 )1(  IIJ  (1.3) 
Where I is the spin angular momentum quantum number and is Planck’s 
constant. The magnitude of the angular momentum along a chosen axis is given 
by convention as: 
 
Iz
mJ   (1.4) 
Where 
I
m is the magnetic quantum number and generally = -I, -I+1,…I-1, I. 
There are 2I+1 allowed orientations or quantum states of the nucleus. All of 
which have the same energy in the absence of a magnetic field. 
 TMHz /6.42   (1.2) 
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1.5 Hydrogen Nuclei 
Protons, neutron and electrons are spin one-half particles. An atom with one 
proton, one neutron and one electron has a net nuclear spin of 1 and a net 
electronic spin of ½. Where two spins of opposite signs are paired, the 
observable manifestation of spin is eliminated. 
Hydrogen (1H) nuclei only contain a single proton, giving them a net nuclear 
spin of ½. This, coupled with their relatively high gyromagnetic ratio and 
biological abundance of ~63% in the human body, makes them ideal for 
magnetic resonance imaging. Water-based tissues, such as the myocardium, 
have an even higher biological abundance of ~80%. 
1.6 The Zeeman Effect  
In the absence of an external magnetic field (B0), the individual magnetic dipole 
moments of the protons within a sample have no preferred orientation, and 
therefore precess incoherently. However, once exposed to an external field, the 
spin one-half nuclei experience a torque that causes their magnetic moments to 
begin precessing in one of two allowed quantum states. The lower energy, spin 
up or spin +½ state, is aligned parallel with the applied magnetic field whilst 
the higher energy, spin down or spin -½ state, is aligned anti-parallel to the 
external field. 
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1.7 The Boltzmann Distribution 
At room temperature, the population of spins in the lower energy level (N+) will 
slightly outnumber the population of spins in the upper energy level (N-)  
(Figure 1.2). This spin excess would equate to 1 in 106 at 1.5 Tesla. 
  
 
 
This division of spins is predicted by the classical Boltzmann distribution: 
 
kT
E
e
N
N 

   (1.5) 
Where E = the energy difference between the spin states (1.4); k = Boltzmann’s 
constant, (1.3805x10-23J/K); and T = the temperature in Kelvin.  
 
012
2 BEEE   (1.6) 
 
0
2 BmE
I
  (1.7) 
 
Figure 1.2 The Zeeman energy levels for a spin one-half system. 
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1.8 Larmor Equation  
For the spin ½ proton, 
I
m = +/- ½, hence the energy difference between the two 
states is: 
 
0
BE   (1.8) 
By applying Planck’s Law to equation (1.6), we obtain: 
 
0
Bhv   (1.9) 
thus, allowing us to determine a value for the precessional frequency of the 
protons using the most fundamental equation in MRI physics – the Larmor 
Equation: 
 0B   (1.10) 
1.9 Net Magnetisation Vector 
Although individual spins obey the laws of quantum mechanics, the average 
behaviour of a group of spins (called spin packets) experiencing the same 
magnetic field strength, is best described using classical mechanics. Hence, the 
vector sum of the magnetisation vectors from all spin packets is represented by 
a net magnetisation vector (M0) (Figure 1.3). 
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 







2
)(
0

NNM  (1.11) 
From equation (1.5): 
kT
E
e
N
N 

    
And for small E/kT: 




 


kT
E
NN 1   
On rearranging: 
kT
EN
NN

 

)(   
Substituting into (1.11): 
2
0

kT
EN
M

    
We finally obtain: 
22
0
 
kT
BP
M d 





  
(1.12) 
Where Pd represents the density of protons per unit volume (Pd/2 = N-). 
Y 
Z 
B0 
M0 
X 
Figure 1.3 The vector sum of all spin packets is represented by the net magnetisation vector, M0. 
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The signal in MRI comes predominantly from M0 and its magnitude is 
dependent on a number of factors, which include the magnitude of B0, the 
proton density of the tissue, and the proton’s magnetic moment component 
(ħ/2).  
1.10 The Main Magnetic Field 
Magnetic resonance imaging involves the interaction of three types of magnetic 
field: the main (static) magnetic field, an oscillating radio frequency (RF) field, 
and gradient magnetic fields. The primary job of the main magnetic field in 
MRI is to align the spins to form the net magnetisation vector. This is achieved 
using superconducting magnets as they provide a range of desirable attributes 
including field strengths in the Tesla range that have excellent homogeniety 
and temporal stability. 
1.10.1 Superconducting Magnets 
Superconducting magnets are a form of electromagnet and consist of a solenoid 
(a coil of superconducting multifilament wire made of niobium-titanium alloy 
embedded as fine filaments in a copper matrix). The solenoid is cryogenically 
cooled to a very low temperature of around 4.2K using liquid helium. This 
reduces the resistance in the wires to zero, permitting the very strong electrical 
 
0
22
0
4
B
kT
P
M d

  
(1.13) 
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currents required to create high magnetic fields to be passed through the wires 
without generating significant heat. A superconducting magnetic field stores a 
substantial amount of energy (Es), which can be calculated using:  
 2
2
1
LIEs   
(1.14) 
Where L is the inductance of the coil windings and I is the current flowing 
through them. So for a 1.5T magnet with 150 Henrys of inductance and 200 
amperes of current, the stored energy would equate to 3.6MJ. 
1.11 The Radio Frequency Field 
In equilibrium, the net magnetisation vector aligns with the main magnetic field 
along the z-axis. M0 is several magnitudes smaller than B0 (T v 1.5T). In 
addition to this, M0 is not an oscillating function, and hence cannot be detected 
by a receiver coil. To resolve this issue, a radio frequency (RF) pulse (B1) is 
applied in a plane perpendicular to B0 (Figure 1.4). 
 
 
 
 
Figure 1.4 An RF pulse is applied in a plane perpendicular to B0  
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1.12 Resonance 
If the precessional frequency of the RF pulse matches that of the Larmor 
frequency of the protons then energy is added to the system and resonance can 
occur. During resonance, spins are encouraged to align with the B1 field. This 
phase coherence results in the formation of a net transverse magnetisation 
vector in the x–y plane (Mxy) (Figure 1.4) that precesses simultaneously about B0 
and B1 in a process known as nutation. 
1.12.1 Rotating Frame of Reference 
 
 
 
 
 
The concept of nutation is simplified in MRI physics by considering a rotating 
frame of reference (rotating at the Larmor frequency about the z-axis). In a 
rotating frame, spins rotating at the Larmor frequency appear stationary whilst 
those rotating at higher or lower frequencies are seen to gain or lose phase in 
comparison.  
Figure 1.5 Using a rotating frame of reference simplifies the concept of flipping. 
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An observer within the rotating frame of reference will witness a simple arc 
motion as the magnetisation vector is flipped from the z-axis into the x–y plane 
(Figure 1.5). An observer standing outside the rotating frame of reference 
would witness the more complicated nutational motion of the spins.  
1.12.2 Flip Angles 
The angle () through which the spins are flipped from the z-axis into the 
transverse plane is referred to as the flip angle. It is the choice of amplitude, and 
duration (τ) of the applied field (B1) that determines the flip angle of the 
magnetisation. 
  1B  (1.15) 
It is possible to obtain the same angle by applying a strong pulse for a short 
duration of time, or by applying a weak pulse for a longer period of time. If the 
entire M0 vector is flipped into the x–y plane by the RF pulse, then the pulse is 
referred to as a 90 RF pulse and the angle as a 90 flip angle. At this point: 
Mxy = M0. 
A 180 pulse would have twice the amplitude or twice the duration of a 90 
pulse. The application of a 180 RF pulse inverts the net magnetisation vector by 
exciting the excess spins in the lower energy level into the upper energy level, 
without inducing phase coherence.  
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1.12.3 Partial Flip Angles 
It is possible to flip the net magnetisation vector into the x–y plane by less  
than 90 simply by reducing the power and/or duration of the RF pulse.  
This results in the magnitude of Mxy being less than the original magnitude  
of M0: 
 SinMM xy 0  (1.16) 
1.12.4 Free Induction Decay 
Once in the x–y plane, the precessing net magnetisation induces a voltage and 
current in a receiver coil which is sensitive only to magnetic fields in the 
transverse plane. This induced current is the source of the signal for all MRI 
imaging.  
A large signal is induced and detected immediately after a 90 pulse, as all the 
spins are in phase. This signal is known as the Free Induction Decay (FID) 
(Figure 1.6).  
 
 
 
 Figure 1.6 Left to its own devices the FID would quickly decay away 
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Left to its own devices, the FID would rapidly decay away to zero as described 
by the Bloch Equations (Appendix A). These macroscopic equations describe 
nuclear magnetisation as a function of time when T1 (1.10.8) and T2 (1.10.9) 
relaxation processes (Figures 1.7 and 1.8) are present.  
1.12.5 T1 Relaxation  
The T1 relaxation process is also known as the longitudinal or spin-lattice 
relaxation time and describes the recovery of the Mz component of the  
net magnetisation vector as it returns to its equilibrium position along the  
z-axis after the application of the RF pulse. To relax back into equilibrium,  
the spins have to transfer the energy gained from the RF pulse to the 
environment. This transfer of energy is not spontaneous and can only happen  
if the spins experience an oscillating magnetic field at or near the  
Larmor frequency. The rate of energy transfer depends on a molecule’s natural 
motions (rotation, vibration and translation). Hydrogen, in the form of water, is 
a small molecule and therefore, moves quite rapidly. Larger molecules,  
such as fat molecules move more slowly. The T1 relaxation time reflects  
the relationship between the natural frequency of these molecules and  
the resonant or Larmor frequency. When these frequencies are similar, the  
T1 recovery of M0 is rapid, when they are very different, the T1  
recovery is slow. Hence different tissues exhibit different T1 recover curves 
(Figure 1.7). 
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The equation that describes the T1 relaxation process as a function of time (t) is: 
 )1()(
1/
0
Tt
z
eMtM   (1.17) 
The T1 relaxation process also governs the recovery of the net magnetisation 
vector after a 180 pulse.  
 )21()(
1/
0
Tt
z
eMtM   (1.18) 
1.12.6 T2 Decay 
The phase coherence witnessed immediately after the application of the RF 
pulse is short lived as the spins interact with each other. This loss of coherence 
results in the decay of the transverse magnetisation and ultimately, the loss of 
signal. Again, this process varies between tissue types with larger molecules, 
Figure 1.7 The T1 relaxation curves of blood pool of the heart and the heart wall (myocardium) at 1.5T 
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such as fat, experiencing many static internal magnetic fields in the presence of 
B0 due to their chemical structure. The rate of decay of Mxy is governed by the 
spin-spin relaxation time (T2) of each tissue (Figure 1.8). The equation that 
describes T2 relaxation as a function of time is: 
 
)2/()0( Tt
xyxy
eMM   (1.19) 
 
 
 
 
 
 
 
Figure 1.8 The T2 relaxation curves of the myocardial tissue and the blood pool of the heart at 1.5T. 
T1 and T2 are exponential processes. In general, T2 decay is five to ten times 
more rapid than T1 recovery.  
1.12.7 T2* Relaxation  
T2* (t-two star) is a time constant that includes the additional dephasing effects 
that influence the decay rate of Mxy, such as small magnetic field 
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inhomogeneities and magnetic susceptibility. T2* therefore, describes a quicker 
loss of signal than T2 and as a result, T2* is always smaller than T2: 
 BTT  2/12/1*2/1  (1.20) 
The dephasing effects that are exclusive to T2* are reversible under certain 
circumstances. This reversal can be exploited in MR imaging methods [9]. 
1.13 Image Formation 
Image formation in MRI works by defining the signal intensity in an array of 
pixels so that it corresponds to a three-dimensional co-ordinate system (x, y and 
z) within the patient. This is a challenging process in MRI as the signal 
originates from the entire object rather than a point source and is therefore, not 
simply a case of collimating the receiver coils.  
In a highly homogenous magnetic field such as B0, identical spins in different 
locations will precess at the same frequency and as a result, the detected signal 
will contain no spatial information regarding their distribution. However, by 
distorting B0 with gradient fields, in a precise and controlled way, protons at 
different locations will precess at different resonant frequencies. This permits 
the signal amplitude to be measured as a function of frequency and phase 
whilst the density of protons in the tissue allows an image of spatial structure to 
be obtained. 
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1.13.1 Gradient Magnetic Fields 
Gradients fields are small perturbations that have magnitude and direction and 
are represented as vectors. They are normally applied as pulses in any chosen 
direction or orientation using gradient coils. These gradient fields provide MRI 
with its three-dimensional capabilities. When applied in the x, y and z direction 
the gradient fields are represented by the symbols Gx, Gy, and Gz respectively. 
The isocentre of the magnet is the point where x, y, and z = (0, 0, 0). The 
magnetic field at this point is B0 and the resonant frequency is 0.  
1.13.2 Slice Select Gradient 
The strength of the gradient characterises the slope of the field as a function of 
its position along the axis. For a field gradient in the z direction:  
 zGgradB zz   (1.21) 
The Larmor frequency of each spin is therefore dependent on its position along 
the axis, effectively dividing the patient into 2D slices Larmor frequencies 
(Figure 1.9): 
 zGzGBz zz   )0()()( 00  
(1.22) 
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The centre frequency of the RF pulse controls the location of the slice whilst the 
range of frequencies in the pulse controls the width. Protons either side of the 
selected slice will be resonating at higher or lower frequencies. However, the 
required frequency has to be present within the RF pulse’s transmit bandwidth 
for resonance to occur, thus excitation only takes place close to the isocentre. 
This allows the position, orientation and thickness of the slice to be 
manipulated simply by adjusting the gradient or RF waveform properties.  
1.13.3 Frequency Encoding 
During imaging, a frequency encoding gradient is applied perpendicular to the 
slice select gradient. Once again the centre of the slice remains unaltered but the 
resonant frequency of the spins reduces to the left of the central point and 
increases to the right, thus creating columns of varying Larmor frequency 
within the slice. 
Figure 1.9 A slice select gradient is applied that effectively divides the patient into slices of varying 
Larmor frequencies. 
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1.13.4 Phase Encoding 
The application of these two gradients is still not enough to ascribe a unique 
frequency to each column and row of protons. For this reason, the signal is 
encoded in terms of phase in the third direction. The phase encoding gradient 
induces a change in phase that is proportional to distance, effectively dividing 
the columns of spins into voxels, each with varying precessional speeds (Figure 
1.10). When this gradient is switched off the spins revert to their original speeds 
but keep their phase encoding until either another gradient is applied or the MR 
signal decays.  
Gradients are applied with or after an RF pulse. They can be applied 
individually or in combination to create transverse, sagittal or coronal, oblique 
or double oblique slices. During imaging, spatial localisation in the phase 
encoding direction requires many steps. Each step is performed with an 
The selected imaging slice 
is divided into voxels of 
spins  
 
 
 
Apply  
Gx Gy 
Gradients 
Gz 
Gz 
 
Gx 
Apply Gz Gradient 
Figure 1.10 The signal is encoded in three directions (Gx, Gy and Gz) resulting in voxels of spins within 
the selected imaging slice. 
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incremental change in gradient amplitude so that the protons in the same row 
have the same phase but the protons in the same column have different phases.  
The gradient system of a modern scanner comprises of a gradient amplifier and 
several gradient coils, each of which is positioned around the bore of the 
magnet. The z gradient (Gz) is provided by a Maxwell pair (Figure 1.11), whilst 
the x and y gradients are provided by a Golay pair 
 
Figure 1.11 A Maxwell coil pair is the most efficient choice for producing a z-gradient (Gz).  
 
Figure 1.12 The preferred design for a transverse gradient (Gx or Gy) is the Golay pair. 
Z 
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Modern scanners use shielded gradient coils where secondary coils are used to 
cancel out undesired fields from the primary coils. 
Gradient strength is a measure of the change in field strength over distance and 
is directly proportional to the applied current in the coil. Gradient rise time is a 
measure of the rate of change of field generated when the gradients are 
switched on and off. The gradient strength divided by the rise time gives the 
slew rate of the gradient coils. Slew rates refer to the speed with which the 
gradients can be turned on and off. Higher gradients are desirable as they allow 
thinner image slices or smaller fields of view (FOV) to be obtained without 
changing any other measurement parameters. 
Gradient linearity is another important factor in today’s high end scanners as 
gradient non-linearity can lead to image distortion and signal loss. Thus, 
manufacturers strive to restrict gradient deviations to within 5% of their desired 
value.  
1.13.5 Repetition Time 
Typical MR experiments use a series of pulsed RF energy. The repetition time 
(TR) between successive RF pulses should be long enough to allow additional 
absorption during the next RF pulse and to prevent the spin system from 
becoming saturated, but insufficient for complete T1 relaxation. 
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1.13.6 Echo Time 
Fundamental limitations in the electronics of an MR system prevent a 
measurement of the signal immediate after the application of the RF pulse. 
Hence, the signal is measured after a short time period, known as the time to 
echo (TE). TR and TE are intimately related to T1 and T2 respectively. However, 
unlike T1 and T2, TR and TE can be adjusted and controlled by the operator. 
1.13.7 Biological Parameters 
T1, T2, T2* and proton density values are inherent properties of biological 
tissue. Generally, T1 lengthens with increasing field strength as the energy 
exchange between the spins and their surroundings is less efficient at higher 
frequencies. Field strength also impacts on T2* values as higher fields have an 
increased influence on intrinsic susceptibility changes in tissues.  
1.14 Pulse sequences  
A pulse sequence is basically an MRI software program that has the timing 
parameters TR and TE embedded within it. A pulse sequence diagram  
(Figure 1.11) is a timing diagram that illustrates the timings of the RF  
pulses, gradients and echoes. Pulse sequences control all hardware aspects of  
an MRI imaging session. Many of the advances in CMRI have resulted from 
pulse sequence developments rather than hardware updates or alterations.  
Pulse sequences can be used to accentuate or suppress different tissues, reduce 
imaging times, produce spatial localisation and minimise or avoid artefacts. 
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Sequences can be selected that are sensitive or insensitive to dynamic 
parameters such as flow, contrast uptake or perfusion, offering exceptional 
versatility.  
There are two main sequence types in MRI, known as Spin Echo (SE) and 
Gradient Echo (GE). 
1.14.1 Spin Echo  
The spin echo (SE) technique uses a 90 excitation pulse to flip the  
net magnetisation vector into the x–y plane where the spins start to precess  
and de-phase. A short time later (TE/2), a 180 refocusing pulse is applied  
that rotates the magnetisation about the axis (Figure 1.15). Spins continue to de-
phase; however, as the magnetisation has been rotated, the spins are now 
refocusing. This rotation eliminates the de-phasing effects caused by magnetic 
field inhomogeneities resulting in the creation of an echo that is dependent on 
T2 decay. Multiple RF refocusing pulses can be applied after the 90 RF 
excitation pulse, as long as there is sufficient transverse magnetisation. This 
creates a train of spin echoes.  
 
Figure 1.15 The spin echo pulse sequence has a 90 excitation pulse followed by 180 refocusing 
pulse. 
 
Chapter 1|The Basics of MRI 
Page | 27  
 
1.14.2 Spin Echo – T1 Weighted Images 
Image contrast can be manipulated in SE imaging simply by varying the TR and 
TE values. The selection of a long TR (e.g. 2000ms) will allow the complete (or 
almost complete) recovery of the T1 curves of the different tissues. Conversely a 
short TR (e.g. 300ms) will limit the time allowed for the longitudinal 
magnetisation vector to fully recover and result in the incomplete T1 recovery 
for some or all tissues. This results in the contrast in such images being 
dependent on the T1 characteristics of the different tissue types (Table 1.1). 
Thus, these images are described as being T1 weighted.  
1.14.3 Spin Echo – T2 Weighted Image 
Similarly, the relaxation (dephasing) rates of the transverse magnetisation 
vector can provide T2 weighted images in SE if a long TR and a long TE (e.g. 80-
140ms) are selected (Table 1.1). The long TR allows the complete recovery of the 
longitudinal magnetisation vector and the long TE provides sufficient time for 
T2 relaxation to happen. These T2 weighted images depend on the T2 relaxation 
rates of the different tissues only as the application of the 180 refocusing pulse 
at TE/2 refocuses the dephasing spins and cancels the dephasing effects of static 
magnetic field inhomogeneities. Tissues with a long T2 provide a stronger 
signal than tissues with a short T2 (e.g. 10-20ms). 
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Table 1.1 The contrast in SE images is determined by the choice of TR and TE values 
Spin Echo Imaging Short T2 Long T2 
Short TR T1 Weighted X 
Long TR Proton density T2 Weighted 
 
1.14.4 Spin Echo – Proton Density Image 
Where the operator selects a long TR and a short TE, the T1 and T2 dependence 
of these images is insubstantial. For this reason, image contrast is dictated by 
the density of protons in the different tissue types. Tissues with a high 
Hydrogen content will appear bright whilst tissues with a low Hydrogen 
content will appear dark. 
1.14.5 Gradient Echo 
Gradient echo (GE) pulse sequences differ from SE pulse sequences in that they 
can use an excitation pulse of < 90 to produce an echo. This partial flip angle 
means that at the time point TE/2, a large component of the net magnetisation 
vector is lying in the z-axis. Applying a 180 pulse at this point would invert 
this magnetisation (Mz) into the negative z-axis. This is not desirable as a long 
TR would be required for Mz to fully recover. Alternatively, measuring the FID 
would not provide the time interval essential to spatially encoding the signal. 
Hence, in GE the FID is de-phased and then re-phased at a later time using a 
refocusing gradient (Figure 1.16). The gradient reversal in GE sequences 
refocuses only the spins that have been de-phased by the action of the gradient 
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itself and not those de-phased by magnetic field inhomogeneities. Hence, GE 
image contrast is dictated by T2*.  
 
As only one RF pulse is applied in GE, it is possible to record the signal more 
quickly than in SE, resulting in a shorter TE. Partial flip angles also allow the 
use of shorter TRs. Consequently, GE images are ideal for cardiac imaging as 
their short TRs and reduced flip angles allow faster imaging times, significantly 
reducing motion related artefacts. GE sequences are commonly referred to as 
white-blood imaging, as generally blood and fat appear white in these images.  
The signal weighting in a GE image depends on the TR, TE and flip angle. The 
higher the flip angle, the more T1 weighted the image will be (Table 1.2). The 
shorter the TE, the less T2* weighted the image will be. In addition to this, there 
is an optimal combination between TR and flip angle for maximum MR signal. 
The optimal angle is known as the Ernst angle (E) and is calculated from the 
TR and T1 values: 
Figure 1.16 The gradient echo pulse sequence uses a partial flip angle of <90 and a refocusing gradient. 
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(1.22) 
As the TR is always assumed to be short for a GE sequence, it has much less of 
an effect on image contrast. By selecting a small flip angle the magnetisation 
will be almost completely recovered, so there will be very little difference in T1 
recovery curves (Table 1.2). 
Table 1.2 The contrast in GE images is determined by the choice of flip angle and TE 
Gradient Echo Imaging Short TE Long TE 
Small flip (< 40) PD weighted T2* weighted 
Larger flip (>50) T1 weighted X 
1.14.6 Anatomy Scans 
T1 weighted images usually have excellent contrast making it easy to 
differentiate between fluids, water-based tissue and fat. For this reason, they are 
commonly referred to as anatomy scans. 
 
Figure 1.13 A T1 weighted image of the brain shows excellent contrast between normal and abnormal 
tissues 
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1.14.7 Pathology Scans 
Fluids have the highest intensity in T2 weighted images, showing up very 
brightly against the darker soft tissue. It is possible to differentiate between 
normal and abnormal fluids (such as oedema) in an image as they have 
different T2 relaxation rates and hence different signals. For this reason, T2 
scans are considered pathology scans. Most cardiac images are acquired using a 
ratio of T2 to T1 (Chapter 5). 
 
Figure 1.14 A T2 image of the same brain highlights abnormal fluid 
1.14.8 Proton Density Scans 
Proton density images are dependent primarily on the concentration of mobile 
hydrogen atoms within the imaging volume. The variation of proton densities 
in different tissues provides the range of signal intensities and hence, image 
contrast. 
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1.15 Coils 
In addition to the solenoid coil and gradient coils mentioned previously in this 
chapter, a body coil and shim coil sets are also built in to the bore of the magnet.  
1.15.1 Body Coil 
The body coil surrounds the patient in the magnet bore. The main function of 
this coil is to transmit the RF pulse for all scans and to receive the MRI signal 
when large parts of the body are being imaged. 
1.15.2 Shim Coil Sets 
Shim coil sets are built into all state-of-the-art MRI systems. These coils are used 
to compensate for undesirable field distortions in a passive or active manner. 
Passive coils consist of shim plates (pieces of metal) that correct for field 
distortions. Active coils are comprised of loops of wire that a current is passed 
through to produce supplementary magnetic fields. Shim coils are essential for 
cardiac imaging at 1.5T and 3.0T as they provide improved field homogeniety 
across the heart. This will be discussed in Chapter 7. 
Various other radio frequency coils are used in MRI to transmit energy and to 
receive signals. These coils are placed on or around the region of tissue to be 
scanned. They comprise of transmit receive coils, receive only coils and transmit 
only coils.  
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1.15.3 Surface Coils 
Insulated surface coils are placed directly on top of the patient’s clothing to 
ensure that the receiver is as close as possible to the MR signal. Surface coils are 
commonly used in MRI as their close proximity to the patient limits the volume 
from which noise is detected thus providing good SNR for superficial tissue.  
1.15.4 Phased Array Coils 
Phased array coils consist of an array of surface receiver coil elements with 
known sensitivity profiles whose signals are combined to provide a uniform 
signal intensity over a volume that is in excess of each of the smaller individual 
coils (Figure 1.17). Phased array coils have a superior SNR to larger coils 
covering the same area, as the design of these coils ensures that the noise from 
coil to coil is largely uncorrelated.  
 
 
 
Figure 1.17 Phased array coils are designed so that the noise from coil to coil is largely uncorrelated. 
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This technology is ideal suited for cardiac imaging as the array can be wrapped 
around the patient’s torso in a bid to obtain optimal images of the heart (Figure 
1.18). 
1.16 K-Space 
Applying gradients in MRI changes the frequency across the patient as a 
function of position effectively taking the patient from a physical space into a 
frequency space. Hence, the signal we obtain is a sum of sine waves that add to 
create a rapidly changing continuous voltage in our receiver coil. This complex 
signal originates from every voxel in the image.  
Figure 1.18 A 32 channel phased array cardiac coil 
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The signal is digitised by sampling the voltage at each point across the  
echo using an analogue to digital converter (ADC). This allows the amplitude 
and phase of the signal to be determined as a function of time. Each of  
these points is represented by a complex number that includes a real  
and `imaginary part. Rather than directly expressing position, the points 
indicate the amount of spatial encoding that has taken place at that point,  
with each point being identified by its value and location, which are equivalent 
to the amplitude and the frequency of a sinusoid respectively. 
In conventional imaging, each excitation pulse provides a single echo that  
is sampled to fill a single line in k-space (Figure 1.19), with the number  
of samples acquired across the echo in the x direction determining the number 
of pixels in the x direction. The number of echoes sampled determines  
the number of lines in the y direction, which in turn determines the number of 
Figure 1.19 The signal is digitised by sampling the voltage across the echo. Each echo fills a single line in the  
k-space array. 
 Ky  
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pixels in the y direction. Hence, filling k-space conventionally is a time 
consuming process as an image with 128 pixels in the y direction would require 
128 echoes each with a different phase encoding step. 
It would be impossible to create an image before the gradient fields are  
applied as the uniform precession of all the spins would simply create a 
uniform sine wave that would superimpose as one dot in K-space. The  
effective position in k-space is determined by the gradient amplitude and 
duration as well as the gyromagnetic ratio.  
Applying a gradient to de-phase the spins creates a temporary shift in 
frequency across the sample, making the phases of the protons change as a 
function of position. The spins at the centre of k-space effectively do not 
experience a gradient and therefore, they do not experience a frequency shift 
(0), whereas those over towards the edges of k-space experience the greatest 
shift 
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Figure 1.20 Each point in k-space is represented by a complex number that contains a real and an 
imaginary part and represents the spatial encoding that has taken place at that point.  
As the middle point of k-space does not experience a gradient, every proton is 
in phase, providing a very strong constant signal across the image space. When 
a mathematical operation [known as a Fourier transform (FT)] is performed on 
the k-space array to produce the final image, this one point in k-space creates a 
sheet of uniform intensity that determines the intensity of every pixel in the 
image. The next point along the x-axis in k-space creates a second sheet of 
intensity that has an oscillation along the x-axis but is constant in y. This 
additional sheet is added to the first sheet to increasing the intensity across the 
whole image, improving the spatial resolution.  
The centre of k-space provides the image with contrast and the edges of k-space 
provide the image with high frequency definition. Frequency is proportional to 
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distance from the centre of k-space. Removing high frequency data would 
result in a blurred image with normal contrast.  
The desired spatial resolution of the final image (Figure 1.21) is specified by 
selecting the field of view (FOV) and the number of phase and frequency 
encoding steps. This in turn determines the extent of the k-space array. The 
more tightly packed k-space is, the larger the field of view (FOV). Conversely, if 
the echo is loosely sampled a small field of view is obtained; however the pixel 
size, contrast and resolution are the same.  
 
 
1.17 SAR limitation 
The specific absorption rate (SAR) is a measure of the rate at which energy is 
absorbed by tissue when exposed to a radiofrequency electromagnetic field. 
More precisely, it is a measure of the energy deposited by a radiofrequency 
field in a given mass of tissue. The SAR is limited by the Medicines and 
Healthcare Regulatory Agency (MHRA) guidelines [10], which state that the 
FT 
Figure 1.21 A 2-D Fourier Transform is performed on the k-space array to produce the final image.  
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SAR must not exceed 10 W/kg of tissue for the head and trunk or 20 W/kg for 
the limbs over any 6-minute period. The SAR value is affected by many 
parameters such as the flip angle, amplitude of the RF pulse, selected protocol 
parameters, the subject’s weight and region of exposure, and the 
radiofrequency coil. To prevent limits being exceeded, the scanner will slow 
imaging or suggest that a parameter is reduced, such as increasing the TR or 
reducing the number of slices to be acquired. 
1.18 Cardiac Magnetic Resonance Imaging 
Initially, CMRI failed to gain widespread acceptance due to the challenges 
associated with imaging the beating heart using a complicated technique that is 
inherently sensitive to patient/organ motion. Despite this, CMRI remained an 
area of intense interest within the cardiac community due to its unique 
potential to provide an accurate, and reproducible, full cardiac assessment of 
morphology and function, perfusion and viability, valvular disease and 
coronary artery stenosis, all within a single imaging session. The sustained 
development of CMRI hardware and software techniques discussed in  
Chapter 3 of this thesis have resulted in a paradigm shift in CMRI’s clinical 
potential, allowing it to fulfil its promise beyond the limitations of other well 
established cardiac imaging modalities.  
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1.19 Other Techniques and their Limitations 
Although cardiac magnetic resonance imaging is now well-established and has 
growing popularity within the radiology and cardiology communities, other 
imaging modalities are presently utilised more frequently in clinical practice. 
1.19.1 SPECT and PET 
Single photon emission computed tomography (SPECT) and positron emission 
computed tomography (PET) are imaging techniques that work on the same 
basic principles. Patients are injected intravenously with a labelled 
radioisotope, which travels through the coronary arteries to the myocardium 
where it is absorbed. The decay rate of the isotope is then measured using either 
a gamma camera or PET scanner, providing a functional picture of the blood 
supply to the myocardium.  
 
Figure 1.22 A series of SPECT images in three planes showing the uptake of a radioisotope in the heart 
muscle. 
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Single Photon Emitted Computed Tomography has become the most popular 
imaging technique for the diagnostic work-up of patients with coronary artery 
disease. Conversely, cardiac PET imaging initially failed to become widely 
established in the United Kingdom because of its requirement for isotopes from 
restricted sites with a cyclotron. However, this situation is now changing as the 
required isotopes become more available.  
In comparison to CMRI, SPECT and PET are immediately limited by their use 
of ionising radiation. A further limitation is the difficulty in assigning cardiac 
wall boundaries when coronary arteries are narrowed or occluded due to the 
reduced blood flow and hence reduced isotope count in the area fed by the 
diseased vessel (Figure 1.22).  
1.19.2 Computed Tomography 
Computed tomography (CT) is an imaging modality that is known to  
provide accurate and reproducible images [11, 12] of the heart and coronary 
arteries (Figure 1.23). It does this using a fan-shaped beam of x-rays that pass 
through the patient to reach detectors. Subsequently, the radiation exposure  
to the patient is non-trivial. This naturally restricts the use of CT for 
longitudinal studies designed to chart the progression of cardiac disease-related 
changes.  
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A further restriction of CT is that images can only be obtained in sagittal  
or coronal planes. 
 
 
 
 
 
 
 
1.19.3 Echocardiography 
Echocardiography (echo) is the modality of choice for the detection of heart-
wall motion abnormalities that are often the earliest manifestations of coronary 
blood flow restrictions. Echo is a non-ionising technique, which uses a 
transducer to create a beam of very high frequency sound (ultrasound) waves 
that are transmitted into the patient and reflected back. The shape, size, density 
and motion of all objects lying in the path of the beam are then reconstructed on 
a screen as an image (Figure 1.24).  
Figure 1.23 A CT image of the four chambers of the heart. 
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Figure 1.24 An echo image of the heart. 
In comparison to CMRI, echo has a number of limitations, the most significant 
of which are; a significant number of patients (15–20)% do not have adequate 
acoustic windows to visualise the whole of left ventricle [14], also echo is 
operator-dependent, and the geometric assumptions made when calculating 
ventricular and atrial volumes from two-dimensional images can result in large 
errors [14].  
1.20 The Advantages of Cardiac Magnetic Resonance Imaging 
CMRI is superior to the other imaging modalities as it is non-ionising and non-
invasive. It provides three-dimensional, high-resolution images that have 
excellent contrast between air, fat, muscle, and blood, without geometric or 
acoustic window limitations. A further advantage of CMRI is its unique 
capacity to accentuate or suppress specific tissues (Figure 1.25) simply by 
choosing the correct imaging sequence. It is CMRI’s opulence in terms of 
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techniques, plus its ability to provide the clinician with a wide range of 
diagnostic information in a single imaging session that provides it with such an 
advantage over all the other competing modalities.  
 
 
 
 
 
1.21 The Limitations of Cardiac Magnetic Resonance Imaging 
The main limitation of CMRI is the relatively lengthy acquisition times. This can 
be particularly problematic for very young, old, or infirm patients as they are 
required to remain motionless and breath-hold throughout each acquisition. A 
surprisingly small number of patients are too claustrophobic to enter the bore of 
the magnet, but an increasing number are too large. Manufacturers are 
responding to the mounting obesity problem by producing systems with 70cm 
diameter bores (in comparison to the current 60cm), which offer similar field 
homogeneities to that of the standard systems.  
In addition to these limitations, patients presenting for CMRI with metal 
fragments or some medical implants may be considered unsuitable for imaging 
Figure 1.25 A CMR image of the four chambers of the heart. 
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For example, ferromagnetic materials act like dipoles in a magnetic 
environment. Hence the magnetic field produces a torque to align the dipole 
with the field. This torque is substantial at high fields. 
 2BTorque    (1.23) 
where  is the angle from the z-axis of the dipole to the z-axis of the main 
magnetic field.  
  
 
Chapter 1|The Basics of MRI 
Page | 46  
 
References 
1. University Hospitals of Leicester. How the heart works. Anatomy and physiology; 
2010. Available from: http://www.activateyourheart.org.uk/How-The-Heart-
Works/AP.aspx (cited 25 April 2011). 
2. World Health Organization. Cardiovascular diseases (CVDs); 2011. Available from: 
http://www.who.int/mediacentre/factsheets/fs317/en/index.html (cited November 
2011). 
3. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J 
et al. European guidelines on cardiovascular disease prevention in clinical practice. 
European Heart Journal 1998; 19: 1434–503. 
4. Arrighi J. Nuclear probes for assessing myocardial viability in heart failure. Heart 
Failure Clinics 2006; 2:129–43. 
5. Sharma S, Raman S, Sun B, Sai-Sudhakar C, Firstenberg M, Sirak J et al. Anterior 
wall viability and low ejection fraction predict improvement after CABG. Journal of 
Surgical Research 2010; 171: 416–21. 
6. Haacke EM, Brown RW, Thompson MR, Venkatesan R. Magnetic Resonance Imaging, 
Physical Principles and Sequence Design. New York: John Wiley & Sons, 1999. 
7. McRobbie DW, Moore EA, Graves MJ, Prince MR. MRI from Picture to Proton. New 
York: Cambridge University Press, 2006. 
8. Sutton R, Kanal E, Wilkoff BL, Bello D, Luechinger R, Jenniskens I, et al. Safety of 
magnetic resonance imaging of patients with a new Medtronic EnRhythm MRI 
SureScan pacing system: clinical study design 2008. Trial; 9: 689.  
9. Hahn EL. Spin echoes. Physical Review 1950; 80: 580–94. 
10. Medicines and Healthcare Regulatory Agency (MHRA) guidelines [mhra.gov.uk 
26/04/12].  
11. Neubauer S. MRI and CT. Oxford University, UK 2007; Elsevier.  
12. Raman SV, Shah M, McCarthy B, Garcia A, Ferketich A. Multi-detector row cardiac 
computed tomography accurately quantifies right and left ventricular size and function 
compared with cardiac magnetic resonance. American Heart Journal 2006; 151: 736–44. 
13. Assomull SK, Cannell TM, Prasad SK. CMR assessments of myocardial infarction 
and post infarct complications. Coronary Artery Disease 2005; 16: 373–8. 
Chapter 1|The Basics of MRI 
Page | 47  
 
14. Hudsmith LE, Cheng ASH, Tyler DJ, Shirodaria C, Lee J, Petersen SE, et al. 
Assessment of left atrial volumes at 1.5 Tesla and 3 Tesla using FLASH and SSFP cine 
imaging. Journal of Cardiovascular Magnetic Resonance 2007; 9: 673–9.
Chapter 2|The Human Heart 
Page | 49  
 
2. The Human Heart 
 
 
 
Blood enters the heart 
from the Vena Cava 
Left 
Ventricle 
 
Tricuspid 
Valve 
Mitral 
Valve 
Aorta 
Pulmonary 
Arteries 
Right 
Atrium 
Left 
Atrium 
Coronary 
Arteries 
Major organs and 
circulatory system 
Pulmonary 
Veins 
Lungs 
 
 Pulmonary 
Valve 
Right 
Ventricle 
 
Chapter 2|The Human Heart 
Page | 50  
 
A healthy human heart is a thick, muscular, conical-shaped organ that is 
slightly larger than a clenched fist and normally weighs between 200g and 400g 
[1]. It is anchored in the mediastinal space of the thoracic cavity by an extremely 
tough, protective, fluid filled sac known as the pericardium (Figure 2.1).  
 
Figure 2.1 The cardiovascular system with the heart anchored in the mediastinal space of the thoracic 
cavity 
2.1 The Chambers of the Heart 
The heart consists of four main chambers known as the left and right atria and 
the left and right ventricles (Figure 2.2). The atria of the heart are principally 
blood receiving chambers whilst the ventricles of the heart are powerful pumps. 
A wall known as the septum separates the right side of the heart from the left 
side, and each chamber is closed off by a one-way valve.  
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Figure 2.2 This heart consists of four main chambers: the left and right atria and the left and right 
ventricles. 
2.2 The Valves of the Heart 
Each valve has a set of flaps or cusps that work in a synchronised manner; 
opening when the pressure behind them builds up, and closing once blood has 
passed through them, alleviating the pressure. This simple system ensures 
blood flows through the heart in a forward direction. The valves on the left side 
of the heart are known as the mitral and aortic valves, whilst those on the right 
side of the heart are known as the tricuspid and pulmonary valves (Figure 2.3). 
The valves and the inner surface of the chambers are lined by a smooth layer of 
cells (membrane) known as the endocardium.  
The Right and the Left Artia 
The Right and the Left Ventricles 
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Figure 2.3 The valves of the heart work in a synchronised manner ensuring that blood flows in a forward 
direction through the heart. 
2.3 The Papillary Muscles  
The papillary muscles of the heart are attached to the atrio-ventricular valves by 
the chordae tendinae. These muscles prevent the regurgitation of blood within 
the cardiac chambers by bracing the valves against increasing pressure; thus 
limiting their movement (Figure 2.4). There are three papillary muscles in the 
right ventricle and two in the left.   
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Figure 2.4 The papillary muscles are attached to the valves of the heart by the chordae tendinae 
2.4 The Myocardium 
The outer layer of the heart consists mostly of connective tissue and fat and is 
known as the epicardium. The heart walls are positioned between the 
epicardium and the endocardium and consist mainly of a layer of cardiac 
muscle known as the myocardium, which is responsible for the contraction and 
relaxation of the heart. In a healthy heart, the left ventricular myocardium is 
considerably thicker than that of the right ventricular myocardium.  
The cells that make up the myocardium (myocytes) differ from other muscle 
cells found in the body in that they are lightly striated, have a single nucleus 
(Figure 2.5) and are involuntarily controlled [2].  
Mitral Valve 
Chordae Tendinae 
Papillary Muscles 
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Figure 2.5 The cells that make up the myocardium are lightly striated and have a single nucleus. 
2.5 Path of Blood through the Heart 
Deoxygenated blood enters the right atrium of the heart and flows in a forward 
direction to reach the right ventricle. When the ventricle is full, the tricuspid 
valve snaps shut and the ventricle contracts. This forces blood forwards into the 
lungs, via the pulmonary valve and arteries. Once in the lungs, carbon dioxide 
is efficiently removed and replaced with oxygen.  The blood is then pumped 
back into the left atrium of the heart, via the pulmonary veins, before flowing 
into the left ventricle. When the ventricle reaches capacity, the mitral valve 
snaps shut and the ventricle contracts (Figure 2.6). The oxygen-rich blood is 
forced out of the ventricle, via the aortic valve. It flows through the aortic arch 
(Figure 2.7) and into the descending aorta to be distributed to the rest of the 
circulatory system. Under normal physiological conditions, the volume of blood 
pumped out of the right atrium at the start of this process is equal to the 
volume of blood returned to it via the circulatory system [3]. 
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Figure 2.6 The path of blood through the heart (1–10). 
 
Figure 2.7: Blood leaves the heart through the aortic arch. 
Aortic arch 
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2.6 The Coronary Arteries 
The first vessels to branch off from the aorta are the right and left coronary 
arteries [4] (Figure 2.8). These relatively narrow vessels provide the only supply 
of oxygen to the myocardium, and therefore any blockage of these vessels is 
critical. The left coronary artery is usually larger than the right coronary artery 
as it supplies the major part of the heart [5]. The arteries divide to form 
arterioles and capillaries similar to those found elsewhere in the body.  
 
Figure 2.8 The coronary arteries provide essential blood and nutrients to the myocardium. 
2.7 Blood Pressure 
Blood flows through the chambers of a healthy heart at different pressures. 
Blood entering the right ventricle develops low pressures of ~25mmHg, whilst 
the blood returning from the pulmonary veins into the left atrium would 
typically have a pressure of ~80mmHg. However, blood leaving the left 
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ventricle needs to successfully travel around the whole of the circulatory system 
and therefore, typically reaches pressures of ~120mmHg. The values quoted for 
left atria and ventricle would correspond to a normal blood pressure reading of 
120/80mmHg. 
2.8 The Cardiac Cycle 
The heart expands and contracts in a synchronised fashion that maximises its 
pumping efficiency, and constitutes the cardiac cycle. During each heart-beat, 
the right and left atria contract simultaneously, whilst the ventricles elongate 
and fill (ventricular diastole). This is followed in quick succession by the 
simultaneous contraction of the ventricles (ventricular systole) [6] before the 
heart returns to its resting state. 
2.9 The Electrocardiogram 
An electrocardiogram (ECG) is a recording of the electrical changes in the 
myocardial muscle during the cardiac cycle and has significant diagnostic 
benefits in a clinical context. The normal heart produces a typical waveform 
(normal sinus rhythm) that consists of five deflection waves, universally known 
as the PQRST complex [7] (Figure 2.9). The P wave is detected as a result of the 
contraction of the atrial myocardium, whilst the QRS complex results from the 
contraction of the larger ventricular myocardium. Finally, as the heart returns 
to an electrically resting state, the T wave is detected. 
Chapter 2|The Human Heart 
Page | 58  
 
 
 
 
Figure 2.9 The normal heart produces a typical waveform consisting of five deflecting waves. 
2.10 Diseases of the Heart  
Heart diseases can present in a number of ways, depending on the nature of the 
underlying disease process and whether the disease process results in impaired 
cardiac function, coronary insufficiency or rhythm disturbances [8]. Not all 
cardiac diseases are relevant to the research carried out for the purpose of this, 
but the cause and effect of those that are have been listed below. 
2.10.1 Coronary Artery Disease 
The volume of blood flowing in a given portion of myocardium per unit of time 
is formally known as myocardial perfusion [9]. A myocardial perfusion deficit 
is a reduction in the blood flow to the myocardium (ischemia) and is indicative 
of coronary artery disease (CAD) [10]. Coronary artery disease is a chronic 
progressive disorder of the coronary arteries. It begins with the build-up of 
fatty material and cholesterol in the blood vessels. This attracts fibrous tissue 
and calcium, which harden into plaques, resulting in thickening of the artery 
walls (Figure 2.10). Plaques can break off, altering the endothelial layer and 
causing a thrombus (or blood clot) to form within the cardiovascular system 
P 
PR 
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[11]. This can partially or totally block (occlude) the coronary arteries, a process 
known as atherosclerosis. The section of myocardium fed by the affected vessel 
may be rendered virtually bloodless (infarcted) and thus the supply of oxygen 
and nutrients to the body may be greatly restricted.  
 
Figure 2.10 Fatty materials and cholesterol can build up in the blood vessels  
Under normal resting conditions, the myocardium can recover almost 
completely from 10–15 minutes of ischemia as the myocytes remain viable [12]. 
However, certain changes do take place in the myocardium, such as post-
ischemic contractile dysfunction, which refers to abnormal mechanical 
properties of the ventricle wall.  
Severe and prolonged ischemia can lead to the destruction of cell membranes 
and consequently, cell death [13]. Non-viable myocytes cause tissue scarring 
(myocardial infarction, MI) and irreversible contractile dysfunction. Myocardial 
Time 
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infarction progresses through the myocardium in a wave-like fashion. It starts 
at the sub-endocardium and progressing through the mid-myocardium, before 
finally reaching the sub-epicardium. Timely clinical intervention has the 
potential to prevent the progress of the infarction through the myocardium and 
thus preserve some contractile function in the myocardial wall segment fed by 
the occluded vessel or vessels.  
2.10.2 Valve Disease 
Disease, congenital defects and age-related changes can all affect the ability of 
the heart valves to open and close correctly. The mitral and aortic valves are 
more prone to these changes than the tricuspid and pulmonary valves due to 
the increased pressure (and hence, greater workload) on the left side of the 
heart [14].  
Cusps can become rigid, thickened, or fused together; resulting in a narrowing 
or stenosis of the valve and subsequent backing-up of blood in the  
preceding chamber. Where a valve fails to close properly, blood is forced  
in a backwards direction through the heart by the contracting atrium or 
ventricle. Both of these scenarios significantly increase the size and the 
workload of the heart, which has to pump out an extra volume of blood  
with each beat.  
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2.10.3 Left Ventricular Hypertrophy 
Left ventricular hypertrophy is an enlargement of the left ventricle of the  
heart and is a result of any chronic disease process that increases the  
pressure that the left ventricle has to generate in order to pump blood out  
of the heart (afterload) [8]. The mass of the myocardium increases as 
myocardial muscle fibres thicken (Figure 2.11). This increases the distance by 
which oxygen has to diffuse from the capillaries, eventually leading to impaired 
oxygenation of the centre of the fibre. This hypoxia is believed to be an 
important factor in the fibrosis that frequently develops in hypertrophied 
muscle [8]. Left ventricular hypertrophy is most commonly the result of 
uncontrolled hypertension. Previous studies have found a strong linear and 
independent link between increased LV mass and cardiovascular risk in 
patients [15, 16].  
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Figure 2.11 Left ventricular hypertrophy is an enlargement of the left ventricle of the heart. 
2.10.4 Cardiac Arrhythmias  
Cardiac arrhythmia is a term used to describe an abnormal heart rhythm. The 
heart rate may be too slow, too fast, or too irregular. The main cause of 
arrhythmias is injured myocytes, which interfere with the electrical activity of 
the heart. This electrical disequilibrium impairs the synchrony of the heart and 
impacts on the efficiency of the cardiac cycle. Consequently, the supply of 
oxygen and nutrients to the body is reduced. 
2.10.5 Heart Failure 
Heart failure is a major complication of many heart diseases. It is a syndrome 
defined by the symptoms resulting from diminished contractility and/or the 
loss of contractile tissue. The volume of blood leaving the right ventricle does 
  
Chapter 2|The Human Heart 
Page | 63  
 
not equal that leaving the left ventricle. Hence, blood backs up, engorging the 
veins in the lungs and other parts of the body. The supply of blood and 
nutrients to the body is significantly reduced. Heart failure is a deadly disease 
that has reached epidemic proportions in industrialised countries [17].  
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3. The Development of Cardiac Magnetic Resonance Imaging  
Current cardiac magnetic resonance imaging (CMRI) is virtually  
unrecognisable from the primitive scans of the 1980s. Significant  
advancements have transformed CMRI from a lengthy, complicated,  
artefact-prone technique that was largely avoided by clinicians, into an  
essential clinical tool that has recently emerged as the accepted gold  
standard imaging modality for cardiac mass, function and myocardial viability 
[1, 2]. 
 
 
 
 
 
 
 
Figure 3.1 A 3.0T MRI scanner and a volunteer encased in a combination of surface coils. 
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3.1 Hardware Developments 
Speed and efficiency are a fundamental requirement of successful CMRI 
because of the associated physiological motion and flow constraints. These 
requirements were the motivating force for many developments involving 
advanced CMRI hardware and software. We begin this chapter with a 
discussion on the main hardware developments before moving on to the 
software developments and cardiac application that have contributed to the 
transformation of CMRI. 
3.1.1 Higher Fields 
Progression in CMRI has been intimately related to the rapid historical 
increments in the magnitude of the external magnetic field. The first clinical 
whole-body scanner, constructed in Aberdeen in 1980, had a static magnetic 
field strength of 0.04 Tesla (T). By 1998, researchers at The Ohio State 
University, USA, had designed and assembled the world’s first 8T whole-body 
scanner [3] although the primary components were manufactured by different 
well established instrumentation companies. More recently, the University of 
Illinois, USA, developed a whole-body scanner with a main magnetic field 
strength of 9.4T.  
Presently, MRI scanners with field strengths in excess of 4T can only be used for 
research purposes due to strict international regulations that were introduced to 
protect the patient [4]. When this limit was introduced in 2002 there was an 
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immediately shift in 3.0T systems from the research to the clinical setting [5] 
after approximately 15 years of optimisation.  
Field strengths in the Tesla range would not have been possible without the 
introduction of niobium-titanium alloy superconducting magnets in the early 
1980s. These magnets have greatly improved magnetic field stability and 
homogeneity compared to those of the air or iron core electromagnets that 
preceded them [6]. 
The cardiac images obtained for the purpose of this research were acquired 
using a 1.5T Siemens Avanto and a 3.0T Siemens Trio (Figure 3.1). Fields of 
these magnitudes are considered crucial for CMRI as they provide the essential 
combination of spatial and temporal resolution. In addition to this, both 
systems are equipped with top-of-the- range gradient systems.  
3.1.2 Gradient Capabilities  
Cardiac imaging requires high performance gradients in order to take 
advantage of the potential for faster imaging and to provide images of a beating 
heart that have sufficient spatial resolution for diagnostic purposes. Thus, 
gradient performance has been another focus of intense research and 
development over the past three decades.  
Gradient strengths have increased from 10mT/m in the 1980s to 50mT/m today, 
whilst current slew rate limits are in the order of 200Tm-1s-1.  
Chapter 3|The Development of CMRI  
Page | 69  
 
However, gradient systems are now considered to be at human physiological 
limits because of peripheral nerve stimulation [7], which occurs when rapidly 
switching gradients induce electric fields in the tissue of the patient. This shifts 
the charge in the nerve fibres and stimulates peripheral nerves. Peripheral 
nerve stimulation can be avoided by restricting the exposure of the patient or 
volunteer to pulsed magnetic fields below a magnitude of 20 Ts-1. This 
corresponds to a current density of 400mAm-1.  
3.1.3 Phased Array Coils 
Due to the restrictions on gradient performance, other techniques were 
explored and developed in a continuing bid to improve temporal resolution. 
One such development was the design and implementation of phased array coil 
technology in the late 1980s (Figure 3.2). The first multi-element coil was a 
simple two-element array. Since then, phased array coil technology has 
developed at an efficient pace and now state-of-the-art coil systems with up to 
32 elements are available in the clinical setting.  
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Figure 3.2 Phased array coil technology helps to improve spatial and temporal resolution. 
Phased array coil technology has not yet reached its full potential. Scientists are 
continuing to design, develop and perfect systems with an ever increasing 
numbers of array coil elements [8]. As each element of an array coil must be 
attached to a separate independent receiver channel (to minimise coupling 
between the elements), magnet manufacturers have had to quickly respond to 
this technology by increasing the number of available channels in their MRI 
receivers [9, 10]. 
Phased array technology has successfully improved the spatial and temporal 
resolution of cardiac imaging, but just as importantly, it has also provided the 
necessary hardware for parallel imaging techniques.  
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3.1.4 Parallel Imaging 
The concept of parallel imaging (PI) was introduced between the years of 1987 
and 1993 [11–13] as a means of compensating for the severe limitations resulting 
from gradient capabilities. The initial idea of parallel imaging was to achieve 
ultra-fast imaging by eliminating the time-consuming phase encoding steps 
required to build an MR image. This was thought to be achievable by exploiting 
the differences in sensitivities between the multiple individual coil elements in 
a receive array. However, it soon became apparent that there was a 
fundamental and practical limit to the number of phase encodes possible using 
this technique [14]. Hence, a new strategy for parallel imaging was successfully 
developed, which uses the spatial information inherent in an array coil to allow 
a reduction in phase encoding steps. [15]. Although this technique is formally 
known as partially parallel imaging (PPI) in a bid to differentiate it from the 
earlier technique, it is commonly referred to as parallel imaging.  
3.1.5 Nyquist Criteria 
Loosely sampling the MRI data by reducing the number of phase encoding 
steps violates the Nyquist criteria if the sampling rate is less than twice that of 
the highest frequency expected. This would result in a reduction in the field of 
view if spatial resolution is not to be compromised [16]. For this reason, parallel 
imaging applies various reconstruction techniques to reconstruct full images 
from the sub sampled data. These techniques recover the sampling to the 
Nyquist rate by exploiting spatial or temporal correlations [17]. 
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Practical implementation of PI techniques began in 1997 with the introduction 
of simultaneous acquisition of spatial harmonics (SMASH) [18]. SMASH 
performs image reconstruction in the k-space domain by using coil sensitivity 
maps from the image domain to determine the reconstruction parameters.  
The introduction of this technique attracted enthusiastic interest from the  
MRI community due to the fact that it was proposed and implemented  
in cardiac imaging, which is considered one of the most challenging MRI 
disciplines [19].  
The introduction of other novel PI techniques quickly followed. These 
techniques included two of the most popular and successful PI techniques to 
date: sensitivity encoding for fast MRI (SENSE) was introduced in 1999 [20] and 
generalised autocalibrating partially parallel acquisitions (GRAPPA) in 2002 
[21]. With SENSE the coil reference data and the sub-sampled MRI data are 
operated on in the image domain to produce the final image whilst with 
GRAPPA, all data are operated on in the k-space domain. GRAPPA and SENSE 
both provide good results [22] and are now widely available on commercial 
scanners.  
Parallel imaging in combination with phased array coil technology considerably 
enhances the performance of CMRI by reducing acquisition times, speeding up 
fast imaging techniques and reducing flow and motion artefacts. PI is 
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particularly beneficial at high fields as the reduced scanning times make it 
easier for the operator to remain within specific absorption rate (SAR) 
thresholds [23].  
3.2 Software Developments 
Over the past three decades there has been a rapid growth in the number and 
type of pulse sequences available in a bid to meet the growing demand for new 
applications. The class of sequences that have now become standard in a 
cardiac imaging protocol will be discussed in Chapter 5 of this thesis. However, 
special mention must be given at this point to a one of these rapid imaging 
sequences that is based on a fast gradient echo acquisitions known as balanced 
steady-state free precession (SSFP). SSFP sequences provide excellent SNR and 
T2/T1 contrast allowing the generation of exceptional contrast between blood 
and muscle, regardless of flow.  
3.2.1 K-Space 
As previously mentioned, the conventional way to fill k-space was in a linear or 
sequential fashion, one horizontal line at a time. Each line of the k-space matrix 
required a new echo and hence, a new excitation pulse. K-space could be filled 
from the bottom (linear) or from the top (reverse linear) with the centre line of 
k-space always being acquired in the middle. This was a lengthy process with 
spin echo techniques as a sufficient ‘wait time’ is necessary between excitation 
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pulses to allow the net magnetisation vector to recover enough to produce a 
detectable signal with the next RF pulse. 
The introduction of gradient echo techniques in 1991 helped address this 
problem as their reduced flip angles improved temporal resolution by reducing 
the required wait time (as partial flips need less time to relax back into 
equilibrium than 90 or 180 pulses) [24].  
3.2.2 K-Space Segmentation 
Similar developments since then have looked at filling k-space in a more time 
efficient manner [25]. Multi-echo imaging uses a single excitation pulse to create 
a train of echoes, each of which is used to simultaneously fill a line of k-space. 
For example, a train containing four echoes would fill k-space four times faster 
than conventional k-space filling. An added advantage of this technique is that 
it can also be used to determine the contrast of an image as each of the echoes in 
the train will have a different TE. Hence, placing the first echo in the centre of 
K-space will provide a proton density weighted image, whilst placing the last 
echo in the centre of k-space provides a heavily T2-weighted image.  
Another novel technique exploited the conjugate symmetry of k-space in a bid 
to improve temporal resolution. Simply by collecting slightly more than the 
second half of the echo only (fractional echo), just over one half of k-space could 
be filled and the fractional data flipped to fill the whole of k-space. In the same 
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way, the whole echo could be used to fill just slightly more than the top or 
bottom of k-space, before the data is flipped to fill the whole of k-space.  
Although these techniques provide full resolution data, they do impact on the 
SNR. However, SNR could be increased by increasing the number of times the 
signal was sampled (averages). These k-space techniques had a major impact on 
CMRI as they significantly reduced acquisition times from 3–5 minutes for four 
to five slices, to just a few seconds [26].  
3.2.3 Echo Planar Imaging 
Echo planar imaging (EPI) [27] is the fastest imaging method available at 
present. EPI acquires multiple lines of imaging data after a single RF pulse. 
There are a number of different EPI methods available that differ in the way 
that they efficiently fill k-space. For example, single shot EPI can fill k-space in a 
blipped (blipped phase encoding) or constant (constant phase encoding) way. 
Single shot techniques fill the whole of k-space in a single TR, effectively 
eliminating any degree of T1 weighting in the image. Hence image contrast 
depends on proton density and T2.  
Echo planar imaging is a technologically challenging technique that requires 
high performance gradient systems and special RF coils to minimise gradient 
induced Eddy currents. However, the introduction of these techniques allowed 
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images to be acquired in milliseconds rather than minutes, in some cases 
reflecting nearly a 10,000-fold gain in speed [28].  
3.3 Cardiac Applications 
It is not just hardware and software developments that have transformed 
CMRI. Certain applications have also contributed as they have had a major 
impact on the reduction of cardiac and respiratory motion artefacts. 
3.3.1 Breath-Holding Techniques 
Efficient k-space segmentation brought cine cardiac imaging into the realms of 
a single breath-hold, permitting the introduction of breath-holding techniques 
for most cardiac acquisitions. By instructing the patient to hold their breath at 
end-expiration, for the duration of an acquisition (typically around 15 seconds), 
respiratory motion-induced artefacts could be dramatically reduced.  
3.3.2 Gating and Triggering Techniques 
Cardiac gating and triggering techniques were first employed in CMRI in 1981 
[29] and introduced as a standard application 1984 [30]. Gating and triggering 
techniques significantly reduced motion artefact by correlating the acquisition 
of cardiac images at a specific phase of the cardiac cycle with a physiological 
signal from the patient; generally, an electrocardiogram (ECG) (Figure 3.3). 
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Figure 3.3 Cardiac gating significantly reduces motion artefact 
3.3.2.1 Prospective Triggering 
Prospective triggering utilises the preceding R wave of the QRS complex to 
trigger image acquisition during the subsequent R–R interval. This technique 
requires the image acquisition length to be shorter than the R–R interval, 
otherwise the next R wave will be ignored, prolonging acquisition times and 
potentially creating image artefacts. This technique is particularly useful 
whenever data acquisition is too slow to occur during a short fraction of the 
cardiac cycle.  
An unfortunate limitation of this technique is that it is not possible to capture 
the whole cardiac cycle. Hence, end of diastole and early atrial contraction are 
not acquired [31].   
3.3.2.2 Retrospective Gating 
Retrospective gating is particularly useful when acquiring images of the  
beating heart, as data is acquired continuously throughout the R–R interval  
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and then retrospectively matched to the patient’s ECG tracing. Retrospective 
gating does not require a trigger window, allowing irregular heartbeats  
to be rejected. Hence, this technique is valuable for alleviating the problems 
associated with arrhythmias where irregular heartbeats can fail to trigger  
image acquisition, potentially resulting in an inaccurate assessment of  
cardiac function.  
3.4 Contrast Agents 
The introduction of gadolinium-based contrast agents to CMRI [32] played a 
significant role in the overall success of the technique. Gadolinium (Gd) is a rare 
Earth element that has seven electrons in its outer shell, making it one of the 
most effective paramagnetic agents. Due to the extreme toxicity of free 
gadolinium, it is always chelated to diethylene triamine pentaacetic acid (Gd-
DTPA) for imaging purposes. This makes it non-toxic and easily cleared via the 
kidneys.  
 
 
 
 
Figure 3.4 Dotarem is a gadolinium-based contrast agent used frequently in MRI. 
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Gd-DTPA is administered intravenously and rapidly diffuses from the  
vascular space to the extracellular space due to its small molecular size of 550 
Da. It enhances imaging by shortening the T1 and T2 of tissues (although the 
decrease in T2 is very slight) through the interaction of its unpaired electrons 
with the Hydrogen nuclei in water. The effect on T1 is linearly proportional to 
the concentration of the agent.  
 
ic
TT 1
1
1
1
 CR 
1
 
(1) 
Where T1c is the T1 of the tissue after the administration of Gd-DTPA, T1i is the 
inherent T1 of the tissue, R is the relaxivity of Gd-DTPA (~4.5L/mmol/s) and C 
is the concentration of Gd-DTPA. 
3.5 Conclusion 
 The hardware, software and cardiac applications discussed in this chapter have 
all made a significant contribution to the successful development of CMRI as a 
powerful imaging tool. Many of the techniques mentioned continue to develop 
at an efficient pace with the ultimate goal of providing real-time cardiac 
imaging.  
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4. The Advantages, Challenges and Limitations of Imaging at 
3.0T in Comparison to 1.5T 
4.1 Introduction 
Two MRI scanners with similar high-end gradient systems were used for the 
purpose of this research; a 1.5T Avanto that had been installed 6 years prior to 
the start of this work, and a 3.0T Trio that was installed 1 year after it 
commenced. Both systems were manufactured and installed by Siemens 
Medical Solutions (Erlangen, Germany). 
Cardiac imaging at 1.5T has been established for many years. This allowed us to 
use the Avanto to look at disease related changes in the right ventricle of the 
human heart using a previously optimised CMRI protocol (chapter 6). 
However, when the Trio was installed a year into the start of this research, 
CMRI at 3.0T was still relatively new. For this reason, the studies carried out in 
Chapters 7 and 8 of this thesis had to initially focus on image optimisation at 
this field strength. 
Cardiac imaging at 3.0T is immediately advantageous for the gain in SNR but it 
also presents many limitations and challenges. This chapter discusses the pros 
and explains the cons of imaging at 3.0T in comparison to 1.5T. 
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4.2 Technical Details of the Magnetic Fields  
The technical details of the main, RF and gradient magnetic fields of each 
system are listed in tables 4.1–4.3.  
Table 4.1 External Magnetic Field. 
Scanner Avanto Trio 
Operating Strength (Tesla) 1.5 3.0 
Superconductor Niobium-Titanium Niobium-Titanium 
Stability Over Time (ppm/h) < 0.1 < 0.1 
 
Table 4.2 Gradient Magnetic Field Performance per Axis. 
Scanner 
Engine 
Avanto 
(76 x 32)SQ 
Trio 
(102 x 32)TQ 
Max. Amplitude (mT/m)  45* or 40      45* or 40  
Min. Rise Time in μsec (mT/m)  200 (0–40)   200 (0–40)  
Max, Slew Rate  (T/m/s) 200                200               
*DSV, diameter spherical volume (x,y,z) direction. 
Table 4.3 Radiofrequency (RF) System. 
Scannner Avanto Trio 
Peak Power of Transmit Amplifier (kW) 15 35 
Transmitter Bandwidth (kHz) 500 800 
Receiver Bandwidth per channel (Hz) 500-1x106 500-1x106  
Maximum Applied RF Field (μT) 30.0 24.7 
 
4.3 The Images 
Magnetic resonance images are composed of a distribution of voxels, each of 
which is comprised of a mixture of signal power and random or systematic 
Chapter 5|CMRI Protocols 
Page | 85  
 
noise. The ratio between this signal and noise [signal-to-noise ratio (SNR)] is of 
paramount importance for determining the image quality.  
4.4 The Signal 
As discussed briefly in chapter 1 of this thesis, the signal in MRI comes from the 
precession of the net magnetisation vector Mxy. The precessing vector produces 
a time-varying magnetic flux that induces a voltage or electromotive force (emf) 
in an appropriately positioned receiver coil [1], According to the principle of 
reciprocity this can be considered as equivalent to a constant flux, produced by 
a unit current that is flowing around a receive coil and that penetrates the 
precessing magnetisation of the sample. Thus, the emf induced in the coil is 
given by [2]:   
 
rd
dt
d
emf BM
3)(
1

   
(4.1) 
Where B1 is the time varying magnetic flux produced by the receiver coil per 
unit current. The vectors M and B1 form the dot product. 
In an ideal system, (ignoring any spin–spin interactions and field 
inhomogeneities) the signal in each voxel of an MR image can be quantified as a 
function of the transverse magnetisation in equilibrium (M0), the centre 
frequency (0), the B1 magnetic field and the voxel size (Vs = x, y, z) [2].  
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By substituting for M0 (Eq. 1.5) and the Larmor relationship (Eq. 1.6), the signal 
gain can be shown to be proportional to the square of B0. Thus, by imaging at 
3.0T rather than 1.5T we should anticipate a theoretical four-fold increase in 
signal.  
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(4.3) 
4.5 The Noise 
This noise emf in an MR image is uniformly distributed over all frequencies and 
increases as the square of the Larmor frequency at high fields [3]. It is 
dominated by Johnson or ‘white’ noise [4], which is a consequence of the 
thermally driven Brownian motion of electrons within the patient’s tissue and 
within the receiver coil. Human tissue contains many electrolytes that are 
essential for normal cell function and movement of these ions generates weak 
electric currents within the body.  
The noise emf in MRI is proportional to the square root of the receiver 
bandwidth (BWr) [5] and is influenced by averaging parameters, such as the 
number of signal averages (NSA), the number of phase encoding (NPE) steps 
and the number of frequency encoding (NFE) steps used to create the image. 
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Noise from the coils in MRI comes in the form of electrical noise (from the 
receiving circuit and other external noise contributions). Electrical noise is 
present in all electrical conductors and is a result of random fluctuations in 
electrical currents [6]. However, the coils used today in MRI are highly 
optimised and as a result of this, electrical noise contributions are now 
considered trivial. 
The variance, or random fluctuations, of the noise voltage gives a measure of 
the quality of the MR data. Noise variance is also a crucial parameter in image 
processing algorithms such as noise reduction [7]. The equation used to 
calculate noise variance in MRI is a very fundamental and widely used 
expression. It is presented here without proof as [8]:  
  2)var( 
noise
emf
reff
BWkTR4  (4.5) 
Where Reff is the effective resistance of the receiver coil loaded with the patient. 
4.5.1 Signal-to-Noise Ratio 
Taking the theoretical four-fold increase in signal into consideration, and 
offsetting it with the associated linear increase in noise, there is an expected 
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doubling in signal-to-noise ratio (SNR) between 1.5T and 3.0T under ideal 
imaging conditions and optimised acquisition techniques [9].  
However, CMRI is never performed under ideal imaging conditions due to the 
challenges of motion and flow associated with the heart. In addition to this, 
there are further challenges associated with CMRI at 3.0T which include specific 
absorption rate limits, external field inhomogeneities, susceptibility effects and 
tissue relaxation times. These challenges have to be taken into consideration as 
they can all impact on image quality, and correcting for them is nearly always 
at the expense of SNR. In practice, the actual gain in SNR between 1.5T and 3.0T 
is usually around 40% with CMRI [10]. This is still a very desirable signal gain 
and it can be further enhanced by adjusting certain parameters during imaging. 
For example, the SNR is inversely proportional to the square root of the 
bandwidth (BW) and proportional to the square root of the number of phase-
encoding steps (Ny) and the number of excitations (NEX): 
 
BW
NEXN
epixelvolumSNR
y
)(  (4.6) 
4.6 The Advantages of CMRI at 3.0T 
The gain in SNR is the driving force behind cardiac imaging at 3.0T as it can be 
utilised to facilitate higher spatial and/or temporal resolution than was 
previously possible at 1.5T.  During the image optimisation at 3.0T the 
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preference was to utilise the increased SNR to improve temporal resolution. 
Thus, where possible, two to three image slices were acquired per breath-hold 
at 3.0T in comparison to one to two slices per breath-hold at 1.5T. Increasing 
temporal resolution provides obvious advantages for volumetric coverage of 
the heart as it reduces imaging times, and thus decreases the likelihood of 
motion and flow induced artefacts.  
4.7 The Challenges and Limitations of CMRI at 3.0T 
The challenges and limitations of CMRI at 3.0T are reflected in its relatively 
slow acceptance at this field strength [11]. A fundamental reason for many of 
these challenges and limitations is the linear increase in resonance frequencies, 
as determined by the Larmor equation. Frequencies increase from 63.9MHz at 
1.5T to 127.8MHz at 3.0T and this increase impacts on many physical 
parameters, some of which are described below. These challenges and 
limitations had to be considered when optimising left ventricular and left atrial 
imaging on the 3.0T Trio. 
4.7.1 Chemical Shift 
The bulk of the MRI signal comes from hydrogen nuclei in the form of water 
molecules; however other molecules also contribute to the MR signal, including 
hydrogen nuclei in fatty tissues (lipids). Fat molecules differ considerably in 
structure and size from water molecules as each fat molecule contains 10–20 
carbon atoms and each carbon atom has two hydrogen atoms attached to it.  
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Figure 4.3 The magnetic field that molecules experience is determined by their chemical environment 
When water and fat molecules are placed within a strong magnetic field, their 
electrons circulate within their atomic orbits, inducing a small magnetic field Bi. 
Depending on the electronic structure of the molecule, this induced field will 
act to increase or oppose B0 (Figure 4.3) [12]. Thus, water and fat molecules 
experience a magnetic field (B) that is determined by both their chemical 
environment and the magnitude of the applied field B0. The electron cloud 
around fat molecules acts to reduce the strength of B0 and a consequence of this 
is that the hydrogen atoms in fat molecules have a lower Larmor frequency 
than the hydrogen atoms in water molecules, which have less chemical 
shielding.  
 )1(
00
 BBBB
i
 (4.8) 
Where  is the shielding constant of proportionality between B0 and Bi. 
B0 B0(1-) 
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The difference is only 3.5 parts per million (ppm) but it often results in chemical 
shift artefact where fat and water protons with the same spatial location in 
tissue emit different signals, and as a consequence of this, fat signals are shifted 
by a number of pixels in the frequency encoding direction of the image. This 
manifests on the image as a hypo-intense band of one or more pixels in width, 
towards the higher frequencies (due to the subtraction of the fat and water 
signals) and a hyper-intense band towards the lower frequencies (due to the 
addition of overlapping water and fat signals) (Figure 4.4b).  
Chemical shift artefact of this type occurs with spin echo and gradient echo 
pulse sequences and scales linearly with field strength. It is usually expressed in 
Hertz or parts per million (ppm):  
 
0
6105.3
2
B


   
(4.9) 
 
 
 
 
 
Figure 4.4a Overhead view of a phantom containing a bag of butter (lhs), a cup of oil, and a bag  
of fat (rhs). 
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Figure 4.4b The phantom in 4.4a has been filled with water and imaged at a bandwidth of 780Hz/ pixel to 
show areas of hyper- and hypo-enhancement in the frequency encoding direction (arrow). 
4.7.2 Chemical Shift of the Second Kind 
The linear increase in resonant frequencies between 1.5T and 3T can also result 
in a second type of chemical shift artfact when gradient echo techniques are 
used. Immediately after the RF excitation pulse is applied, fat and water 
molecules precess in phase. However, due to the difference in their resonant 
frequencies, they quickly begin to precess in and out of phase with each other. 
At 1.5T, the hydrogen atoms in fat and water precess in-phase at an echo time 
(TE) = 0msec, 4.5msec etc., and out of phase at a TE = 2.25msec, 6.75msec etc 
(4.10).  
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 sec5.4220/1/1 mHzfT   (4.10) 
 sec3.2440/1/1 mHzfT   (4.11) 
At 3.0T, this periodicity is almost halved (4.11) making it more difficult for the 
operator to ensure that the echo time falls at a desired point in the cycle when 
the fat and water atoms are in phase. 
 When water and fat are in phase, the signals add together and no artefact 
occurs. Conversely, when they are out of phase, a signal cancellation occurs and 
leads to a ‘boundary effect’ artefact on images; so-called as the artefact 
manifests itself as a dark boundary along water–fat interfaces (in particular, 
organs that are surrounded with fat).  
A number of techniques are available to eliminate or reduce chemical shift 
artefacts. For example, the severity of the chemical shift artefact is dependent on 
the receiver bandwidth used for imaging. Therefore, it is possible to avoid this 
artefact by increasing the receiver bandwidth, but this will be at the expense of 
SNR as doubling the receiver bandwidth reduces the SNR by 2 (approximately 
30%). However, this may be acceptable at 3.0T due to the increased SNR 
available.  
Other options for reducing or eliminating chemical shift artefact include 
increasing the strength of the frequency encoding gradient to make subtle 
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differences to the Larmor frequency less relevant or, in the case of the first type 
of chemical shift artefact, simply switching the phase and frequency encoding 
directions during imaging.  
4.7.3 Dielectric Effect 
The propagation velocity of the electromagnetic wave can be considered 
independent of the frequency in MRI. Hence, the wavelength of the RF 
excitation pulse (B1 field) decreases with increasing field strength.  
It is estimated that the RF wavelength () is ~ 234cm in free space. However, the 
dielectric constant for biological tissue is high, ranging from between 10 and 
100, and this reduces the wavelength of the RF excitation pulse as it enters the 
body by the inverse of the square root of the constant [13]. Hence, it is estimated 
that  at 3.0T is reduced from ~234cm in free space to about 25–30cm in human 
tissue, making it comparable to human body dimensions. This ‘dielectric effect’ 
can lead to standing wave patterns within the body cavity as the short RF 
wavelength interferes with its own reflection due to the boundary between air 
and water. Constructive and destructive interferences of the transmitted RF 
field give rise to regional brightening or regional signal loss in the image.  
4.7.4 B1 Inhomogeneities  
The reduction in the RF wavelength at 3T also impacts on B1 penetration, and 
often results in a non-uniform absorption across the patient. As expected,  
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measurements have shown that the B1 field is more inhomogeneous for cardiac 
imaging at 3.0T in comparison to 1.5T [14, 15]. This increases the likelihood of 
image artefacts and can also result in non-uniform flip angles across the 
imaging volume. In a recent study, flip angles and hence the RF power setting 
in CMRI, were found to be 20% lower than requested for a flip angle of 60 [16]. 
These incorrect power settings are problematic as they can result in the failure 
of magnetisation preparation pulses and consequently produce biased 
quantitative measurements [17].   
4.7.5 Changes in Power Deposition and the Impact on SAR limitations 
SAR thresholds are the same for 1.5T and 3T however the power required to 
create a fixed B1 amplitude quadruples from 1.5T to 3.0T, due to the doubling in 
 
 = 234cm 
Inside Magnet Bore 
Patient Torso 
 
 = 30cm 
Free Space 
Figure 4.5 The dielectric effect can result in standing wave patterns within the patient’s body  
cavity at 3.0T. 
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frequency. By reciprocity, the energy deposited in the tissue of the patient will 
also quadruple. 
 2
0 2
1
0
BP
SAR B dt
V Q


     
(4.12) 
Where P = power, V = volume of the coil, Q is the Q factor of the coil and µ0 is 
the permittivity of free space. 
 As discussed previously, increased receive bandwidths (BWr) are commonly 
used at 3T in a bid to reduce chemical shift artefacts. However, by doubling the 
BWr you double the SAR. So, potentially SAR can increase by a factor of 8 from 
1.5T and 3.0T. Other factors, such as the position of the patient with respect to 
the isocentre of the magnet and coil design, can also impact on SAR.  
Fortunately, a range of options are available to reduce the amount of RF energy 
deposited in human tissue allowing the operator to remain within the SAR 
limits. For this reason, imaging at 3T often involves compromises between the 
number of applied RF pulses, their duration time (dT), the magnitude of the flip 
angle () and the pulse repetition time (TR).   
 dTTB )(
1  (4.13) 
 
TR
SAR
2
  
(4.14) 
Chapter 5|CMRI Protocols 
Page | 97  
 
Parallel imaging can limit the SAR, as can the right choice of pulse sequence. 
The reduced flip angle of gradient echo pulse sequences are preferential to the 
90 and 180 flips angles used in spin echo sequences as they deposit less 
energy on the patient. 
4.7.6 Field Inhomogeneities and Susceptibility   
All MRI systems are defined in terms of their external magnetic field strengths. 
The homogeniety of these fields describes their uniformity and, hence their 
quality. Today’s high field superconducting systems have extremely 
homogenous external fields, particularly in the isocentre of the bore (Table 4.4).  
Table 4.4 Siemens Guaranteed Homogeniety of the External Field. 
(DSV) 1.5T Avanto (ppm) 3.0T Trio (ppm) 
50 cm <1.50 <1.50 
45 cm <1.00 <0.50 
40 cm <0.75 <0.20 
30 cm <0.50 <0.10 
20 cm <0.25 <0.02 
10 cm <0.05 <0.002 
This table contains guaranteed values based on a highly accurate 24-plane plot. DSV = Diameter Spherical 
Volume (x, y, and z direction). 
Very small variations in the external field will always exist, even in an ideal 
magnet, however they are now so small in today’s superconducting magnets 
that they are measured in parts per million (ppm). 
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4.7.7 Susceptibility Effects 
Magnetic susceptibility () is a measure of the response of a substance to an 
applied magnetic field.  Substances are divided into one of three main groups 
depending on their susceptibilities: paramagnetic, diamagnetic and 
ferromagnetic. The extent of a substance’s susceptibility is determined by the 
degree to which its electrons become magnetised and align with or against the 
external magnetic field.  
Human tissue is ~99% diamagnetic. However, different human tissues exhibit 
different levels of magnetic susceptibility and this induces tiny internal 
gradients (Bi) at the interface of different tissue types and between tissue and 
air-filled structures (such as the lungs). These gradients substantially increase 
the dephasing rate () of the spins on both sides of the interface. The phase 
change caused by magnetic susceptibility at time TE is given by: 
 TEB
i
   (4.15) 
The increased dephasing produces B0 field inhomogeneities (B0), signal loss, 
off resonance effects (where signals have the ‘wrong’ resonant frequency), and 
ultimately, image artefacts. Susceptibility induced inhomogeneities scale 
linearly with field strength, doubling between 1.5T and 3.0T [18].  
 
00
BB   (4.16) 
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Tissue-related susceptibility artefacts can be quite subtle on images, as the 
signal tends to be reduced rather than eliminated. These artefacts can be 
minimised in a number of different ways. For example, reducing the pixel size 
of an image makes it less likely that voxels will contain tissues with different 
susceptibilities. Another option is to restrict the dephasing time of the spins by 
selecting a short TE or opting for a spin echo pulse sequence with its 180 
refocusing pulse.  
4.7.8 Metal Artefact 
Ferromagnetic materials, such as nickel, iron and cobalt, are strongly attracted 
to a magnetic field and become permanently magnetised when exposed to this 
environment. A small percentage of patients presenting for a CMRI exam will 
have ferromagnetic materials within their bodies, usually in the form of surgical 
clips and devices or shrapnel. These implants may experience a torque in the 
presence of B0, and hence there are important safety issues regarding the 
management of such patients. This has been a challenge at 3T, as safety 
assessments established for imaging at 1.5T cannot be automatically 
extrapolated to 3.0T [19].  
Chapter 5|CMRI Protocols 
Page | 100  
 
 
 
 
However, safety information on such  
 
However, information on the ‘MRI compatibility’ of medical implants and 
devices at 3.0T is becoming more readily available as more and more centres 
carry out routine imaging at this field strength. 
Ferromagnetic materials also cause significant geometric distortions during 
imaging. This is commonly seen as an area of zero signal surrounded by one or 
two partial high intensity rims at the edges (Figure 4.6) [20].  
4.7.9 Shimming 
Hardware solutions such as active shimming can also reduce susceptibility 
artefacts by applying linear gradients to correct B0 inhomogeneities. Recently, 
higher order shimming has been introduced that can improve magnetic field 
homogeneity in a specific region of interest such as the heart. This has been 
particularly beneficial at 3.0T.  
 
Figure 4.6 (a) A ferromagnetic Capio suture. (b) The image distortion caused by the suture at 1.5T . 
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4.7.10 Parallel imaging  
As mentioned previously (3.1.4), parallel imaging speeds image acquisitions by 
utilising the additional spatial encoding information provided by phased array 
coil technology to reduce the number of time-consuming phase encoding steps 
needed to construct an image.  
Parallel imaging techniques are beneficial at 1.5T and 3.0T as they reduce the 
length of the echo train, and thus reduce the build-up of phase errors. A 
disadvantage of this technology is that the reduced imaging time results in a 
decreased SNR that is approximately equal to the square root of the time saved. 
For example, by using parallel imaging to reduce a scan time by a factor of two, 
the SNR would be reduced by a factor of at least 2.   
Parallel imaging at 3.0T has the potential to compensate for this reduction by 
exploiting the SNR gain at this field strength to reduce the imaging time by a 
factor of two whilst providing the same SNR available at 1.5T. 
At present, parallel imaging methods are limited to acceleration factors of 
around three in most two-dimensional (2D) imaging situations at 3.0T. This is a 
result of the nonorthogonality of coil-encoding leads increasing the spatially 
varying noise amplification beyond the inherent increase in noise from 
undersampling only. However, recent work on dynamic imaging has 
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demonstrated the feasibility of acceleration factors greater than three with 
methods that exploit spatial and temporal data correlations jointly. 
4.7.11 Coils 
Both receiver-only and transmit-receive coils have to be tuned to the resonance 
frequency of the system they are used with, so coils used at 1.5T cannot be used 
at 3T.  Although the number of accessory-receiving coils has been limited in the 
past, the coil availability problem is now completely resolved due to more 
engineering developments being applied to 3T. 
4.7.12 The Magnetohydrodynamic Effect 
Blood is an ionic fluid and when the ionic velocity vectors of flowing blood 
within large blood vessels lie perpendicular to a strong external magnetic field, 
a charge separation will occur. This results in the establishment of an electric 
field (Faraday’s law). This interaction of flowing blood with the high external 
magnetic field is known as the Magnetohydrodynamic (MHD) effect [21]. 
 The MHD effect only became of interest with the introduction of cardiac 
imaging, around the mid 1980s. This was due to the transverse alignment of the 
aortic arch with respect to the high external magnetic field. 
The greatest impact from the MHD effect is during systole, when the flow of 
blood into the aortic arch is greatest. This phase of the cardiac cycle correlates 
with the S-T segment of the ECG trace (figure 4.7) and therefore, the MHD 
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effect can result in an elevation of the T wave. Imaging is designed to be 
triggered by each R wave, but if the T-wave is similar in magnitude to the R 
wave, imaging can be prematurely triggered resulting in image blurring 
artefacts. 
 
 
 
 
 
The MHD effect is field-dependent and therefore myocardial motion 
suppression becomes more challenging at 3.0T in comparison to 1.5T as a result 
of the magneto-hydrodynamic effect. 
4.7.13 Vector Cardiogram 
Recently, vector cardiogram (VECG) has been introduced to CMRI. This 
technique greatly reduces the interference of the MHD effect on aortic flow by 
examining the 3D orientation of the ECG signal and using the calculated vector 
of the QRS complex as a filter mechanism. This permits electrical signals that 
occur at a similar timing in the cardiac cycle, or those of a similar magnitude, 
Figure 4.7 The MHD effect can elevate the T-wave on the ECG trace to a similar magnitude to the R 
wave resulting in false triggering and image blurring. 
 
ST 
T 
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but of a different vector to be excluded. This technique can reduce or eliminate 
the possibility of the T wave being misinterpreted as the R wave. 
4.7.14 Contrast to Noise Ratio 
Image contrast is defined as the absolute difference in signal intensities 
generated by two different tissue types (SA-SB). T1, T2, T2* relaxation rates and 
proton density provide the most basic contrast generating mechanism in MRI as 
they naturally vary with tissue type. A high contrast-to-noise (CNR) between 
two tissue types (CNRAB) is desirable as it allows subtle signal differences 
between normal and diseased tissue (SA-SB) to be detected above the noise 
standard deviation (SD).  
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
 
(4.17) 
The increased SNR at 3.0T should result in a higher CNR, although this is not 
guaranteed.  
4.8 The Changes in Tissue Relaxation Times 
Tissue relaxation rates are known to be dependent on field strength. Previous 
studies have highlighted an increase in T1 relaxation rates with increasing field 
strength [22–24] as the associated increase in Larmor frequency means fewer 
protons are tumbling at or near ω0, so fewer protons are available to transfer 
energy efficiently to the lattice. As expected, T1 increases with field strength are 
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not consistent across all tissue types. For example, the T1 of myocardium was 
shown to increase by 43% from 1030msec at 1.5T to 1471msec at 3.0T, whilst the 
T1 of blood increased by 34% from 1441msec at 1.5T to 1932msec at 3.0T [25].  
T2 relaxation rates are considered stable between 1.5T and 3.0T as the very 
small decreases found have no impact on imaging [25, 26]. However, an 
increased field strength impacts on T2* values to a much greater degree due to 
the effects on other parameters, particularly susceptibility.  
The changes in relaxation rates need to be considered for the successful design 
and implementation of pulse sequences at higher fields. Sequence parameters 
such as such as the repetition time (TR), echo time (TE) and acquisition 
bandwidth need to be optimised for successful CMRI imaging at 3.0T [27].   
4.9 Contrast Enhancement 
The relaxation rates of gadolinium-based contrast agents have been shown to 
decrease with increasing field strength [28]. These changes slightly reduce the 
T1 shortening caused by the contrast agent; however, this has little impact on 
imaging at 3.0T.  
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5. Cardiac Magnetic Resonance Imaging Protocols 
5.1 Introduction 
Each of the patients and volunteers discussed in chapters 6–9 of this thesis were 
imaged using a pre-selected CMRI protocol. Imaging protocols consists of a 
‘recipe’ of pulse sequences that are specifically selected to answer a particular 
clinical or research question. This chapter provides a brief explanation of the 
basic physics behind two fast gradient echo techniques commonly used in 
cardiac MR imaging, known as True fast imaging with steady-state (TrueFISP) 
and Turbo fast low angle shot (TurboFLASH) (both Siemens Medical Solutions, 
Erlangen, Germany). Following on from this, the cardiac images acquired for 
this research using TrueFISP and TurboFLASH techniques are discussed along 
with the reasons for acquiring these images. Where appropriate, the clinical 
information obtained from these images is also detailed. 
5.2 Fast Gradient Echo 
TrueFISP and TurboFLASH are variations of the conventional gradient echo 
technique discussed in chapter 1 of this thesis. These techniques use very short 
TR values (TR<T2<T1 of the tissues) and small flip angles to shorten acquisition 
times. A consequence of the short TR value is that a small amount of transverse 
magnetisation exists at the end of each sequence cycle. TrueFISP and 
TurboFLASH differ in the way that they deal with this residual magnetisation. 
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5.3 TrueFISP 
TrueFISP belongs to a class of sequences known as balanced steady-state in free 
precession (bSSFP). These techniques have transformed CMRI as they offer 
significant improvements on spatial and temporal resolution, coupled with 
higher tissue contrast, when compared to other CMRI sequences [1, 2]. Balanced 
SSFP sequences are defined by the coexistence of constant, non-zero 
longitudinal and transverse magnetisation vectors throughout the whole of the 
sequence cycle. In order to achieve this equilibrium position, and to enhance 
SNR, bSSFP techniques recycle the residual magnetisation. 
5.3.1 Equilibrium 
It takes several steps to establish a balanced steady-state. Initially, an α/2 
preparation pulse is applied to partially flip the longitudinal magnetisation 
vector (M0) into the x–y plane, creating a transverse magnetisation vector (Mxy) 
(Figure 5.1).  
 
 
Figure 5.1 An α/2 pulse partially flips the longitudinal magnetisation vector into the x–y plane. 
α/2 
M0 
Mxy 
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After the RF pulse is withdrawn, Mxy begins to de-phase (decay) generating an 
FID. With no further intervention, the FID would rapidly decay away to zero 
due to several factors associated with relaxation and precession. These include 
T1 and T2 relaxation, the choice of flip angle (), phase rotation angle (), field 
in-homogeneities, susceptibility effects and gradient encoding.  The decay 
process is halted by the rapid application of a -α pulse at TR/2 (TR/2 < T2*) 
(Figure 5.2) that generates both an FID and a spin (or Hahn) echo (Figure 5.3).  
 
 
 
Figure 5.2 The preparation pulse is followed by a –α pulse at TR/2. 
The -α pulse is followed by a train of ±α pulses, each separated by a time period 
TR. This creates a succession of FIDs and spin echoes. If the flip angle, phase 
and TR remain constant throughout each cycle, a steady-state can be established 
within a few TRs [3]. 
-α 
M0 
-Mxy 
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Figure 5.3 A steady-state can be established after a few TR periods. 
5.3.2 Rewinder Gradient 
As the de-phasing and re-phasing rates of individual spins are equal, the peak 
of the spin echo from the initial /2 pulse occurs at exactly the same time as the 
application of the third  pulse (and so on throughout the sequence) (Figure 
5.3). This creates a potential problem as an MRI system cannot transmit an RF 
pulse and receive an echo signal at the same time due to hardware limitations. 
This issue is resolved by applying a rewinder gradient to prematurely refocus 
the transverse magnetisation. This ensures that each echo occurs prior to the 
next excitation pulse rather than during it (Figure 5.4).  
De-phasing Re-phasing 
FID 1 FID 2 FID 3 
RF pulse 3 RF pulse 2 RF pulse 1 
Spin echo 
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Figure 5.4 A rewinder gradient is applied to ensure the echo occurs before the application of the  
next RF pulse. 
5.3.3 Spatial Encoding 
TrueFISP is described as a ‘balanced’ SSFP sequence as each of the spatial 
encoding gradients are refocused (balanced) by gradients of equal and opposite 
polarity during the sequence cycle. This cancels any of the de-phasing effects 
that would normally be caused by the application of these gradients and 
ensures that the same precessional angle is achieved in each successive TR. This 
increases the available SNR.  Hence, the only source of phase accrual during 
each TR comes from off-resonance precession. 
5.3.4 The Signal 
Once in equilibrium, bSSFP techniques produce two types of signal. The FID 
provides a signal with mixed T1 and T2* weighting whilst the spin echo 
provides a signal that is strongly T2 weighted and has negligible T2* 
contributions [4]. Consequently, the amplitude of the signal is dependent on the 
T1/T2 ratio of the different tissues, the repetition time (TR), and the flip angle 
De-phasing TE 
 FID 2 FID 3 
RF pulse 3 RF pulse 2 
Spin echo 
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(α) of the RF excitation pulse. For a TR<<T1<<T2 the general solution for the 
signal intensity is (given without proof): [5]:  
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(5.1) 
Where E1,2 = e-TR/T1,T2, Mp is the proton density of the tissue and α is the flip angle. 
5.3.5 Optimal Flip Angle 
The optimal flip angle for bSSFP sequences can be calculated from [5] 
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With the signal generated being proportional to [6]: 
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(5.3) 
5.3.6 Optimal Signal 
An optimal signal can be obtained with bSSFP using flip angles in the range of 
45–80. The choice of flip angle determines the degree of steady-state. A larger 
flip angle will result in a larger amount of residual transverse magnetisation 
and hence, the greater the degree of steady-state.  
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5.3.7 Artefacts 
Because of the nature of SSFP sequences, they are very susceptible to artefacts 
caused by magnetic field in-homogeneities. Any non-uniformity in the main 
magnetic field can cause slight differences in the precessional frequencies of the 
spins in Mxy, resulting in the spins having different de-phasing rates. This can 
prevent the transverse magnetisation vector from fully refocusing at the end of 
each sequence cycle. So rather than each Mxy vector adding constructively to 
create an enhanced signal, the phase differences result in the vectors adding 
destructively, which manifests as a dark banding artefact across the image 
(Figure 5.5) [5]. For this reason, cardiac imaging with bSSFP is more demanding 
at 3.0T than 1.5T due to the increased challenges of maintaining a homogenous 
field across the heart at this field strength.  
 
 
 
 
Figure 5.5 Magnetic field in-homogeneities can produce dark banding artefact on images.  
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5.4 TurboFLASH 
TurboFLASH is described as a spoiled gradient echo sequence as an RF spoiler 
gradient is applied after each echo has been sampled to destroy residual 
transverse magnetisation and eliminate any T2 weighting. In addition to this, an 
inversion pulse (~100ms) is applied (followed by a delay) prior to imaging to 
improve spatial resolution and ensure that the images generated are heavily T1 
weighted.  
5.5 The Images 
Most of the images obtained for the purpose of this research were acquired 
using bSSFP techniques. For example, each of our CMRI protocols begin with 
the acquisition of a series of reference, localiser, and cine images that are all 
acquired using bSSFP sequence. 
5.5.1 Reference Images 
Reference images allow the operator to accurately locate the patient or 
volunteer’s heart within their chest cavity, as this is known to vary between 
individuals. These low resolution image slices are acquired rapidly (< 1sec) in 
the axial, coronal and sagittal planes. 
5.5.2 The Localisers 
Localiser images are acquired in the 2 chamber (2CH) (Figure 5.6a), 4 chamber 
(4CH) (Figure 5.6b) and short-axis (SA) (Figure 5.6c) views to satisfy an 
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agreement between the different imaging modalities that all cardiac images 
should be defined, oriented, and displayed using the true long axis of the  
left ventricle (4 chamber view) and selected planes orientated at 90 angles 
relative to it (2 chamber and short axis views). This standardisation was 
introduced in 2002 to ensure accurate and reproducible analysis of cardiac 
function and allow the comparison of functional data between the different 
imaging modalities.  
Localiser images are acquired using a single shot SSFP pulse sequence. The 
2CH localiser is planned using the axial reference image. The cut slice is 
positioned so that it lies in the middle of the left ventricle, parallel to the 
ventricular septum and roughly perpendicular with the plane of the mitral 
valve. 
The 2CH localiser is then used to plan the 4CH localiser. The cut slice is 
positioned so that it lies through the centre of the left ventricle, perpendicular to 
the mitral plane and the apex of the heart. The resulting image is a double-
oblique longitudinal axis view through the heart.  
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Figure 5.6a The reference axial image is used to plan the two chamber localiser. 
 
Figure 5.6b The two-chamber localiser is used to plan the four-chamber localiser. 
The 2CH and 4CH localisers are then used to plan a series of seven short-axis 
localiser slices. The cut slices are positioned so that they lie perpendicular to the 
ventricular septum and parallel to the mitral plane on the 4CH localiser. The 
operator then ensures that the imaging plane also lies perpendicular to the 2CH 
localiser. 
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Figure 5.6c Five short axis slices are planned using the two- and four-chamber localisers. 
5.6 Functional Imaging 
The localiser images are used to plan a series of high-resolution, cardiac-gated 
breath-hold cine images in the 4CH (Figure 5.7a), 2CH (Figure 5.7b) and SA 
(Figure 5.7c) views. Each cine series contains 25 frames providing an ECG gated 
account of the heart as it moves through the different phases of the cardiac 
cycle.  
 
 
 
 
 
 
Figure 5.7a The four-chamber cine is planned using the two-chamber and short-axis localisers. 
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Figure 5.7b The two-chamber cine is planned using the short-axis localiser and the four-chamber cine.  
 
 
 
Figure 5.7c A stack of short-axis cine images are planned using the four-chamber cine. The angulations of 
the cut slices lie perpendicular to the two-chamber cine. 
5.6.1 Clinical Information 
The localiser, 2CH and 4CH cine images are used to assess overall cardiac 
morphology in terms of cardiac chamber orientation, pericardial, aortic and 
pulmonary arterial anatomy. The SA cine images provide a visual assessment of 
left ventricular (LV) and right ventricular (RV) movement and an assessment of 
cardiac function (Chapter 6).  
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5.7 First Pass Perfusion Imaging 
First pass perfusion imaging plays a central role in the diagnosis, clinical 
management and prognosis of patients with known or suspected ischemic heart 
disease. First pass images are obtained using a 2D single-shot gradient echo 
technique (TurboFLASH) as it provides excellent visualisation of the first pass 
of a contrast agent as it transits through the cardiac chambers and into the 
myocardium (Figure 5.8).  
 
Figure 5.8 First pass perfusion images track a bolus of gadolinium-based contrast agent as it travel 
through the chamber of the heart and into the myocardium. 
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5.7.1 Clinical Information 
First pass perfusion images are used to help detect any flow limiting lesions in 
the coronary arteries and therefore, provide an accurate assessment of the 
functional status of the myocardial microcirculation. 
5.8 Post Processing of Cardiac Images 
The stack of short-axis cine images discussed above is post-processed by an 
MRI physicist on a remote workstation using the manufacturer’s software 
(Argus, Siemens Medical Solutions, Erlangen, Germany) to provide measures of 
end-diastolic volume (EDV), end systolic volume (ESV) stroke volume (SV), 
ejection fraction (EF), left ventricular mass (LVM) and cardiac output (CO).  
5.8.1 Cardiac Volumes 
End-diastolic and end-systolic volumes provide a measure of the volume of 
blood in the cardiac chambers when the heart is most dilated (diastole) and 
most contracted (systole). Stroke volume (SV) quantifies the difference between 
EDV and ESV and is therefore a measure of the volume of blood ejected from 
the chamber with each heartbeat.  
5.8.2 Cardiac Mass 
Ventricular mass is a measure of the ventricular myocardium from the base of 
the ventricle to the apex of the heart. The left ventricle has a much thicker 
myocardium than the other chambers of the heart due to its increased workload 
(Chapter 2). 
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5.8.3 Cardiac Output and Ejection Fraction 
The volume of blood pumped out of the ventricle each minute is termed the 
cardiac output (CO). It is the product of the SV and the number of times the 
heart beats per minute (heart rate). The ejection fraction (EF) quantifies the 
percentage of blood pumped out of the cardiac chamber with each heart beat. It 
is calculated using the SV and the EDV (5.1). The function of the heart is most 
commonly defined by the ejection fraction. 
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SV
EDV
ESVEDV
EF 

  
(5.1) 
Quantitative analysis of cardiac function traditionally focuses on the left 
ventricle (LV) of the heart, as it is the main pumping chamber. However, it is 
also possible to provide an equivalent assessment of right ventricular (RV) 
function (Chapter 6) and left atrial (Chapter 8) using the same short-axis stack 
of images.  
It is essential that short-axis image analysis is accurate and reproducible as the 
measures this semi-automated process provides are crucial in the evaluation of 
disease progression, response to therapy and appropriate clinical/surgical 
intervention. For this reason, intra- and inter-observer reproducibility 
measurements are an essential requirement of any functional CMRI study. 
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6. Assessment of clinical differences at 1.5T between quantitative 
right and left ventricular volumes and ejection fractions using MRI 
6.1 Introduction 
Cardiac MRI (CMRI) has excellent accuracy and reproducibility and is currently 
considered the gold standard modality for the assessment of left ventricular 
(LV) function and mass (LVM) [1, 2]. It is known that clinical assessment of 
right ventricular (RV) function can provide independent diagnostic and 
prognostic value in many congenital and acquired heart diseases [3]. The three-
dimensional (3D) volume acquisition of CMRI is well suited for determining 
right ventricular (RV) parameters [4], with previous studies [5, 6] establishing 
good RV reproducibility in healthy subjects and patients with various cardiac 
pathologies. However, CMRI assessment of right ventricular function is often 
neglected in the evaluation of cardiac function as the right ventricle's complex 
3D shape, [7] heavy trabeculations and irregular endocardial border all make 
assessment of right ventricular parameters more challenging.  
6.2 Aims 
This study had two aims:  
1. To perform right ventricular (RV) and left ventricular (LV) analysis on 
the short-axis images of three distinct clinical cohorts with the 
hypothesis that the inclusion of RV data may generate a more 
informative characterisation of cardiac function. 
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2. To assess the reproducibility between a novice segmenter, with 2 months 
experience of cardiac MRI (CMRI) analysis (physicist 1) and  
an experienced segmenter with 4 years CMRI analysis experience 
(physicist 2).  
6.3 Cohorts 
The thirty subjects enrolled in this study were individually assigned to one of 
three distinct cohorts, each containing nine Males (M) and one female (F):  
 Group A, consisting of normal healthy volunteers (NHV), with a mean 
age of 32 and age range of 24–42 years, selected from individuals with no 
known cardiac history or underlying health condition.  
 Group B, consisting of patients diagnosed with congestive heart failure 
(CHF), with a mean age of 73 and age range of 59–83 years, selected from 
individuals clinically diagnosed with left ventricular systolic dysfunction 
as demonstrated using echocardiography.  
 Group C, consisting of patients diagnosed with left ventricular 
hypertrophy (LVH), with a mean age of 65 and age range of 52–78 years, 
selected from individuals clinically diagnosed by echocardiography.  
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6.4 Acquisition Protocol 
All magnetic resonance imaging was performed on a 1.5 Tesla whole-body 
system (Magnetom Avanto Scanner, Siemens Medical Solutions, Erlangen, 
Germany). A combination of body matrix and spine matrix radio frequency 
coils and a two-dimensional, prospective cardiac-gated, breath-hold, segmented 
True-FISP Cine sequence were used to acquire a series of standard short-axis 
plane images, from the base of the ventricle to the apex of the heart. The 
imaging parameters used were: TR 38.25 msec, TE 1.08 msec, and flip angle  
(60°–70°). Acquisition time was reduced using parallel imaging acceleration 
factor (GRAPPA) of two, allowing one or two slices to be acquired per breath-
hold, depending on patient/volunteer ability to sustain breath-hold. A slice 
thickness of 6mm and inter-slice gap of 4mm was used consistently throughout 
this study. The selected in-plane resolution was 192 pixels over an optimal field 
of view (FOV) ranging from 340 to 450 mm, depending on patient/volunteer 
size.  
6.5 Image Analysis 
Images were transferred to a remote Leonardo workstation where analysis was 
performed using ARGUS software (version VA60C; Siemens Medical Solutions, 
Erlangen, Germany) by two MRI segmenters. Each segmenter independently 
defined endocardial and epicardial myocardial borders on all LV images from 
base to apex, corresponding to end-diastole (ED) and end-systole (ES). On RV 
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images, endocardial borders were defined independently from base to apex, 
corresponding to ED and ES (Figure 6.1). 
 
 
 
 
Figure 6.1 Contours were defined independently on the right and left ventricles. 
Segmentation rules defining appropriate inclusion and exclusion of papillary 
muscles as well as appropriate basal slice selection were discussed prior to 
analysis with the aim of providing consistency between segmenters. In cases 
where it was impossible to distinguish the papillary muscle structure from the 
endocardial boundary it was agreed that those papillary muscles would be 
included within the endocardial contour.  
6.6 Statistical Analysis  
Statistical analysis was performed on data using SPSS (Chicago, Illinois, USA) 
in order to test for any significant changes in the parameters of end-diastolic 
volume (EDV), end-systolic volume (SV), stroke volume (SV) and ejectin 
fraction (EF) between the normal healthy volunteers and the two patient 
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cohorts. The mean values obtained by segmenters for both patient cohorts were 
compared to the mean values obtained for the healthy volunteers, using the 
paired t-test and assuming unequal variances. There were no systematic 
differences in the values obtained by the individual segmenters.  
6.7 Results 
Mean values ± SD were calculated for the left and right ventricular parameters 
of EDV, ESV, SV and EF using the individual values obtained by each 
segmenter. The results obtained by segmenter 1 for each clinical cohort are 
displayed in Table 6.1.  
Table 6.1 Mean Values  Standard Deviation (SD) for the LV and RV parameters of 
each cohort. 
Left Ventricle    
Cohort (n=10) NHV CHF LVH 
LV EF ± SD (%) 66.0 ± 6.4 30.3 ± 6.1 74.1 ± 7.6 
LV EDV ± SD (ml) 149.4 ± 32.2 244.6 ± 60.7 126.3 ± 42.4 
LV ESV ± SD (ml) 52.1 ± 18.8 158.6 ± 52.4 34.5 ± 15.0 
LV SV ± SD (ml) 97.3 ± 15.8 65.9 ± 15.4 91.8 ± 29.5 
Right Ventricle    
Cohort (n=10) NHV CHF LVH 
RV EF ± SD (%) 52.0 ± 4.6 45.0 ± 7.8 57.6 ± 6.4 
RV EDV ± SD (ml) 177.1 ± 28.3 135.94 ± 36.8 141.6 ± 40.7 
RV ESV ± SD (ml) 85.5 ± 20.1 74.7 ± 23.0 59.9 ± 19.6 
RV SV ± SD (ml) 91.3 ± 10.8 61.3 ± 18.5 81.7 ± 26.4 
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The ranges detailed in Table 6.1 fell within the ranges obtained by other groups 
carrying out similar work [5, 6].-Inter-observer reproducibility between 
segmenters, for each parameter, demonstrated a strong positive Pearson 
correlation (t-test), as detailed in Table 6.2.  
Table 6.2 Inter-observer Reproducibility. 
Inter-Observer NHV CHF LVH 
LV EF (P-Value) 0.98 0.89 0.91 
RV EF (P-Value) 0.80 0.91 0.96 
LV SV (P-Value) 0.96 0.80 0.96 
RV SV (P-Value) 0.87 0.79 0.95 
 
In all but one parameter, the diseased hearts displayed a larger range of values 
than those of the normal healthy volunteers. Ejection fraction values clearly 
varied to a much greater extent with disease than stroke volume values, as 
demonstrated in Table 6.1. 
When compared to the NHV group, patients with congestive heart failure 
exhibited a reduction in ejection fraction and stroke volume values for both left 
and right ventricles, whilst patients with left ventricular hypertrophy displayed 
elevated ejection fraction values but reduced stroke volume values for both 
ventricles.  
It was established that the CHF cohort demonstrated a significant reduction in 
ejection fraction and stroke volume values for both left and right ventricles 
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when compared to the NHV. The LVH cohort demonstrated a significant 
increase in ejection fraction values but no significant change in stroke volume 
values for both ventricles (Table 6.3).  
Table 6.3 The differences in the values obtained for the cardiac parameters of each 
cohort were compared using a student’s t-test.  
t-test values (LV) LV EF  LV EDV LV ESV  LV SV 
NHV v CHF <0.001 <0.005 <0.001 <0.001 
NHV v LVH <0.05 0.1 <0.05 0.6 
CHF v LVH <0.001 <0.001 <0.001 <0.05 
t-test values (RV) RV EF  RV EDV RV ESV  RV SV 
NHV v CHF <0.05 0.01 0.28 <0.001 
NHV v LVH <0.05 <0.05 <0.05 0.34 
CHF v LVH <0.001 0.74 0.1 0.06 
 
Overall, the most significant change in parameter was the reduction in CHF LV 
EF which, when compared to the NHV cohort, showed a dramatic reduction of 
p = 0.00000000002. This significant change led to the CHF patients in this study 
typically displaying a greater RV ejection fraction than LV ejection fraction 
(Figure 6.2). The increase in EF values for the LVH cohort was more significant 
for the right ventricle than for the left. 
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Figure 6.2: Displays: (1) Measures of LV EF, (2) Measure of RV EF, (3) LV minus RV EF. Blue = NHV; 
purple = CHF, white = LVH.  
6.8 Discussion 
Individuals were selected for each cohort based on their previous medical 
history. Although CHF patients can present with normal LV EF, the CHF 
patients selected for this study all had ejection fractions < 40%.  
6.8.1 Reproducibility 
Inter-observer reproducibility between segmenters was sufficiently low for a 
clinical study. Ejection fraction values proved more robust to inter-observer 
variation than stroke volume values. This was particularly evident when there 
was a discrepancy between segmenters as to the appropriate choice of basal 
slice selection in n = 4 datasets. Also, the majority of data sets used in this study 
were of good diagnostic quality, however in n = 3 cases poor image quality led 
to a slightly larger than expected variation in values between segmenters. A 
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decision was made to include these data sets in this study as it was believed 
that it led to a more realistic interpretation of a true clinical setting.  
6.8.2 Significant Changes in Cardiac Parameters 
The parameter of SV changed equally in the left and right ventricles of the CHF 
cohort when compared to the NHV cohort, with both ventricles showing 
significant changes. Significant changes in EF were also found in this cohort; 
however the change in EF was much more significant in the left ventricle than 
the right ventricle. The small reduction found in SV for the LVH cohort was not 
significant when compared to the NHV. The changes in EF in LVH cohort were 
found to be significant with the RV changing more significantly than the LV 
when compared to the NHV. 
6.9 Conclusion 
Our investigation has shown that ventricular analysis is accurate and reproduc-
ible even for the novice segmenter. It has also demonstrated that in addition to 
LV changes, RV function can display a more significant change than LV func-
tion in different clinical conditions. This finding provides further information 
on the simultaneous function of both ventricles that may be of assistance in 
guiding appropriate clinical intervention. 
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7. Normal Ranges of Left Ventricular Functional Parameters at 3 
Tesla 
7.1 Part 1 
The prevalence of heart disease in the general population rises with increasing 
age. Consequently, disease-related functional changes generally become 
problematic in individuals over the age of 60 years. In the research setting, it is 
common practice to quantify the magnitude of these changes by post-
processing the patient or volunteer’s CMRI short-axis cine images (Chapter 5) 
and comparing the calculated values with those of ‘normal healthy’ volunteers.  
Volunteers are considered to be normal and healthy if their calculated values of 
cardiac function fall within the ranges provided by the scanner manufacturer 
(Siemens Medical Solution, Erlangen, Germany) (Table 7.1). Any values that fall 
out with these ranges are considered abnormal and will therefore, be taken into 
consideration for the diagnosis, management and prognosis of the individual.  
The ranges provided by Siemens are generous. They are stratified for gender 
but not for age or field strength. This may be considered a limitation as a recent 
large (n = 400) multi-centre study, in which volunteers were divided by age, 
gender and ethnicity, [1] detected natural age related changes in cardiac 
function, which varied between race and gender. These findings highlighted a 
need to accurately determine age- and gender-specific normal ranges of cardiac 
Chapter 7|Normal Ranges of Left Ventricular Functional Parameters at 3 Tesla 
Page | 133  
 
function for local populations, as this may allow a more accurate assessment of 
cardiac function in patient and volunteer groups.  
Table 7.1 The normal ranges of cardiac function provided by Siemens Medical 
Solutions for images acquired at 1.5T and 3.0T. 
Calculated Parameter 1.5T Female 1.5T Male 3.0T Female 3.0T Male 
Ejection Fraction (%)  56–78 56–78 56–78 56–78 
End-diastolic Volume (ml) 52–141 77–195 52–141 77–195 
End-systolic Volume (ml) 13–51 19–72 13–51 19–72 
Stroke Volume (ml) 33–97 51–133 33–97 51–133 
Cardiac Output (l/min) 2.65–5.98 2.82–8.82 2.65–5.98 2.82–8.82 
LV Mass at End-diastole (g) 75–175 118–238 75–175 118–238 
 
Several other single-centre studies have produced normal ranges of cardiac 
function (Table 7.2). But these studies have been limited by their small cohort 
size [2–5] and/or limited age stratification [6–9].  
Hence, the initial aim of this study was to acquire and post-process the  
short-axis cine images for 100 normal healthy volunteers (NHV) at 3.0T with the 
aim of: 
 highlighting age and gender specific trends in the normal ranges of left 
ventricular (LV) ejection fraction (EF), end diastolic volume (EDV), end 
systolic volume (ESV), stroke volume (SV) and LV mass at end diastole 
(LVM) for our local population; 
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 comparing the ranges obtained for our local population with the universal 
ranges provided by Siemens. 
7.2 The Normal Healthy Volunteers 
A total of 100 informed and consenting normal healthy volunteers were 
recruited for this study. Those aged 40 years and over were chosen from an ‘at 
risk’ population of healthy volunteers participating in a large single-centre 
study* whilst the younger volunteers were recruited from healthy members of 
staff.  
7.2.1 Exclusion Criteria 
Exclusion criteria included any previous cardiac event or recognised cardiac 
disease, known alcohol abuse, pregnancy, claustrophobia, and any other known 
contraindication to MRI. 
7.2.2 The Cohorts 
The healthy volunteers were sub-divided into the following age and gender 
specific cohorts (Table 7.2). 
Chapter 7|Normal Ranges of Left Ventricular Functional Parameters at 3 Tesla 
Page | 135  
 
Table 7.2 The healthy volunteers were sub-divided into small age- and gender-specific 
ranges. 
Cohort Female NHV(n) Male NHV (n) 
20–39 years 10 10 
40–49 years 10 10 
50–59 years 10 10 
60–69 years 10 10 
70+ years 10 10 
 
7.3 Imaging Parameters 
Each volunteer was imaged using a 3T Magnetom Trio Scanner (Siemens, 
Erlangen, Germany) and a spine matrix and six element body array matrix coil. 
Multi-slice short-axis images (slice thickness 6mm, gap 4mm) were acquired 
from the base to the apex of the left ventricle using a cardiac-gated segmented 
cine TrueFISP sequence, 173×256 matrix, TR 3.2ms, TE 1.5ms, flip angle 50, and 
average field of view 140×171mm (depending on volunteer size) and a parallel 
imaging (GRAPPA) acceleration factor of 2. 
7.3.1 Image Optimisation 
Cardiac imaging proved more challenging at 3.0T than at 1.5T due to chemical 
shift artefact, SAR limitations, the magnetohydrodynamic effect and increased 
static field (B0) and transmit radiofrequency field (B1) in-homogeneities (Chapter 
4). To enable images of good diagnostic quality to be obtained for this study, 
two additional techniques were introduced that are not required for cardiac 
imaging at 1.5T.  
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7.3.2 Localised Shimming  
The increased field inhomogeneities at 3.0T demand a more precise shimming 
method. This was achieved by performing a localised volume (green box) shim 
over the heart region (Figure 7.1).  
 
Figure 7.1 A volume shim is performed prior to the acquisition of all cardiac images at 3T. 
7.3.3 Frequency Scout 
Even after volume shimming the increased B0 inhomogeneities proved 
particularly troublesome for steady-state sequences (Chapter 5). Small 
frequency shifts considerably reduced the transverse steady-state 
magnetisation, resulting in dark banding artefact across the images. It was not 
always possible to avoid these artefacts, but it was usually possible to move 
them out of the region of interest (ROI) by applying a frequency offset. The 
required frequency offset was chosen by performing a frequency scout to 
provide the operator with a series of images, each obtained at an incremental 
frequency (Figure 7.2). This allowed the centre frequency to be visually 
determined.  
Chapter 7|Normal Ranges of Left Ventricular Functional Parameters at 3 Tesla 
Page | 137  
 
 
Figure 7.2 A frequency scout provides a series of images rapidly acquired at incremental frequencies.  
7.4 Image Analysis  
Image analysis was performed on a Siemens multi-modality work station using 
ARGUS software (Siemens, version VB15). Semi-automated placement of 
endocardial and epicardial borders was completed on all slices pertaining to 
end-diastole and end-systole. Statistical analysis was carried out using Sigma 
Plot 10.0 statistical analysis package (SSI, San Jose, California).  
7.5 Calculated Values of Cardiac Function for the Age- and Gender-Defined Cohorts 
All images were successfully acquired over an 18-month period. The mean 
quantitative values ( standard deviation (SD) of EF, EDV, ESV, SV and LVM 
for the healthy volunteers are listed in Tables 7.3 (age-defined females) and 7.4 
(age defined males). 
-250Hz -200Hz -150Hz -100Hz 
-50Hz -0Hz 50Hz 100Hz 
150Hz 200Hz 250Hz 
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Table 7.3 Mean values ± SD for each age defined female cohort  
Female (NHV) 20–39 years 40–49 years 50–59 years 60–69 years 70+ years 
EF ± SD (%) 66.6 ± 6.2 67.9 ± 3.5 71.7 ± 7.0 72.2 ± 4.5 76.6 ± 4.51 
EDV ± SD (ml) 131.9 ± 12.3 124.4 ± 23.3 119.1 ± 19.9 104.3 ± 13.6 92.5 ± 11.9 
ESV ± SD (ml) 44.3 ± 10.9 39.8 ± 7.1 34.1 ± 11.6 29.0 ± 5.5 21.87 ± 5.8 
SV ± SD (ml) 87.6 ± 9.6 84.6 ± 18.2 84.9 ± 13.5 75.3 ± 11.0 70.62 ± 8.0 
LV mass ± SD (g) 89.7 ± 8.1 89.8 ± 22.4 88.61 ± 14.2 84.6 ± 13.0 89.11 ± 6.4 
 
Table 7.4 Mean values ± SD for each age defined male cohort 
Male (NHV) 20–39 years 40–49 years 50–59 years 60–69 years 70+ years 
EF  ±  SD (%) 66.6 ± 6.2 68.4 ± 6.7 70.4 ± 6.1 68.8 ± 6.8 69.15 ± 6.8 
EDV  ±  SD (ml) 131.9 ± 12.3 174.8 ± 19.2 158.0 ± 23.5 144.1 ± 29.6 128.9 ± 33.3 
ESV  ±  SD (ml) 44.3 ± 10.9 55.5 ± 13.8 47.7 ± 15.3 46.1 ± 16.1 40.6 ± 16.5 
SV  ±  SD (ml) 87.64 ± 9.6 119.3 ± 17.5 110.3 ± 11.9 98.0 ± 17.8 88.3 ± 20.0 
LV Mass  ±  SD (g) 89.7 ± 8.1 147.7 ± 17.1 145.1 ± 32.5 124.2 ± 23.4 122.4 ± 23.4 
 
7.6 Visual Analysis 
An initial visual comparison of the images failed to highlight any significant 
structural differences between the age and gender defined cohorts (Figure 7.3). 
 
Figure 7.3 A visual assessment of the female cohorts with age. 
20–39 years 40–49 years 50–59 years 60–69 years 70+ years 
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7.7 Discussion 
When the volunteers were defined into age- and gender-specific cohorts, the 
female volunteers displayed greater age-related reductions in their EDV and 
ESV than the male volunteers (30% v 22% and 50% v 25% respectively). 
However, all age- and gender-specific cohorts displayed similar reductions 
(20%) in stroke volume values over time. In addition to this, the female age-
specific volunteers demonstrated a significant increase in ejection fraction 
values (66.7% to 76.6%, p < 0.05) throughout the ageing process whilst the EF 
values of the age-defined male cohorts remained relatively consistent (68.4% to 
69.2%, p >> 0.05).  
Conversely, age- and gender-specific measures of LV mass remained stable 
throughout the aging process for the female cohorts but reduced significantly 
for male cohorts (133.6g to 122.4g, p < 0.05) over the same period. These 
observations closely reflect previous autopsy findings where males 
demonstrated decreasing left ventricular mass and progressive left ventricular 
myocyte loss with increasing age but female values remained constant [10].  
7.8 Conclusion 
This study demonstrated that, in addition to gender, age has a significant effect 
on the calculated mean LV quantitative parameters of our local population and 
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that these subtle age-related changes lie hidden in the generous ranges 
provided by Siemens.  
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7.9 Part 2 
Armed with this information, the final part of this study aimed to determine if 
comparing the mean values obtained from age- and gender-matched patient 
and NHV cohorts would provide a more informative assessment of cardiac 
function than that of the gender-specific ranges currently used.  
7.10 The Cohort 
A small cohort of 7 female (mean age and range = 54, 39–62 years) systemic 
lupus erythematosus patients were selected for this investigation.  
7.11 Image Analysis and Post-processing 
A short-axis stack of cine images was obtained for each SLE patient using 
identical imaging parameters to those detailed above for the healthy volunteer 
cohort. The images were then post-processed to obtain the calculated values of 
cardiac function detailed in Table 7.5.  
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Table 7.5 The calculated values of cardiac function for the SLE cohort. 
SLE Patient EF (%) EDV (ml) ESV (ml) SV (ml) LV Mass (g) 
1 66.0 107.6 36.6 71.0 89.7 
2 70.7 127.5 37.4 90.1 88.6 
3 73.7 138.1 36.4 101.8 107.3 
4 72.8 105.4 28.7 76.7 95.7 
5 73.0 86.9 23.5 63.5 85.1 
6 80.4 82.1 16.1 66.0 109.8 
7 77.1 108.8 24.9 83.9 93.9 
Mean  73.4 108.1 29.1 79.0 95.7 
SD 4.6 20.0 8.1 13.8 9.5 
Maximum 80.4 138.1 37.4 101.8 109.8 
Minimum 66.0 82.1 16.1 63.5 85.1 
All values of EF, EDV, SV and LV mass for the patient SLE cohort fell within both the normal ranges of 
cardiac function provided by Siemens and those calculated using our local population.  
7.12 Like for Like Comparison 
The SLE cohort was then compared to specifically chosen age- and gender-
matched cohort of seven NHV allowing their mean values of cardiac function to 
be compared. In addition to this, a student’s t-test (assuming equal variances) 
was performed on the individual values obtained for each patient and 
volunteer to determine if significant differences in cardiac function existed 
between the SLE and NHV cohorts (Table 7.6).  
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Table 7.6 Age- and gender-matched values were compared using a paired t-test. 
Parameter SLE (n=7) NHV (n=7) p value 
EF ± SD (%) 73.4 ± 4.6 70.7 ± 3.5 0.25 
EDV ± SD (ml) 108.1 ± 20.0 108.2 ± 14.5 0.99 
ESV ±  SD (ml) 29.1 ± 8.1 31.5 ± 5.3 0.53 
SV  ±  SD (ml) 79.0 ± 13.8 76.7 ± 14.6 0.77 
LV Mass  ±  SD (g) 95.7 ± 9.5 87.8 ± 8.0 0.04 
 
Comparing these age- and gender-matched cohorts revealed a significant 
increase in LV mass for the SLE cohort when compared to the NHV cohort (p < 
0.05). Mean values of EF and SV were also mildly elevated for the SLE cohort in 
comparison the NHV cohort (2.7% and 2.3ml respectively, p > 0.05) whilst 
measures of EDV volume were almost identical. Measure of ESV were mildly 
reduced for the SLE cohort in comparison to the NHV cohort (2.4 ml, p > 0.05).  
7.13 Conclusion  
The second part of this study has highlighted a significant change in LV mass 
between age- and gender-matched cohorts of SLE patients and NHV at 3.0T. 
This is of particular interest as the individual mass values for the SLE cohort all 
fall within the normal ranges provided by both Siemens and our local 
population. Hence, these significant changes would remain undetected using 
normal post-processing procedures. 
These findings suggest that age- and gender-matching patient groups to normal 
healthy volunteers may provide a more accurate assessment of cardiac function 
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and disease-related changes that potentially could assist early disease 
management and permit accurate tracking of disease progression over time.  
7.14 Future work 
This study was significantly limited by the size of the SLE cohort, which was 
out with the control of the department. Further investigations using larger 
patient groups are warranted to determine if this trend continues with larger 
patient numbers. 
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8. Left Atrial Dimensions as Determinants of Cardiac 
Dysfunction  
This chapter restricted at the authorʹs request
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9. The Impact of Contrast Agents on Quantitative Parameters in 
Cardiac MRI 
9.1 Introduction 
It is possible to obtain cardiac images of good diagnostic quality in high-field 
Cardiac MRI (CMRI) without the need for gadolinium-based contrast agents; 
however as previously discussed in this thesis, contrast agents are required 
during cardiac perfusion to aid the evaluation of different patterns of 
myocardial scarring seen in myocardial infarctions and cardiomyopathies [1]. 
Normally, the short-axis stack of images used to derive ventricular volumes 
and mass measurements is acquired before the administration of contrast agent. 
However, in studies where perfusion analysis is required, there is a temporal 
window of approximately 10 minutes available between ‘first pass’ and 
‘delayed enhancement’ acquisitions. This could potentially provide the 
opportunity to obtain short-axis left ventrical (LV) datasets during this period, 
thus minimising the length of time that the patient is in the scanner. 
Previous comparisons of spoiled-gradient echo and steady-state gradient echo 
sequences (e.g. FLASH and TrueFISP) for the assessment of LV function [2] 
have identified significant differences in the resulting LV variables on the basis 
of these different sequences and contrast mechanisms. More specific studies 
have also investigated the use of inversion recovery gradient-echo (IR-GRE) 
techniques for combined post-contrast perfusion and LV mass analysis in 
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children and patients (with and without previously documented myocardial 
infarcts) and these have been compared to pre-contrast steady state free 
precession (SSFP) methods [3, 4]. In this latter report, significant LV mass 
differences were identified between IR-GRE and SSFP for pre- and post-contrast 
LV mass assessment, with the SSFP sequence being validated as the more 
accurate measure of LV mass using ex-vivo methods. 
To date, previous assessments of pre- and post-contrast LV parameters have 
been undertaken using different pulse sequences only. Hence, this provided the 
motivation to examine possible perfusion differences using a single pulse 
sequence (SSFP) to establish if differences between LV variables might exist on 
the basis of whether the SSFP data were collected before or after the delivery of 
a gadolinium contrast agent. This research study specifically addresses left 
ventricular analysis at 3T in order to determine what effect the administration 
of contrast agent has on the calculated measurement of ejection fraction (EF), 
end diastolic volume (EDV), end systolic volume (ES), stroke volume (SV) and 
LV mass. A correct understanding of any such differences is deemed important, 
as MRI-derived normal human left and right ventricular ranges are routinely 
defined from pre-contrast short-axis images [5]. Identifying and acknowledging 
such differences may also allow the most appropriate post-scan clinical 
management of patients with LV dysfunction. 
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9.2 Methods and Materials 
Fifteen healthy volunteers, 8 females (average age 48 years, range 41–61 years), 
and 7 males (average age 59 years, range 48–71 years), with no previous history 
of atherosclerotic disease, primary muscle disease, statin therapy or serious 
illness were selected for imaging from a large database of individuals who were 
participating in a separate local MRI cardiovascular screening study known as 
TASCFORCE. Exclusion criteria included: age less than 40 years, known alcohol 
abuse, pregnancy, claustrophobia, and any other known contraindication to 
MRI. Approval for this study was obtained from the local ethics committee and 
volunteers provided written informed consent.  
This study was completed over a 5 month period with the pre- and post-
contrast stacks of short-axis images (slice thickness 6mm, inter-slice gap 4mm) 
for each volunteer being obtained during a single imaging session using a 3T 
Magnetom Trio MRI scanner (Siemens, Erlangen, Germany). Initially, pre-
contrast images were acquired (during end-expiration breath hold) from the 
atrio-ventricular ring to the apex of the heart, using a two-dimensional 
retrospectively-gated segmented 25 CINE frame TrueFISP sequence with spine 
matrix and six element body array matrix radio frequency (RF) coils. One or 
two slices were imaged per breath hold, depending on the R-R interval of the 
volunteer. Imaging parameters included an in plane data acquisition matrix of 
173 × 256 and a field of view ranging from 320 to 420mm, (depending on patient 
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size), TR 3.4ms, TE 1.5ms and flip angle 50. Post-contrast images (using the 
same imaging parameters) were subsequently obtained after intravenous 
injection of 10ml of gadolinium-based contrast agent (Dotarem, Villepinte, 
France) via a power injector (Spectris Solaris EP, MedRad Inc., Indianola, USA) 
followed by a saline flush of 20ml. Contrast was administered at a consistent 
rate (1.5ml/s) for all volunteers. The elapsed time between the administration of 
contrast agent and the acquisition of the mid-slice at end-diastole in the post-
contrast short-axis stack consistently fell between 4 and 5 minutes for each 
volunteer. 
9.3 Image Analysis 
Image analysis was performed on a remote Siemens multi-modality 
workstation using ARGUS software (version VB15). An MRI physicist with 4 
years’ experience of quantitative cardiac MRI analysis (segmenter 1) performed 
semi-automated placement of endocardial and epicardial myocardial borders, 
from base to apex, on all slices pertaining to end-diastole (Figure 1) and end-
systole. Each contour was defined by manually placing a circular region of 
interest (ROI) over each myocardial border and then invoking an automated 
edge-detection algorithm to optimise the placement of these contours. Finally, 
manual adjustment of each epicardial and endocardial contour was undertaken 
where required – thus ensuring optimised precision and consistency of contour 
placement. Papillary muscles and trabeculae were included in the left 
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ventricular mass when they were indistinguishable from the endocardial 
border, but otherwise they were assigned to the blood pool volume. Care was 
taken to ensure that slice selection at end-diastole and end-systole was 
consistent between the pre- and post-contrast images of each volunteer selected 
for this study, and images were retrospectively reviewed to ensure that the 
inclusion or exclusion of papillary muscles was consistent between the pre- and 
post-contrast images of each volunteer. 
 
Figure 9.1 A comparison of pre- and post-contrast short-axis images (at end-diastole) of one volunteer 
showing (a) pre-contrast administration and (b) post-contrast administration.  
Segmenter 1 repeated the analysis of ten randomly selected short-axis data-sets 
to establish intra-observer reproducibility. A second MR physicist segmenter 
with 6 years of cardiac MRI analysis experience (segmenter 2) repeated the 
analysis on seven data-sets from the study in order to establish inter-observer 
reproducibility. Segmenter knowledge/memory effects were minimised by 
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ensuring that no individual segmentations were repeated within a 1 month 
period. 
9.4 Statistical Testing 
Statistical testing for normality of data was undertaken using the  
Shapiro-Wilks test (SPSS, IBM Corporation, Somers, NY, USA), and 
subsequently the original and repeat values of each parameter were compared 
using a paired t-test (assuming equal variances) (Sigma Plot, version 10; Systat 
Software, Inc., San Jose, CA, USA). Results of the t-tests were deemed 
significant if p < 0.05. 
9.5 Results 
Initial inspection of the images showed subtle qualitative differences between 
the contrast of the myocardium, the blood pool and other surrounding tissues 
(Figure 1). Tables 9.1 & 9.2 contain the individual pre- and post-contrast 
measures of cardiac function calculated for each volunteer. 
Table 9.1 The pre-contrast measures of cardiac function for each volunteer 
 EF (%) EDV (ml) ESV (ml) SV (ml) LV Mass (g) 
1 76.54 102.95 24.16 78.79 70.49 
2 71.40 105.80 30.20 75.60 79.40 
3 65.73 104.91 35.95 68.96 69.93 
4 59.20 183.10 74.70 108.30 121.60 
5 63.20 176.60 65.00 111.70 125.00 
6 75.30 158.80 39.30 119.70 123.30 
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7 68.60 153.80 48.30 105.50 123.80 
8 62.60 138.70 51.80 86.90 94.20 
9 72.67 174.66 47.73 126.92 126.95 
10 72.02 120.27 33.66 86.62 94.21 
11 66.20 112.40 38.10 74.40 95.80 
12 79.40 104.10 21.50 82.50 92.40 
13 68.10 119.00 37.90 81.10 94.20 
14 70.60 166.30 49.20 118.10 146.50 
15 69.60 214.80 65.20 149.50 163.30 
 
Table 9.2 The post-contrast measures of cardiac function for each volunteer 
Post Contrast (n) EF (%) EDV (ml) ESV (ml) SV (ml) LV Mass (g) 
1 75.16 105.24 26.14 79.10 63.71 
2 70.40 107.50 31.60 75.80 77.80 
3 65.16 107.92 37.59 70.32 65.34 
4 60.51 182.89 72.22 110.66 116.10 
5 62.40 180.20 67.70 112.50 121.50 
6 73.55 157.21 41.57 115.63 119.06 
7 66.20 149.50 50.50 99.00 115.80 
8 61.80 138.70 53.00 85.70 89.80 
9 73.55 176.74 46.75 129.98 122.77 
10 70.80 122.44 35.75 86.69 84.74 
11 67.50 116.50 37.90 78.70 85.90 
12 78.40 107.60 23.20 84.40 83.00 
13 66.90 121.40 40.10 81.20 89.20 
14 69.70 165.00 49.90 115.00 135.20 
15 68.20 216.70 68.90 147.80 160.10 
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A significant reduction to the mean EF and LV mass parameters was noted 
following delivery of gadolinium contrast agent (Table 9.3). Additionally, a  
small but significant increase to the mean EDV and ESV parameters was  
also noted after contrast agent delivery. Individual values (i.e. on a  
per-volunteer basis) for LV mass were consistently lower for every volunteer 
following contrast agent, with reductions ranging from 1.6g to  
11.3g (mean/median: -6.1g/-5.0g). The EF in 12 out of 15 volunteers was also 
reduced, with post-minus pre-contrast values of all volunteers ranging from  
-2.4% to 1.3%, (mean/median: -0.7%/-1.0%). In contrast, the majority (n = 10)  
of calculated EDV and calculated ESV (n = 12) parameters displayed a small  
but significant increase with the administration of contrast agent, post-minus 
pre-contrast values ranged from -4.3ml to 4.1ml (mean/median: 1.3ml/2.1ml) 
and -2.5ml to 3.7ml (mean/median: 1.3ml/1.7ml) respectively. Stroke volume 
was found to be particularly stable; no mean pre- versus post-contrast change of 
any significance was noted. 
There was no correlation found between the age, sex, and body mass index of 
the volunteers and the extent of change between the calculated pre- and post-
contrast values obtained for each cardiac parameter. 
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Table 9.3 Results of analysis performed on pre- and post-contrast datasets by 
segmenter 1.  
Parameter Pre-contrast Post-contrast 
EF  SD (%) 69.4 ± 5.3 68.7 ± 5.0* 
EDV  SD (ml) 142.4 ± 34.5 143.7 ± 33.7* 
ESV  SD (ml) 44.2 ± 14.9 45.5 ± 14.6* 
SV  SD (ml) 98.3 ± 22.6 98.2 ± 21.9 
LV mass  SD (g) 108.1 ± 26.5 102.0 ± 26.6* 
Mean values  SD for all pre- and post-contrast cardiac parameters of ejection fraction (EF), end diastolic 
volume (EDV), end systolic volume (ES), stroke volume (SV) and left ventricular mass (LV mass).  
*denotes significant difference at p<0.05 level. 
9.5.1 Reproducibility 
Segmenter 1 carried out repeat analysis on four pre-contrast and six post-
contrast datasets in order to provide measurements of intra-observer 
reproducibility. Segmenter 2 performed repeat analysis on seven randomly 
selected pre-contrast datasets, previously analysed by segmenter 1, in order to 
determine inter-observer reproducibility. Full data for single time-point, test re-
test, repeated measures for each parameter made by segmenter 1 and segmenter 
2 are included in Table 9.4. 
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Table 9.4 Intra- and inter-observer reproducibility of pre- and post-contrast datasets.  
 Intra-observer analysis (n=10) Inter-observer analysis (n=7) 
Parameter First analysis Second analysis Segmenter 1 Segmenter 2 
EF  SD (%) 70.0  6.2 69.0  5.4   71.9  4.4 72.1  4.8 
EDV  SD (ml) 141.6  28.5 142.1  28.0 126.7  25.3 128.5  27.6 
ESV  SD (ml) 44.3  13.0 44.4  12.2 35.7  8.5 35.9  9.7 
SV  SD (ml) 97.3  19.8 97.8  19.9 91.2  19.4 92.6  20.1 
LV mass  SD (g) 108.7  19.7 108.4  19.6 103.7  23.0 105.0  20.7 
Segmenter 1 analysed 10 data sets twice whilst segmenter 2 performed repeat analysis on seven data sets 
previously analysed by segmenter 1. Data are presented for ejection fraction (EF), end diastolic volume 
(EDV), end systolic volume (ESV), stoke volume (SV) and left ventricular mass (LV mass) as mean  SD. 
No significant differences between the means of any of the parameters were identified. 
Bland Altman plots displaying the correlation in pre- and post-contrast 
measures of SV (Figure 2) and EF (Figure 3) highlight the stability between pre-
and post-contrast stroke volume values and the downward trend in ejection 
fraction values. Bland Altman plots also highlight the variation between pre- 
and post-contrast LV mass variables (Figure 4), and also the correlation 
between intra-observer measurement 1 and measurement 2 (Figure 5) and inter-
observer variation on measurement 1 (Figure 6). It can be seen that the spread 
of data in Figure 4 is greater than that in Figure 5, with the mean ‘shift from 
zero’ in Figure 4 highlighting the consistent post-contrast reduction in the LV 
mass values.  
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Figure 9.2 Correlation between pre- and post-contrast measures of SV values. 
 
 
 
 
 
Figure 2: Correlation between pre- and post-contrast measures of SV values. 
Figure 9.3 Correlation between pre- and post-contrast measures of EF. 
  
 
 
 
 
Figure 9.4 Correlation between pre- and post-contrast measures of LV mass. 
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Figure 9.5 Intra-observer reproducibility of LV mass measurements. 
 
 
 
 
 
 
 
 
Figure 9.6 Inter-observer reproducibility of LV mass measurements. 
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9.6 Discussion 
This study has demonstrated that significant changes to cardiac MRI values of 
EF, EDV, ESV and LV mass have been measured in this cohort of healthy 
volunteers, with the calculated values of EF and LV mass decreasing after 
contrast delivery, and EDV and ESV increasing after contrast delivery. The 
most significant of these changes was found between the pre-and post-contrast 
values of LV mass. 
These data appear to be consistent with the hypothesis that the administration 
of contrast agent leads to a change in the visual detection of the endocardial and 
epicardial borders during image analysis. The presence of contrast agent in the 
left ventricle improves the high-contrast detection of the endocardial border, 
and this appears to result in an LV mass reduction together with increased 
blood pool volumes during segmentation. However we do acknowledge that 
this has not been independently measured and it is not possible to eliminate 
other possible covariate effects. 
The relative differences between our pre-contrast and post-contrast LV mass 
measurements are very similar to those reported by Stephensen et al. [4]. This is 
reassuring from the point of view of study consistency, although our data 
suggest that LV mass differences arise from the presence of the contrast agent 
as opposed to the particular pulse sequence used. 
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The findings vary in their clinical significance. For example, if precise follow-up 
data are being assessed as part of a quantitative longitudinal study, then a 7g 
drop in LV mass is highly likely to be regarded as significant. However, if the 
data are being used for a quick single time-point quantitative assessment of a 
particular cardiac condition then these differences may be less important. We 
do acknowledge that the pre- and post-contrast differences between other 
parameters such as EF, EDV, etc. are far smaller, and as such we have reported 
these more from the perspective of an interesting and consistent observation. 
Care was taken to eliminate systematic errors and maintain consistency in the 
acquisition and analysis of all datasets – resulting in minimal intra- and inter-
observer variation. A single experienced segmenter carried out the analysis of 
all data sets for this study, as cardiac analysis (in particular LV mass) is known 
to be more reproducible for intra-observer assessments [6]. 
It is acknowledged that this study has some limitations. It is possible that a 
larger sample size might have resulted in the detection of more significant 
changes to each parameter, as the systematic differences reported in our work 
were rather small. It would also be advantageous to see whether the changes 
found could be replicated in patient groups. However, our sample size is 
consistent with other cardiac MRI studies of a similar nature [7, 8] and this was 
considered as part of the design phase of this work. 
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We acknowledge the fact that our ‘standard dose’ approach for contrast agent 
delivery is different from routine clinical practice in cardiac MRI perfusion 
where a weight-corrected dose would normally be delivered. The reason for 
this design compromise was due to the fact that this cardiac imaging was 
performed within the framework of a larger whole-body MRA investigation 
where a standard dose approach was required as part of this study design. 
Furthermore, from a clinical perspective the inclusion criteria for our subjects 
(see the Methods and Materials section) was such that a formal clinical 
assessment of cardiac perfusion involving weight-corrected dose was not 
deemed essential for this cohort. 
9.7 Conclusion 
In conclusion, this study has demonstrated that the administration of contrast 
agent in this cohort of healthy volunteers has significantly altered the calculated 
cardiac parameters of EF, EDV, ESV and particularly LV mass. Such changes 
should be considered correctly in the context of clinical decision-making in 
cardiac patients after CMRI perfusion examination when future therapy or 
intervention may be required. It is also recommended that image analysis is 
undertaken on either pre- or post-contrast datasets and that this choice is kept 
consistent for the case of repeat scans or longitudinal studies. 
This chapter is reproduced in part with the kind permission of the British Journal of 
Radiology, 85 (2012), e343–e347. 
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10. Conclusion 
This first half of this thesis reports on many of the key developments that have 
transformed cardiac magnetic resonance imaging (CMRI) from a slow, artefact-
prone technique that was difficult to master, into the clinically accepted gold 
standard modality for the assessment of cardiac function, mass and viability. 
Particular attention was given to the rapid increase in the magnitude of the 
main magnetic field, as high-field MRI provided the essential signal-to-noise 
(SNR) ratio essential for cardiac magnetic resonance imaging. The challenges 
and limitations associated with imaging at higher field strengths were also 
highlighted in a discussion on cardiac imaging at 3.0T in comparison to 1.5T. 
The second half of this thesis actively contributes to the continuing 
development of CMRI by presenting a number of novel studies that 
demonstrate the accuracy and sensitivity of CMRI to highlight age- and disease-
related changes in the human heart. The first of these studies was performed at 
1.5T and effectively validates that ventricular analysis is accurate and 
reproducible, even for the novice segmenter. This study also establishes that in 
addition to LV changes, RV function can display a more significant change than 
LV function in different clinical conditions. These findings provide further 
information on the simultaneous function of both ventricles that may be of 
assistance in guiding appropriate clinical intervention.  
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(Oral Presentation 1 and 4; Poster Presentation 1 and 5). 
The focus of the thesis then shifts to a newly installed 3.0T system. The initial 
aim of this work was to provide age- and gender-specific normal ranges of 
cardiac function for our local population. This study revealed that in addition to 
gender stratification, age stratification can provided a more accurate assessment 
of cardiac function. 
A subsequent investigation at 3.0T established that the MRI-derived 
quantitative measurements of LA function are reproducible and able to 
distinguish clear structural and functional differences between healthy 
individuals and patients with left ventricular hypertrophy. This holds promise 
for possible future identification of early cardiac remodelling in clinical cohorts 
with non-diagnosed but ‘high risk’ cardiovascular disease. These LA endpoints 
may also be useful for monitoring of cardiac structure and function in response 
to intervention.  
(Poster Presentation 4; Publication Submission 1) 
Finally, research into the administration of contrast agent on the quantitative 
parameters of a cohort of healthy volunteers demonstrated that it significantly 
alters the calculated cardiac parameters of ejection fraction (EF), end-diastolic 
volume (EDV), end-systolic function (ESV) and particularly left ventricular 
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mass (LV mass). These changes should be considered correctly in the context of 
clinical decision-making in cardiac patients after CMRI perfusion examination 
when future therapy or intervention may be required. Further, they highlight 
that image analysis should be undertaken on either pre- or post-contrast 
datasets and that this choice be kept consistent for the case of repeat scans or 
longitudinal studies. 
(Poster Presentation 2 and 3; Publication 1)  
10.1 Future Developments 
Cardiac magnetic resonance imaging is still an area of intensive research. For 
example, there is substantial interest in the evaluation of the coronary arteries, 
as the non-ionising, non-invasive nature of CMRI makes it ideally suited to 
assess disease progression over decades in ‘at risk’ populations. This has the 
potential to improve patient outcome as it would permit active disease 
management. However, the coronary arteries are tiny vessels and accurate 
imaging on this scale is presently limited by inadequate spatial and temporal 
resolution, even at 3.0T. However, ultra-high field 7T systems are being 
optimised in the research setting and ultimately promise to provide even 
greater speed and efficiency than today’s 1.5T and 3.0T clinical scanners. The 
additional SNR available at this field strength can be used to improve and 
streamline structural and functional imaging and to potentially bring us one 
step closer to real-time, high resolution cardiac imaging. Real time imaging 
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would eliminate the need for cardiac gating, reduce breath-holds and permit 
faster patient throughput, making CMRI less challenging, more patient-friendly 
and more cost-effective.  
Current research is also actively focused on novel contrast agents. These agents 
have targeting capabilities considered superior to conventional contrast agents 
as they have the potential is to provide atherosclerotic plaque characterisation 
to distinguish between fatty plaque (which is more likely to rupture) and 
calcified, fibrous plaque (which tends to be more stable).  
We have established that CMRI can accurately detect subtle disease-related 
changes in the human heart. If we can also achieve the goals discussed in future 
developments, then CMRI would have the unique ability to offer a non-
invasive, non-ionising full cardiac assessment of morphology, function, 
viability and coronary artery patency (with plaque characterisation) within a 
single imaging session. This would ultimately set CMRI above all other cardiac 
imaging modalities, including CT angiography.  
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10.2 Present and Future Work 
The experience gained during this research has provided a sound platform for 
current work. This includes a study that complements the research detailed in 
chapter 9 of this thesis by providing a semi-quantitative assessment of the first 
pass of contrast agent as it passes through the cardiac chambers and 
myocardium of 67 clinical patients, imaged at 1.5T. This work will highlight the 
impact of cardiac disease on the transit time of contrast agent (Dotarem, 
Guerbet, Paris, France) and the ‘time to peak’ and peak signal intensity in the 
myocardium during first pass.  
Delayed enhancement imaging was also performed on all 67 volunteers. These 
images will be used to assess myocardial viability [myocardium that still has 
the ability to contract (viable) versus myocardium that is replaced by fibrosis or 
scar tissue (non-viable)]. Delayed enhancement images are acquired between 10 
and 15 minutes after the administration of the contrast agent. This time delay is 
an essential requirement as it allows the contrast agent to exit the blood vessels 
and diffuse freely through the extravascular, extracellular space. As gadolinium 
is hydrophilic, it cannot pass through the intact membranes of healthy 
myocytes. However, in areas of scarring and fibrosis, the membrane integrity is 
often compromised allowing the contrast agent to enter the cell, where is 
becomes trapped for a short period of time. Hence, by nulling the signal from 
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normal myocardium, areas of scarring and fibrosis will appear hyper-enhanced 
on delayed enhancement images.  
The final part of this project aims to investigate the correlation between initial 
myocardial enhancement during first pass and any areas of focal hyper-
enhancement in the delayed enhancement images of our patient groups. 
(Conflict of interest: This study is funded by Guerbet.) 
The research detailed in Chapter 6 of this thesis demonstrated that CMRI can 
accurately define disease related changes in the right ventricle of the human 
heart. Following on from this research, a CMRI pilot study is underway to test 
the hypothesis that a widely available and economical licenced drug can reduce 
inflammation in the pulmonary vessels of a distinct patient cohort and 
ultimately, reverse right ventricular hypertrophy commonly found in such 
patients.  
10.2.1 Novel Work 
In addition to the studies discussed above,  a novel, multi-centre research study 
is underway that aims to quantify the phosphocreatine (PCr) and adenosine 
triphosphate (ATP) ratios of certain patient groups, as this will provide 
important information on myocardial energetics. Patient groups, such as renal 
patients, are known to have particularly low PCr/ATP ratios and hence, poorer 
outcomes. Providing an accurate, non-invasive, non-ionising way of measuring 
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cardiac energetics will allow the impact of pharmaceutical intervention or 
enhanced treatment plans to be assessed over prolonged periods of time. 
10.2.2 Present Challenges 
Phosphorus imaging is a relatively new technique with many challenges. Pres-
ently, Siemens do not manufacture phosphorus array coils, and therefore these 
coils have to be purchased from an independent manufacturer. The current 
multi-centre- study, in collaboration with Siemens Medical Solutions and RAP-
ID Biomedical, has highlighted an incompatibility between the RAPID phos-
phorus coils and the Siemens MRI systems resulting from a hardware re-
striction on power and a software restriction on pulse duration. Collaborative 
work is underway to resolve this issue.  
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10.3 Presentations, Posters and Publications 
10.3.1 Oral Presentations 
1. European Society for Magnetic Resonance in Medicine and Biology 
(ESMRMB). Assessment of Clinical Differences at 1.5T between Quantitative 
Right and Left Ventricular Volumes and Ejection Fractions Using MRI: Valencia 
2008.  
2. Medical Physics Journal Club, Ninewells Hospital. Cardiac magnetic 
Resonance Imaging: Dundee 2010. 
3. Scottish Universities and Stanford University Collaboration (SU2P). The 
Challenges of Cardiac Magnetic Resonance Imaging. Glasgow, February 2012. 
4. Scottish Imaging Network (SINAPSE) Annual scientific meeting, Assessment 
of Clinical Differences at 1.5T between Quantitative Right and Left Ventricular 
Volumes and Ejection Fractions Using MRI: Glasgow May 2012.  
5. Image Analysis in Life Science. The Effectiveness and Limitations of CMRI 
Analysis Techniques: Dundee August 2012.  
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10.3.2 Posters 
1. ESMRMB. Assessment of Clinical Differences at 1.5T between Quantitative 
Right and Left Ventricular Volumes and Ejection Fractions Using MRI: Valencia 
2008. 
2. International Society for Magnetic Resonance (ISMRM) Quantitative Analysis 
of Cardiac Left Ventricular Variables Obtained by Magnetic Resonance Imaging 
at 3Tesla: A Pre- and Post-Contrast Comparison. Honolulu 2010. 
3. SINAPSE. Quantitative Analysis of Cardiac Left Ventricular Variables 
Obtained by Magnetic Resonance Imaging at 3Tesla: A Pre- and Post-Contrast 
Comparison. Edinburgh 2010. 
4. SINAPSE. Measurement of Cardiac Left Atrial Volumes in Healthy 
Volunteers and Patients with Left Ventricular Hypertrophy and Angina using 
MRI.  Edinburgh 2010. 
5. University of St Andrews, Postgraduate Day. Cardiac Magnetic Resonance 
Imaging. Department of Physics and Astronomy 2010.  
6. Scottish Society for Experimental Medicine (SSEM). Assessment of Clinical 
Differences at 1.5T between Quantitative Right and Left Ventricular Volumes 
and Ejection Fractions Using MRI.  Dundee May 2012. 
Chapter 10|Conclusion 
Page | 194  
 
10.3.3 Publications 
1. British Journal of Radiology (BJR). Quantitative Analysis of Cardiac Left 
Ventricular Variables Obtained by Magnetic Resonance Imaging at 3Tesla: A 
Pre- and Post-Contrast Comparison. July 2012  
1,2SMatthew, BSc, Hons, 2,3S J Gandy, PhD, 2,3R S Nicholas, PhD, 2S A Waugh, MSc, 3E 
A Crowe, DCR(D), 2R A Lerski, PhD, 1M H Dunn, PhD and 4J G Houston, MD, 
FRCR 
 
1Department of Physics and Astronomy, University of St Andrews, St Andrews, UK 
2Department of Medical Physics, NHS Tayside, Ninewells Hospital and Medical School, 
Dundee, UK 
3Department of Clinical Radiology, NHS Tayside, Ninewells Hospital and Medical School, 
Dundee, UK, and 4Clinical Imaging, University of Dundee, Dundee, UK 
10.3.4 Submissions – Under peer review: 
1. Quantitative MRI Measures of Left Atrial Dimensions as Determinants of 
Cardiac Dysfunction – Technical Evaluation and Validation in Cardiac Patients 
and Healthy Volunteers 
Stephen J Gandy1,2, Shona Matthew3, Sushma Rekhraj4, Benjamin Szwejkowski4, 
Patricia Martin2, Allan D Struthers4, J Graeme Houston4 
 
1NHS Tayside Medical Physics, Ninewells Hospital, Dundee, DD1 9SY, UK.  
2NHS Tayside Clinical Radiology, Ninewells Hospital, Dundee DD1 9SY, UK  
3Department of Physics and Astronomy, University of St Andrews, The North Haugh, St 
Andrews, Fife KY16 9SS, UK 
4Division of Medical Sciences, University of Dundee, Ninewells Hospital Dundee DD19SY, UK 
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10.3.5 Prizes 
Poster Prize (2nd Place), 3rd Year Post Graduate Assessments, University of  
St Andrews 2010. 
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Appendix A. Quality Assurance Testing: T1, T2 and Flip Angle 
A1 The Bloch equations 
The Bloch equations discussed in this thesis are modified below to  
provide explicit forms of the longitudinal and transverse magnetisation 
vectors (Mz, Mx and My) [Eqs. 21, 22 and 25 respectively]. 
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2
M  and M  components
We derive the general solution for M ( ) and M ( ) and solve for 0.
For brevity the full derivation is shown for M ( ). The y component follows 
similarly.
Solving for Eq. (4)
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 he the form of a damped simple harmonic
oscillator (SHO). The solution of the damped SHO is well known and so
our general solution has the form
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Rearranging, we find the A coefficient
1
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then substituting our expression for A into Eq. (14) we find
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0
(0) 0
( ) component
Now we turn to the M ( ) term which is found through direct 
integration of Eq.(6).
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A1.1 FLASH and TrueFISP 
FLASH is a steady-state incoherent imaging technique as all the transverse 
magnetisation is essentially zero before the application of the next excitation 
pulse. The following analysis provides a valid solution to the steady-state 
longitudinal magnetisation for a given T1, T2, TR and flip angle and where 
there are no T2* effects (Eq 33) and for an isochromat of spins where M0 is 
replaced by the voxel spin density and T2* replaces T2 (Eq 34) [1]. 
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1 0 1
From equations (29) and (30), M  must satisfy
M cos (1 )                                                                     (31)
This provides the steady-state or equilibrium value      
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Considering a voxel containg several isochromats, equation (33) becomes
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TrueFISP is a coherent imaging technique as the residual transverse 
magnetisation is ‘recycled’. The magnetisation from TrueFISP [2] is given here 
without proof as: 
0
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Where K is a scaling factor (a.u.). 
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A2 Quality Assurance Checks on Contrast Measurements in MRI  
During the installation of the 1.5T Avanto and the 3.0T Trio, a number of 
acceptance and quality assurance tests were routinely performed to ensure 
that both systems met the manufacturer’s specifications and that the images 
produced by them  were of a sufficient quality to provide relevant diagnostic 
information. During these tests, a set procedure was adhered to so that the 
results obtained could be used for comparative purposes in future quality 
assurance (QA) testing.  
A2.1 Signal Intensity Measurements 
Signal intensity measurements in MRI provide a sound understanding of the 
effects of field strength, flip angle (FA), repetition time (TR) and echo time 
(TE) on inherent T1 and T2 relaxation parameters of different tissues and are 
therefore, fundamental to understanding image optimisation in MRI. Hence, 
it is an essential requirement for any MRI novice to perform these 
measurements at 1.5T and 3.0T using FLASH and TrueFISP pulse sequences 
(chapter 5). As part of this research, signal intensity measurements were 
performed on the 3.0T Trio as part of its installation process, and on the 1.5T 
Avanto as part its regular quality assurance testing.  
A2.2 The Images 
Thorough signal intensity measurements require the acquisition of a very 
large volume of images as the T1 and T2 relaxation rates need to be calculated  
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over a range of TRs (TR = 100–500 in steps of 50; TR = 500–1000 in steps of 100; 
and TR = 1500, 2000, 3000, 5000, 10000) and TEs (TE = 20–640 in steps of 20) 
respectively. Added to this, examining the effect of flip angle on image 
contrast requires the incremental acquisition of phantom images, starting at 
FA = 2 and going on through to FA = 88 or 90 in steps of 2. These 
acquisitions are acquired using cardiac-gated cine sequences at both field 
strengths and with both pulse sequences.  
                               
 
 
The images acquired at 3.0T were analysed in the traditional way. Each cine 
acquisition was pulled forward onto a remote work station and regions of 
interest (ROIs) were manually placed on each of the gel, water and oil 
phantoms. This was performed on the first image frame of each of the 25 
framed cine acquisitions (Figure A2) using the manufacturer’s software 
Figure A1 The agarose gel phantoms are 
positioned within the Eurospin test object 
and placed inside the head coil for imaging. 
 
Figure A2 An image of the gel phantoms 
acquired at 1.5T. 
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(Argus, Siemens Healthcare, Erlangen, Germany). Placement of the ROIs 
provides quantitative signal information such as the mean signal value within 
the ROI (+/- the standard deviation (SD) of the mean) plus the maximum and 
minimum signal within the ROI.  
To calculate the T1 and T2 values of each of the phantoms, the mean signal +/- 
SD had to be manually entered into an Excel spreadsheet so that the signal 
values could be plotted against TR and TE respectively. The flip angle data 
was handled in the same way but this time signal was plotted against 
changing flip angle. 
 This analysis technique proved both time consuming and laborious. It was 
also open to human error due to the large number of signal measurements 
that have to be manually transferred from the workstation to the spreadsheet. 
This inefficient, and potentially inaccurate, method was the motivating force 
to produce a time-efficient method of dealing with this data that was accurate 
and reproducible. 
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Figure A3 Each image had ROIs placed over the gel, oil and water phantoms. 
 
A2.3 The Environment 
The following work was performed in the MAT LAB® (Math Works, Natick, USA) 
environment and the novel MATLAB script created during this work is summarised in 
Appendix B of this thesis.  
A2.4 The Aim 
The purpose of this work was to provide a compact block of functions that 
would efficiently handle the large volumes of images acquired. These 
functions needed to be easily transportable between machines (computers) 
that had the MATLAB environment installed.  
A2.5 The Code 
A class of type MRI data was created that contained all the properties and 
methods required for processing all the TR TE and FA data obtained during 
the spin density measurements.  
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A2.6 The Files 
The images acquired during the routine QA testing of the 1.5T Avanto were 
copied from the scanner onto a CD-ROM and loaded into MATLAB. Placing 
these images in the MATLAB environment automatically separated each cine 
series into 25 individual images, creating 2000 individual files in total. Each 
file was automatically labelled with a series of numbers (string) (e.g. 
21009738) rather than a recognisable label (Figure A4). This presented an 
immediate problem as the strings bore no relation to the file content.  This 
meant that the only way to determine the content of each file was to open the 
image DICOM headers using MATLAB’s image processing toolbox. This was 
an inefficient process similar to that of transferring the signal measurements 
from the work station to the Excel file in the previous method.  Therefore, the 
first step in this work was to create a method for renaming files so that they 
were instantly recognisable. 
A2.7 Renaming the Files 
The MRI data class provides a method for renaming all files dynamically. The 
file names are generated automatically based on the metadata found in the 
respective DICOM header files of the images (Figure A5). (An example of a 
DICOM header is attached to the end of this chapter for the interested reader.) 
The renaming task is performed by initiating the class and selecting the 
relevant option at the prompt (see example below).  The operator then has the 
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option to process the TR, TE or FA data. Each option will provide the operator 
with a range of prompts that work to set up the processing stage.  
EXAMPLE 1: Renaming files 
  Instantiate the class by creating a variable, 
   >> data = MRIdata; 
> Select from the following processing options 
---------------------------------------------- 
1.   Rename DICOM files 
2.   Flip angle data 
3.   TR data 
4.   TE data 
0.   End processing 
 > processing option -->   
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Selecting option ‘1’ will rename the files. The class will then return to this 
point to continue processing the data. Option ‘0’ can be selected to exit the 
process. The files can also be renamed without initiating the class using: 
MRIdata.renameDICOMfiles 
This will perform the task without presenting any prompts. 
 
Figure A4 Each file is automatically labelled with a string in the MATLAB environment. 
 
 
Figure A5 An example of some renamed files. 
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To continue processing the data, the operator must select option 2, 3 or 4. 
As an example, option 3 for processing the TR data will be selected.  
> processing option --> 3 
This selection sets the procedure for starting the processing and organisation 
of the data. The operator then needs to set the working directory in response 
to ‘type the full string for the directory to process’.  
This will be of the form C:\Users\John Smith\mriData\". NB: This directory 
should point to the directory with the renamed files and not the originals. 
>  type the full string for the directory to process:  
 C:\Users\Shona\Documents\MRI\all data\data\TR.  
The operator will then be prompted for the range of files to process. The TR 
data is slightly different to the TE and FA data due to the irregular range over 
which the TRs need to be acquired. As they cannot simply be defined in a 
step-wise fashion, a MATLAB vector is expected for this prompt. The TE and 
FA methods simply prompt for the starting, ending and step points. 
> select the range of TRs to process : NOTE: TR range is in format [start, next, 
next+1, ...] For the data acquired on the Avanto, this would be of the form: 
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type TR range (use [ ] for more than one file):  [100:50:500, 500:100:1000, 1500, 
2000, 3000, 5000, 10000] 
Finally, the operator is prompted to provide the number of ROIs for analyses. 
This allows the operator to analyse any or all of the phantom gels and so the 
response should be a number in the range of 1 to 12.  
> How many masks/ROIs would you like to create? 12 
A3 Measuring the Signal 
Once this number has been returned, an image of the agarose, oil and water 
filled phantoms will appear in a window. Each phantom image is labelled 
with a number, in this case ROI number 1 (Figure A6). The operator is then 
required to manually place an ROI on the first gel by holding down the left 
hand button of the mouse and dragging it over the gel. If the resulting ROI is 
not in the correct position, it can be highlighted and moved by the operator. 
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Once the ROI is in place, the operator is required to double click on the image. 
This automatically replaces the image labelled ROI number 1 with the image 
labelled ROI number 2. The operator now places an ROI on the second gel 
(Figure A7).  
 
Figure A6 The operator places an ROI on gel 1. 
 
Figure A7 When the second image appears, the operator places an ROI on gel number 2. 
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A3.1 Plotting the data 
This process is repeated until all the required phantoms have ROIs placed on 
them. The ROIs are then stored and converted to binary masks, which are 
then applied to each of the 25 frames of the cine series, for each TR value. This 
process is concluded with the option of plotting the data. The response to this 
option can be of the form, "y", "yes", "n" or "no". The case of the response is 
not considered and thus can be either. For example: 
> would you like to plot the data?  yes 
or 
> would you like to plot the data?  y 
By selecting to plot the data, MATLAB will produce a graph for each of the 
ROIs selected at the start of the process (Figure A8). The operator can also 
choose to plot the data at a later date by selecting “no”. The plotting routine 
(function) can then be invoked at a later time by calling the relevant method 
(class function): 
data = data.plotMRIdata; 
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Figure A8 By selecting to plot the data, MATLAB will produce plots for each of the selected ROIs as can be seen here 
for ROIs 2, 3, and 4. 
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A4 Calculating T1 Relaxation Rates 
Once plots have been created of signal v TR, an accurate calculation of the T1 
relaxation rates of the gel, oil and water phantoms can be obtained simply by 
using a fitting routine. This process is invoked via the relevant method calls: 
data = data.calcT1;  
The operator is then asked to examine each plot and, through a series of 
prompts, to choose the range over which the T1 relaxation rates should be 
calculated. The results of the fit are stored in the class property ‘t1’ or ‘t2’ and 
are accessed via: data.t1 
 
 
 
 
 
 
 
Figure A9 The operator visually selects the range over which the T1 values of the gel will be 
calculated. 
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Once these values have been fed into MATLAB, the fitting routine plots the fit 
of the chosen gel in a separate figure. An example of these fits for ROI 2, 3 and 
4 can be seen in Figures A10, A11 and A12. 
 
 
 
 
 
Figure A10 By plotting the fit for ROI 2, the T1 value can be calculated in MATLAB. 
 
 
 
 
 
 
 
Figure A11 By plotting the fit for ROI 3, the T1 value can be calculated for this gel. 
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Figure A12 By plotting the fit for ROI 4, the T1 value can be calculated for this gel. 
Once this step is completed for each gel, the calculated T1 values can then be 
compared to the known theoretical values. In the examples provided in this 
sub-chapter, the calculated values of T1 for the gels in ROI 1, 2 and 3 were 
1483.9ms, 1195.3ms and 952.4ms. These values compare favourably with the 
theoretical values for these gels, which are 1480ms, 1261ms and 959ms 
respectively at 292K. 
A4.1 TE Data 
This time-efficient and accurate process can be repeated using the TE data 
(Figure A12) simply by selecting the relevant prompts, at the start of the 
exercise. The operator should ensure that the correct directory is also selected; 
for example, if the operator wanted to calculate the T2 values of the gels: 
> Select from the following processing options 
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---------------------------------------------- 
1.   Rename DICOM files 
2.   Flip angle data 
3.   TR data 
4.   TE data 
Then option 4 would be selected and the directory would change from: 
>  type the full string for the directory to process:  
 C:\Users\Shona\Documents\MRI\all data\data\TR.  
to: 
>  type the full string for the directory to process:  
 C:\Users\Shona\Documents\MRI\all data\data\TE.  
Care should also be taken at other prompts; for example: 
data = data.calcT1; should be replaced by data = data.calcT2; 
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A4.2 Flip Angle Data 
The flip angle data should be treated in the same way up until the plotting 
stage.  At this point, the operator will be given the option to plot the signal v 
instance number or plot the signal v flip angle (see below). Plotting the signal 
v instance number allows the operator plot a graph detailing how the signal 
changes throughout each 25-frame cine acquisition, whilst plotting signal v 
flip angle will give the operator a picture of how flip angle effects image 
contrast. 
Figure A13 T2 relaxation values for each gel can be determined by using the TE data and selecting  
the relevant prompts. 
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> Flip Angle data 
1. create plot of Signal vs. instance number (time) 
2. create plot of Signal vs. flip angle 
An example of the type of the information available in an image DICOM header. 
1 Format DICOM 
2 FormatVersion 3 
3 Width 256 
4 Height 256 
5 BitDepth 16 
6 ColorType Grayscale 
7 FileMetaInformationGroupLength 210 
8 FileMetaInformationVersion [2x1 uint8] 
9 MediaStorageSOPClassUID 1.2.840.10008.5.1.4.1.1.4 
10 MediaStorageSOPInstanceUID 1.3.6.1.4.1.9590.100.1.2.228772607612717533806987 
11 TransferSyntaxUID 1.2.840.10008.1.2.1 
12 ImplementationClassUID 1.3.6.1.4.1.9590.100.1.3.100.7.1 
13 ImplementationVersionName MATLAB IPT 7.1 
14 SpecificCharacterSet ISO_IR 100 
15 ImageType ORIGINAL\PRIMARY\M\RETRO\DIS2D 
16 InstanceCreationDate 20100405 
17 InstanceCreationTime 143317.421000 
18 SOPClassUID 1.2.840.10008.5.1.4.1.1.4 
19 SOPInstanceUID 1.3.6.1.4.1.9590.100.1.2.228772607612717533806987 
20 StudyDate 20100405 
21 SeriesDate 20100405 
22 AcquisitionDate 20100405 
23 ContentDate 20100405 
24 StudyTime 112253.906000 
25 SeriesTime 143317.421000 
26 AcquisitionTime 143303.417500 
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27 ContentTime 143317.421000 
28 AccessionNumber '' 
29 Modality MR 
30 Manufacturer SIEMENS 
31 InstitutionName NINEWELLS HOSPITAL AVANTO 
32 InstitutionAddress Ninewells,GB,DD1 9SY 
33 ReferringPhysicianName [1x1 struct] 
34 StationName MRC25176 
35 StudyDescription PHYSICS^QUALITY ASSURANCE 
36 SeriesDescription Cine_trueFISP_FA02 
37 PerformingPhysicianName [1x1 struct] 
38 ManufacturerModelName Avanto 
39 ReferencedImageSequence [1x1 struct] 
40 PatientName [1x1 struct] 
41 PatientID test_05042010 
42 PatientBirthDate 19700101 
43 PatientSex O 
44 PatientAge 040Y 
45 PatientWeight 50 
46 ScanningSequence GR 
47 SequenceVariant SK\SS\OSP 
48 ScanOptions CT 
49 MRAcquisitionType 2D 
50 SequenceName *tfi2d1_15 
51 AngioFlag N 
52 SliceThickness 10 
53 RepetitionTime 47.8500 
54 EchoTime 1.3600 
55 NumberOfAverages 1 
56 ImagingFrequency 63.6816 
57 ImagedNucleus 1H 
58 EchoNumber 1 
59 MagneticFieldStrength 1.5000 
60 NumberOfPhaseEncodingSteps 286 
61 EchoTrainLength 1 
62 PercentSampling 100 
63 PercentPhaseFieldOfView 100 
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64 PixelBandwidth 930 
65 DeviceSerialNumber 25176 
66 SoftwareVersion syngo MR B15 
67 ProtocolName Cine_trueFISP_FA02 
68 TriggerTime 0 
69 NominalInterval 1000 
70 CardiacNumberOfImages 25 
71 TransmitCoilName Body 
72 AcquisitionMatrix [4x1 uint16] 
73 InPlanePhaseEncodingDirection COL 
74 FlipAngle 2 
75 VariableFlipAngleFlag N 
76 SAR 3.5875e-004 
77 dBdt 0 
78 PatientPosition HFS 
79 StudyInstanceUID 1.3.12.2.1107.5.2.30.25176.3000001004051022539210 
80 SeriesInstanceUID 1.3.12.2.1107.5.2.30.25176.2010040514331558306800 
81 StudyID 1 
82 SeriesNumber 23 
83 AcquisitionNumber 1 
84 InstanceNumber 1 
85 ImagePositionPatient [3x1 double] 
86 ImageOrientationPatient [6x1 double] 
87 FrameOfReferenceUID 1.3.12.2.1107.5.2.30.25176.2.20100405112254203. 
88 PositionReferenceIndicator '' 
89 SliceLocation -1.3629e-008 
90 ImageComments RR 1000 +/- 2; 11 heartbeats 
91 SamplesPerPixel 1 
92 PhotometricInterpretation MONOCHROME2 
93 Rows 256 
94 Columns 256 
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Appendix B. Matlab® code 
This appendix summarises the MRIdata class discussed in chapter 4b of this 
thesis. It was created using Matlab® with the aim of simply and efficiently 
processing the large volumes of MRI data acquired as part of the departments 
regular quality assurance testing and/or installation procedures. 
A full copy of the latest version of the MRIdata Matlab class is included on the 
accompanying CD. This is stored in the “MRIdata class” directory; and is 
included in the matlab script file “MRIdata.m”. 
B1 Header 
The header or help section for the MRIdata class gives an indication on how 
to use the class for processing the MRI data. 
% This file generates a class of type "MRIdata". It contains all the 
% properties and methods required for processing Flip Angle, TR and TE 
% data obtained from the MRI scanner in Ninewells Hospital. 
% The purpose of this class is to provide a compact block of functions 
% which are efficient and can be easily transported between machines 
% with the MATLAB environment installed. 
% The files from the MRI scanner come with meaningless file names. So, 
% before any processing can be done these files have to be renamed. 
% The MRIdata class provides a method for renaming the files 
% dynamically. Point the class to the base directory with the raw 
% files, and the renamed files will be stored in a sub-directory named 
% "\renamedFiles". The file names will be generated automatically based 
% on the meta data found in the respective DICOM files. To perform this 
% renaming task simply instantiate the class and select the relavant 
% option at the prompt. See the example below. Alternatively, you can 
% perform this task without instanciating the class as the method does 
% not depend on the class properties or methods. See the second example 
% below. 
% The user then has the option to process the data, either the Flip 
% Angle (FA), the TR, and/or the TE data. Each option will then give 
% the user a range of prompts which work to set up the processing 
% stage. An example for the TR data is shown in Example 3. 
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% EXAMPLE 1: Renaming files 
% Instantiate the class by creating a variable, 
% data = MRIdata; 
% This calls the constructor for the class, and provides an initial 
% prompt for selecting a range of options. Select option "1" to rename 
% the files. The class will return to this point to continue processing 
% the data. Option "0" to exit. 
% EXAMPLE 2: Renaming files, without instantiating the class. 
% MRIdata.renameDICOMfiles 
% This performs the renaming without instantiation, and will not 
% present any prompt. 
 
 
% EXAMPLE 3: Process data - TR for illustration 
% data = MRIdata; 
% Option "3" in response to "processing option --> " 
% This results in the setting procedure for starting the processing and 
% organisation of the data. 
% Set the working directory in response to "type the full string for 
% the directory to process: ", this will be of the form, 
% C:\Users\John Smith\mriData\" 
% NB: This directory should point to the directory with the renamed 
% files and not the originals. 
% Next the user is prompted for the range of files to process. The TR 
% data is slightly different and expects a MATLAB vector. The other 
% methods prompt for the starting, ending and step points. 
% This arose from the files that were to be processed. This should be 
% changed in future versions. 
% an example would be of the form, 
% [100:50:500, 600, 1000, 3000] 
% For files with TR values 
% 100, 150, 200, 250, 300, 350, 400, 450, 500, 600, 1000, 3000. 
% Finally, the user is requested to provide the number of ROIs that 
% will be created. The first image in the series is then displayed for 
% the creation of each ROI. These are then stored and converted to 
% binary masks, which are then applied to each image for each ROI. 
% The process is concluded with the option of plotting the data. The 
% response can be of the form, 
% "y", "yes", "n" or "no" 
% The case of the response is not considered and thus can be either. 
% If you would like to plot at a later date simply invoke the 
% plotting method by calling the relevant method, 
% data = data.plotMRIdata; 
% For TE and TR data, a fitting routine is available to find either the 
% T1 or T2 values. These are invoked via the relevant method calls, 
% data = data.calcT1; 
% or, 
% data = data.calcT2; 
% The user is then asked the range to calculate the fit from via a 
% series of prompts like before. The results of the fit are stored in 
% the class property "t1" or "t2" and are accessed via, 
% data.t1 
% or, 
% data.t2 
% The fitting routine also plots, in a separate figure, the fit results 
% for the specific ROI selected. 
%  MATLAB by Dr Tom Gallacher  email: thomas.gallacher@gmail.com 
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%  MRI theory by Shona Matthew 
% Class version: $v4.4 
B2 Class data members 
MRIdata class and its data members define the variables that are used to store 
the MRI data as it is processed. 
*Constant means variable does not change and can be accessed without 
creating an “instance” of the MRIdata class. 
*SetAccess + GetAccess determines whether those variables can be accessed 
from the matlab command window, i.e. outside the class. “public” means the 
variables can be accessed and “private or protected” means that only 
functions internal to the class can access the variables. 
properties (Constant) 
version = '4.4'; 
end 
 
properties (SetAccess = public, GetAccess = public) 
tr_Data = struct;         % intensity data - TR 
te_Data = struct;         % intensity data - TE 
fa_Data = struct;         % intensity data - FA 
 
t1 
t2 
 
s0_in                           % S0 input for T1 fit. 
s0_out                          % s0 from T1 fit. 
r_sq                            % R^2 val - 1 indicates perfect fit to data. 
end 
 
properties (SetAccess = protected, GetAccess = protected) 
sizeChk                 % image size in pixels (one number - img is square) 
noROIs                  % number of gels/ROIs 
noFrames = 25;      % number of frames - usually 25 
noFiles                 % number of files in cur folder 
fa_range                % range of flip angle 
tr_range                % range of TR to process 
te_range                % range of TE to process 
noFA                    % number of flip angle files to process 
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noTR                    % number of TR files to process 
noTE                    % number of TE files to process 
 
filedata = struct;       % struct for file names 
masks = uint16([]);          % holds all the masks 
 
fa_instance_format = '%*s %*s  FA%*d %d %*c %*s'; 
fa_format =  '%*s %*s  FA%d %*d %*c %*s'; 
markerSpec = ['+','o','*','.','x','s','d','^','v','>']; % used for plotting 
 
isFA = 0        % flag to indicate if FA data has been processed. 
isTR = 0        % flag to indicate if TR data has been processed. 
isTE = 0        % flag to indicate if TE data has been processed. 
processOption = 0;    %Process option selected. 0 indicates default: no option 
selected 
processOption_stop = 0; % used in the processMRI while loop 
end 
 
B3 Class methods (functions) 
This section contains a list of the MRIdata methods. These methods are used 
for processing MRIdata and include routines such as formatting the file 
names (from metadata generated by the MRI scanner), plotting data, fitting to 
experimental data, etc. 
The methods are grouped into three different blocks that have specific access 
rights: these are “static”, “public”, and “protected”. 
B3.1 Static method block 
The static method block is similar to the “constant” data member block (see 
appendix B1.2); the routine can be performed without creating an instance of 
the class. 
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methods (Static) 
%------- rename DICOM files to something more useful 
function renameDICOMfiles(varargin) 
% As of v3.3 of class file: varargin format is: 
% - varargin{1} -> function handle of status box 
% - varargin{2} -> handles struct 
 
%** create new directory for renamed files 
newDir = 'renamedFiles'; 
if nargin == 0 %only display if no input args 
disp(' '); 
disp('Renaming DICOM files. New files will be put in "renamedFiles" directory'); 
disp('This directory will be located in the original dicom files folder.'); 
end 
 
% Check that folder doesn't already exist.. 
if isdir(newDir); 
if nargin == 0 
disp(' '); 
disp( 
'****************************************************************'
) 
disp(['WARNING:: the folder "' newDir '" already exists. Move these...']); 
disp( 
'****************************************************************'
) 
disp(' '); 
else 
% defined in MRI GUI file 
varargin{1}(['WARNING:: the folder "' newDir '" already exists. Move these...'], 
varargin{2}); 
end 
else 
%** Data setup 
inFile = struct(); % preallocate memory - makes it run quicker 
NumberOfFiles2Process = 0; 
 
%** Start renaming files 
% generate the new folder for the files - generated below 
mkdir(newDir); 
Direc = [pwd '\' newDir '\']; 
%read files from current directory 
files = dir(); 
 
% how many files is there in the directory 
numFiles = length(files); 
 
% find the number of files that are actually DICOM files - used for 
% progress check 
for k = 1:numFiles 
if files(k).isdir == 0 
NumberOfFiles2Process = NumberOfFiles2Process + 1; 
end 
end 
 
if nargin == 0 
%progress bar 
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pbar = waitbar(0, 'Renaming DICOM files...'); 
end 
 
%loop over all files in current directory 
for i = 1:numFiles 
%check file isn't a folder 
dirtype = files(i).isdir; 
 
% if this is = 0, then file is not a folder -> process this 
if dirtype == 0 
% get all info for DICOM file store in 'info' 
if isdicom(files(i).name) 
info = dicominfo(files(i).name); 
 
% keep hold of the variables that we are interested in. 
inFile.name = files(i).name; 
inFile.protocolName = info.ProtocolName; 
inFile.instanceNumber = info.InstanceNumber; 
inFile.EchoTime = info.EchoTime; 
curImageData = dicomread(inFile.name); 
 
% create new variable with the string for the new file name 
if ~isempty(strfind(inFile.protocolName, 'FA')) 
outFilename = [inFile.protocolName '_' num2str(inFile.instanceNumber) '.dcm']; 
elseif ~isempty(strfind(inFile.protocolName, 'se_mc')) 
outFilename = [inFile.protocolName '_TE' num2str(inFile.EchoTime)  '.dcm']; 
elseif ~isempty(strfind(inFile.protocolName, 'TR')) 
outFilename = [inFile.protocolName '.dcm']; 
end 
 
% write the image to a new file put in the renamed folder. 
dicomwrite(curImageData, [Direc outFilename], info, 'CreateMode', 'Copy'); 
end 
% progress bar... 
per = i/NumberOfFiles2Process; 
 
if nargin == 0 
waitbar(per); 
else 
varargin{1}(['Renaming files:  percentage done -> ' num2str(per*100)], 
varargin{2}); 
end 
end 
end 
end 
if nargin == 0 
close(pbar); 
else 
varargin{1}('Renaming complete', varargin{2}); 
end 
end % end renameDICOMfiles 
end % END STATIC 
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B3.2 Public method block 
These functions are available for use outside of the class. These functions 
consist of mainly processing options, i.e. process TR, TE or FA, and for 
plotting the results of the data processing algorithms. There also functions for 
obtaining the relaxation time parameters for each respective data process; 
these routines call private methods which perform the data fitting (see 
appendix B1.3.3). 
methods (Access = public) 
%------- constructor 
function obj = MRIdata(varargin) 
disp(['Running MRIdata CLASS Version ' num2str(obj.version)]); 
close all 
 
if nargin == 0 
obj = obj.processMRI; 
end 
end %end constructor 
 
%------- process Flip angle (FA) data 
function obj =  proc_flipAngle(obj, FArange, varargin) 
% v3.3 varargin contains 
% - varargin{1} -> noROIs 
% - varargin{2} -> function handle to status box 
% - varargin{3} -> handles struct for UI controls 
 
obj.isFA = 1; 
obj.fa_range = FArange'; 
obj.noFA = length(FArange); 
 
%reset other TR & TE data 
obj.isTR = 0; 
obj.isTE = 0; 
obj.tr_Data = []; 
obj.te_Data = []; 
 
% START PROCESSING 
% Sort file in strctured variables (struct) 
obj = obj.sortFileNames_fa; 
% Create the ROIs 
obj = obj.createROIs(varargin); 
% Apply to our files 
obj = obj.applyROIs(varargin); 
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end % end proc_flipAngle() 
 
%------- process TR data 
function obj = proc_TR(obj, TRrange, varargin) 
% v3.3 varargin contains 
% - varargin{1} -> noROIs 
% - varargin{2} -> function handle to status box 
% - varargin{3} -> handles struct for UI controls 
 
obj.isTR = 1; 
obj.tr_range = TRrange; 
obj.noTR = length(obj.tr_range); 
 
%reset other TR & TE data 
obj.isFA = 0; 
obj.isTE = 0; 
obj.fa_Data = []; 
obj.te_Data = []; 
 
% START PROCESSING 
% Sort file in strctured variables (struct) 
obj = obj.sortFileNames_tr; 
% Create the ROIs 
obj = obj.createROIs(varargin); 
% Apply to our files 
obj = obj.applyROIs(varargin); 
end %end proc_TR() 
 
%------- process TE data 
function obj = proc_TE(obj, TErange, varargin) 
% v3.3 varargin contains 
% - varargin{1} -> noROIs 
% - varargin{2} -> function handle to status box 
% - varargin{3} -> handles struct for UI controls 
 
obj.isTE = 1; 
obj.te_range = TErange; 
obj.noTE = length(TErange); 
 
%reset other TR & TE data 
obj.isTR = 0; 
obj.isFA = 0; 
obj.tr_Data = []; 
obj.fa_Data = []; 
 
% START PROCESSING 
% Sort file in strctured variables (struct) 
obj = obj.sortFileNames_te; 
% Create the ROIs 
obj = obj.createROIs(varargin); 
% Apply to our files 
obj = obj.applyROIs(varargin); 
end % end proc_TE() 
 
%------ plotting data 
function varargout = plotMRIdata(obj, varargin) 
close all 
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% only display if not using GUI 
if nargin == 1 
if obj.processOption == 0 || obj.processOption == 2 
%options 
disp(' '); 
disp(' '); 
disp('----------------------------------------------------------------'); 
disp('To process MRI data, choose from the following options'); 
disp('----------------------------------------------------------------'); 
disp(' '); 
disp('> Flip Angle data'); 
disp('1. create plot of Signal vs. instance number (time)'); 
disp('2. create plot of Signal vs. flip angle'); 
disp(' '); 
disp('> TR data'); 
disp('3. create plot of Signal vs. TR value'); 
disp(' '); 
disp('> TE data'); 
disp('4. create plot of Signal vs. TE value'); 
 
disp(' '); 
optNum = input('> option number:  '); 
disp(' '); 
else 
optNum = obj.processOption; 
end 
end 
 
 
 
if nargin == 2 
optNum = varargin{1}; 
end 
 
%% option 1.    *FA data* 
if optNum == 1 
%get plot range (if not using GUI) 
if nargin == 1 
plt_fa_range = obj.opt1plotRange; 
else 
if nargin  == 2 %no plot range present 
 
farangeMIN = obj.fa_Data(1,1).angle; 
farangeMAX = obj.fa_Data(end,1).angle; 
 
if length(obj.fa_Data) ~= 1 
farangeSTEP = obj.fa_Data(2,1).angle - obj.fa_Data(1,1).angle; 
else 
farangeSTEP = 1; 
end 
plt_fa_range = farangeMIN:farangeSTEP:farangeMAX; 
 
else 
if nargin == 4 
plt_fa_range = varargin{2}:varargin{3}:varargin{4}; 
else 
error('MRIdata::no enough plot range arguments passed to plotMRIdata()'); 
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end 
end 
end 
% Xaxis 
x = 1:obj.noFrames; 
 
% Start plotting with separate windows for each angle 
for FAitr = 1:length(plt_fa_range) 
 
% sort out the plot window 
if length(plt_fa_range) <= 3 
subplot(1,3,FAitr); 
elseif length(plt_fa_range) > 3 && length(plt_fa_range) < 7 
subplot(2,3,FAitr); 
end 
 
if length(plt_fa_range) >= 7 
if FAitr > 6 
if mod(FAitr,6) == 1 
figure 
end 
end 
if mod(FAitr,6) == 0 
subplot(2, 3, 6) 
else 
subplot(2, 3, mod(FAitr,6)) 
end 
end %end sorting out plot window 
 
% Do the plotting 
for z = 1:obj.noFA 
%loop over all FA files. if FA number has been selected -> plot it 
if plt_fa_range(FAitr) == obj.fa_Data(z,1).angle; 
%plot signal for all gels for each selected FA 
for GELitr = 1:obj.noROIs 
y = obj.fa_Data(z,1).roi(GELitr,1).signal; 
plot(x, y, [obj.markerSpec(GELitr) '-'],'LineWidth', 2); 
hold all 
axis tight 
xlabel('instance number'); 
ylabel('signal'); 
set(gca, 'LineWidth', 1.5); 
set(gcf, 'Position', [0 0 1280 750]); 
end 
% sort out legend 
obj.applyLegend; 
title(['Flip angle - ' num2str(plt_fa_range(FAitr))]); 
end 
end 
end 
hold off 
end 
 
%% Option 2 *FA data* 
if optNum == 2 
% loop over all ROIs 
for GELitr = 1:obj.noROIs 
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% loop over all Flip Angles and get corresponding signal 
for FAitr = 1:obj.noFA 
x(FAitr) = obj.fa_Data(FAitr,1).angle; 
y(FAitr) = obj.fa_Data(FAitr,1).roi(GELitr,1).signal(1); 
end 
 
% plot data 
plot(x, y, [obj.markerSpec(GELitr) '-'], 'LineWidth', 2); 
hold all 
axis tight 
xlabel('flip angle'); 
ylabel('signal'); 
clear x y 
end 
 
% sort out gel 
obj.applyLegend; 
set(gca, 'LineWidth', 1.5); 
hold off 
end 
 
%% Option 3 *TR data* 
if optNum == 3 
% loop over all ROIs 
for ROIitr = 1:obj.noROIs 
 
% sort out the plot window 
if obj.noROIs <= 3 
subplot(1,3,ROIitr); 
elseif obj.noROIs > 3 && obj.noROIs < 7 
subplot(2,3,ROIitr); 
end 
 
if obj.noROIs >= 7 
if ROIitr > 6 
if mod(ROIitr,6) == 1 
figure 
end 
end 
if mod(ROIitr,6) == 0 
subplot(2, 3, 6) 
else 
subplot(2, 3, mod(ROIitr,6)) 
end 
end %end sorting out plot window 
 
 
% loop over all TRs and get corresponding signal 
for TRitr = 1:obj.noTR 
x(TRitr) = obj.tr_Data(TRitr,1).TRval; 
y(TRitr) = obj.tr_Data(TRitr,1).roi(ROIitr,1).signal; 
end 
 
% plot data 
plot(x, (y), '*-', 'LineWidth', 2); 
hold all 
axis square 
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xlabel('TR values (msec)'); 
ylabel('signal (a.u.)'); 
legend(['ROI ' num2str(ROIitr)]); 
legend('Location', 'SouthEast'); 
set(gca, 'LineWidth', 1.5); 
xlim([0 x(end)]); 
clear x y 
end 
hold off 
end 
 
%% Option 4 *TE data* 
if optNum == 4 
% loop over all ROIs 
for ROIitr = 1:obj.noROIs 
 
% sort out the plot window 
if obj.noROIs <= 3 
subplot(1,3,ROIitr); 
elseif obj.noROIs > 3 && obj.noROIs < 7 
subplot(2,3,ROIitr); 
end 
 
if obj.noROIs >= 7 
if ROIitr > 6 
if mod(ROIitr,6) == 1 
figure 
end 
end 
if mod(ROIitr,6) == 0 
subplot(2, 3, 6) 
else 
subplot(2, 3, mod(ROIitr,6)) 
end 
end %end sorting out plot window 
 
% loop over all TRs and get corresponding signal 
for TEitr = 1:obj.noTE 
x(TEitr) = obj.te_Data(TEitr,1).TEval; 
y(TEitr) = obj.te_Data(TEitr,1).roi(ROIitr,1).signal; 
end 
 
% plot data 
plot(x, y, 'x' , 'LineWidth', 2, 'MarkerSize', 10); 
hold all 
axis square 
xlabel('TE values (msec)'); 
ylabel('signal (a.u.)'); 
legend(['ROI ' num2str(ROIitr)]); 
legend('Location', 'NorthEast'); 
set(gca, 'LineWidth', 1.5); 
xlim([0 x(end)]); 
clear x y 
end 
hold off 
end 
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if nargout == 1 
varargout{1} = obj; 
end 
end % end plotMRIdata() 
 
%------- process MRI data prompt function 
function obj = processMRI(obj) 
% processMRIdata 
% 
%   This is the master function which will guide you through the processing 
%   of all MRI data. This script currently supports: 
% 
%       - renaming all files to something more meaningful 
%       - processing flip angle data (both TrueFISP & FLASH) 
%       - processing TR data 
%       - processing TE data 
% 
%  To plot this data use the plotMRIdata method. 
% 
% 
%   $vc1  (class version) 
% 
%   Shona Matthew 
 
 
disp(' '); 
disp('     **** Processing MRI data ****'); 
disp(' '); 
disp('NOTE:: DICOM files have to be renamed before processing!!!'); 
disp(' '); 
 
while obj.processOption_stop ~= 1 
 
disp('> Select from the following processing options'); 
disp('----------------------------------------------'); 
disp('1.   Rename DICOM files'); 
disp('2.   Flip angle data'); 
disp('3.   TR data'); 
disp('4.   TE data'); 
disp(' '); 
disp(' '); 
disp('0.   End processing'); 
disp(' '); 
obj.processOption = input('> processing option -->  '); 
disp(' '); 
 
 
 
% string holding the directory to do the processing on 
if obj.processOption ~= 0 
pDir = input('> type the full string for the directory to process:  ', 's'); 
disp(' '); 
%change the current directory to the folder containg the data 
cd(pDir); 
end 
 
%* Option 1 - rename dicom files 
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if obj.processOption == 1 
obj = obj.renameDICOMfiles; 
end 
 
%* Option 2 - Flip angle data 
if obj.processOption == 2 
disp('> select the range of flip angles to process'); 
disp(' '); 
startFA = input('> starting flip angle:  '); 
endFA = input ('> ending flip angle:  '); 
stepFA = input('> flip angle steps:  '); 
 
range = startFA:stepFA:endFA; 
% run the processing script 
obj = obj.proc_flipAngle(range); 
 
%quit the function now that data has been processed 
obj.processOption_stop = 1; 
end 
 
%* Option 3 - TR data 
if obj.processOption == 3 
disp('> select the range of TRs to process'); 
disp('::NOTE: TR range is in format - [start, next, next+1, ....]'); 
disp(' '); 
 
range = input('> type TR range (use [ ] for more than one file):  '); 
% run the processing script 
obj = obj.proc_TR(range); 
 
%quit the function now that data has been processed 
obj.processOption_stop = 1; 
end 
 
%* Option 4 - TE data 
if obj.processOption == 4 
disp('> select the range of TEs to process'); 
 
startTE = input('> starting TE:  '); 
endTE = input ('> ending TE:  '); 
stepTE = input('> TE steps:  '); 
 
range = startTE:stepTE:endTE; 
% run the processing script 
obj = obj.proc_TE(range); 
 
%quit the function now that data has been processed 
obj.processOption_stop = 1; 
end 
 
% Quit the class. 
if obj.processOption == 0 
obj.processOption_stop = 1; 
end 
 
end %end while loop 
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% reset stop flag. 
obj.processOption_stop = 0; 
 
% Do not print if quit 
if obj.processOption ~= 0 
disp(' '); 
disp('--------------------------------------------------------------'); 
plt = input('> would you like to plot the data?  ', 's'); 
 
switch lower(plt) 
case 'y' 
obj = obj.plotMRIdata; 
case 'yes' 
obj = obj.plotMRIdata; 
case 'n' 
disp('> Use ".plotMRIdata" to plot data'); 
case 'no' 
disp('> Use ".plotMRIdata" to plot data'); 
end 
disp(' '); 
else 
disp('> MRIdata process quit. '); 
end 
end % end processMRI() 
 
%------- process gradient T2 for TE data 
function obj = calcT2(obj) 
 
xStart = input('Starting x val --> '); 
xStop = input('Stopping x val --> '); 
ROIno = input('ROI number --> '); 
 
figure 
%get data 
for TEitr = 1:obj.noTE 
x(TEitr) = obj.te_Data(TEitr,1).TEval; %#ok<AGROW> 
y(TEitr) = obj.te_Data(TEitr,1).roi(ROIno,1).signal; %#ok<AGROW> 
end 
 
% Truncate the data to the specified region 
stopIdx = find(x == xStop); 
startIdx = find(x == xStart); 
 
%Re-arrange formula 
yf = log(y(startIdx:stopIdx)); 
 
%plot data 
plot(x(startIdx:stopIdx), yf, 'x', 'MarkerSize', 12, 'Linewidth', 1.5); 
xlabel('TE values (msec)'); 
ylabel('ln(signal) a.u.'); 
 
set(gca, 'LineWidth', 1.5); 
 
% calc gradient & plot fit 
[g,c] = obj.getGradient(x(startIdx:stopIdx), yf); 
obj.t2 = -1/g; 
hold all 
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fit = g*x(startIdx:stopIdx) + c; 
 
% work out R^2 - 1 indicates perfect fit! 
sse = sum((fit - yf).^2); 
ssr = sum((fit - mean(yf)).^2); 
obj.r_sq = ssr/(ssr+sse); 
 
% Add fit to the plot 
plot(x(startIdx:stopIdx), fit, '--', 'Linewidth', 1.5); 
legend(['ROI ' num2str(ROIno) ' data'], ['Fit:: y = ' num2str(g) ' x + ' 
num2str(c)]); 
legend('Location', 'NorthEast'); 
title(['Fit to data for finding T2 [R^2 = ' num2str(obj.r_sq, '%0.2f') ']']); 
hold off; 
 
clear x y stopIdx ROIno 
end 
 
%------- process gradient T1 for TR data 
function obj = calcT1(obj) 
disp(' '); 
xStart = input('Starting x val --> '); 
xStop = input('Stopping x val --> '); 
ROIno = input('ROI number --> '); 
 
figure 
%get data 
for TRitr = 1:obj.noTR 
x(TRitr) = obj.tr_Data(TRitr,1).TRval; %#ok<AGROW> 
y(TRitr) = obj.tr_Data(TRitr,1).roi(ROIno,1).signal; %#ok<AGROW> 
end 
 
% Y should be ln(y) to give rising exponential 
%             y = log(y); 
 
% Truncate data to specified region 
stopIdx = find(x == xStop); 
startIdx = find(x == xStart); 
 
%output s0 in (taken from data) 
obj.s0_in = max(y); 
 
%Re-arrange formula 
%             yf = log(max(y) - y(startIdx:stopIdx)); 
yf = log(1.8080e3 - y(startIdx:stopIdx)); 
 
%plot data 
plot(x(startIdx:stopIdx),  yf, 'x', 'MarkerSize', 12, 'Linewidth', 1.5); 
xlabel('TR values (msec)'); 
ylabel('ln(signal) a.u.'); 
 
set(gca, 'LineWidth', 1.5); 
 
% calc gradient & plot fit 
[g, c, err] = obj.getGradient1( x(startIdx:stopIdx), yf); 
obj.err = err; %return err details of polyfit 
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%output S0 (y-intercept) point from fit. 
obj.s0_out = exp(c); 
 
obj.t1 = -1/g; 
hold all 
fit = g*x(startIdx:stopIdx) + c; 
 
% work out R^2 - 1 indicates perfect fit! 
sse = sum((fit - yf).^2); 
ssr = sum((fit - mean(yf)).^2); 
obj.r_sq = ssr/(ssr+sse); 
 
plot(x(startIdx:stopIdx), fit, '--', 'Linewidth', 1.5); 
legend(['ROI ' num2str(ROIno) ' data'], ['Fit:: y = ' num2str(g) ' x + ' 
num2str(c)]); 
legend('Location', 'NorthEast'); 
title(['Fit to data for finding T1 [R^2 = ' num2str(obj.r_sq, '%0.2f') ']']); 
hold off; 
 
clear x y stopIdx ROIno 
end 
 
%------- Plot the TE data on a natural log scale. 
function plot_TE_logScale(obj) 
% Plot TE data on natural log scale. This helps the fitting 
% rountine for finding the best section of straight line. Use 
% these limits in the calcT2 method. 
% 
% SEE ALSO: calcT2 
 
% Check that TE data has been processed. 
if obj.processOption == 4 
figure 
% loop over all ROIs 
for ROIitr = 1:obj.noROIs 
 
% sort out the plot window 
if obj.noROIs <= 3 
subplot(1,3,ROIitr); 
elseif obj.noROIs > 3 && obj.noROIs < 7 
subplot(2,3,ROIitr); 
end 
 
if obj.noROIs >= 7 
if ROIitr > 6 
if mod(ROIitr,6) == 1 
figure 
end 
end 
if mod(ROIitr,6) == 0 
subplot(2, 3, 6) 
else 
subplot(2, 3, mod(ROIitr,6)) 
end 
end %end sorting out plot window 
 
% loop over all TRs and get corresponding signal 
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for TEitr = 1:obj.noTE 
x(TEitr) = obj.te_Data(TEitr,1).TEval; %#ok<AGROW> 
y(TEitr) = obj.te_Data(TEitr,1).roi(ROIitr,1).signal; %#ok<AGROW> 
end 
 
% plot data 
plot(x, log(y), 'x' , 'LineWidth', 2, 'MarkerSize', 10); 
hold all 
axis square 
xlabel('TE values (msec)'); 
ylabel('ln[signal] (a.u.)'); 
legend(['ROI ' num2str(ROIitr)]); 
legend('Location', 'NorthEast'); 
set(gca, 'LineWidth', 1.5); 
xlim([0 x(end)]); 
clear x y 
end 
hold off 
else 
warning('MRIdata:plotLogScaleTE', 'TE data has not been processed. Run 
".processMRI" method with option "4" first.'); 
end 
 
end 
end % END PUBLIC METHODS 
 
B3.3 Protected method block 
These functions are like a “black box” for the class: They have been created to 
perform specific tasks specific to the processing of MRI data, but the user does 
not require knowledge of them in order to use the MRIdata class. 
methods (Access = protected) 
%------- sort out the names of the files to process - FA 
function obj = sortFileNames_fa(obj) 
% Extract file names, angles and instances into a struct object 
% variable: "filedata". 
% Note this expects 25 instances or frames. Anything else and 
% it will fall over. 
 
%trac progress 
counter = 0; 
pbar = waitbar(0, 'Organising FA file structure...'); 
%  no files to process 
infiles = dir('*FA*.dcm'); 
obj.noFiles = length(infiles); 
 
if obj.noFiles ~= 0 
for fa = 1:obj.noFA %ordering angle increasing 
for frame = 1:obj.noFrames %run through frames 
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for j = 1:obj.noFiles %run through file list 
if obj.fa_range(fa, 1) == sscanf( strrep(infiles(j, 1).name, '_', ' '), 
obj.fa_format)%sort angle increasing 
if  frame == sscanf( strrep(infiles(j, 1).name, '_', ' '), 
obj.fa_instance_format)%sort frame increasing 
 
counter = counter + 1; 
per = counter/obj.noFA/obj.noFrames; 
 
obj.filedata(fa, 1).names(frame,1).name  = infiles(j, 1).name; 
obj.filedata(fa, 1).val                               = sscanf( strrep(infiles(j, 1).name, '_', 
' '), obj.fa_format); 
obj.filedata(fa, 1).names(frame,1).frame = sscanf( strrep(infiles(j, 1).name, '_', ' 
'), obj.fa_instance_format); 
 
% progress bar 
waitbar(per); 
 
end 
end 
end 
end 
end 
close(pbar); 
else 
error('ERR: No FA files found in directory!'); 
end 
clear infiles 
end % end sortFileNames_fa() 
 
%------- sort out the names of the files to process - TR 
function obj = sortFileNames_tr(obj) 
for n = 1:obj.noTR 
obj.filedata(n, 1).name = ['TR=' num2str(obj.tr_range(n)) 'ms.dcm']; 
obj.filedata(n, 1).tr = obj.tr_range(n); 
end 
end %end sortFileNames_tr() 
 
%------- sort out the names of the files to process - TE 
function obj = sortFileNames_te(obj) 
for n = 1:obj.noTE 
obj.filedata(n,1).name = ['se_mc_TE' num2str(obj.te_range(n)) '.dcm']; 
obj.filedata(n, 1).TEval = obj.te_range(n); 
end 
end % end sortFileNames_te() 
 
%-------- generate the masks for processing 
function obj = createROIs(obj, varargin) 
% From v3.3 class file, here varargin contains; 
% - varargin{1} -> noROIs 
% - varargin{2} -> function handle to status box update 
% - varargin{3} -> handles struct from GUI 
 
% Are we using the command line 
if isempty(varargin{1}) 
disp(' '); 
obj.noROIs = input('How masks / ROIs would you like to create?  '); 
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else 
% or the GUI 
obj.noROIs = varargin{1}; 
end 
 
% Create new figure 
figure 
 
for i = 1:obj.noROIs 
% use 1st image to get mask(s) 
if obj.isFA 
inImg = dicomread(obj.filedata(1, 1).names(1, 1).name); 
elseif obj.isTR || obj.isTE 
inImg = dicomread(obj.filedata(1,1).name); 
end 
 
 
% readjust contrast on image - so we can see it 
curImg = imadjust(inImg); 
% show the image 
imshow(curImg); 
title(['Create mask / ROI number ' num2str(i)]); 
 
% Get Screen size so that figure looks big for setting ROIs 
sRes = get(0, 'ScreenSize'); 
sRes(1) = 10; 
sRes(2) = 10; 
sRes(3) = sRes(3)*0.98; 
sRes(4) = sRes(4)*0.90; 
set(gcf, 'Position', sRes); 
% allow us to select area of interest 
hmask = imellipse; 
title(['Create mask / ROI number ' num2str(i)]); 
% wait 'til we are finished then return pos. of each vetex of the ROI 
pos = wait(hmask); 
% convert these positions to generate a binary mask 
obj.masks(:,:,i) = uint16(roipoly(curImg, pos(:,1), pos(:,2))); 
end 
clear inImg curImg 
close all 
end%end createROIs() 
 
%------- apply each roi to image & get the data 
function obj = applyROIs(obj, varargin) 
% From v3.3 class file,  here varargin contains; 
% - varargin{1} -> noROIs 
% - varargin{2} -> function handle to status box update 
% - varargin{3} -> handles struct from GUI 
 
if obj.isFA 
% Get size of images - just use the first one. 
obj.sizeChk = length(dicomread( obj.filedata(1, 1).names(1,1).name) ); 
 
% Loop over all files 
for itr = 1:obj.noFA 
% Loop over all frames/instances 
for fitr = 1:obj.noFrames 
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% Loop over all ROIs 
for i = 1:obj.noROIs 
loadImg = imadjust(dicomread(obj.filedata(itr,1).names(fitr,1).name)); 
 
% If size is the same - apply mask 
if length(loadImg) == obj.sizeChk 
imgData = obj.masks(:,:,i).*loadImg; 
 
% Get data from ROIs 
mskLabels = bwlabel(obj.masks(:, :, i)); 
stats = regionprops(mskLabels, imgData , 'meanIntensity'); 
% FA data variable: Y: av. intensity, X: FA angle 
obj.fa_Data(itr, 1).roi(i,1).signal(fitr) = stats.MeanIntensity; 
obj.fa_Data(itr, 1).angle = obj.fa_range(itr,1); 
else 
obj.fa_Data(itr, 1).roi(i,1).signal(fitr) = NaN; 
obj.fa_Data(itr, 1).angle = obj.fa_range(itr,1); 
 
% Error handling. 
if i == 1 
tmp = dicomread(obj.filedata(itr,1).names(fitr,1).name); 
errSTR = ['WARNING: missed out file '  obj.filedata(itr,1).names(fitr,1).name '. 
File size = ' num2str(size(tmp))... 
' Mask size = ' num2str(size(obj.masks(:,:,1)))]; 
clear tmp 
 
if isempty(varargin{1}) 
disp(['* ' errSTR]); 
else 
varargin{2}(errSTR,varargin{3}); 
end 
end 
end 
end 
end 
end 
elseif obj.isTR || obj.isTE 
 
% Check size before applying mask later 
obj.sizeChk = length(dicomread( obj.filedata(1, 1).name) ); 
 
if obj.isTR 
noItr = obj.noTR; 
elseif obj.isTE 
noItr = obj.noTE; 
end 
 
% Loop oevr each file: either TR/TE 
for itr = 1:noItr 
% Loop over each ROI 
for i = 1:obj.noROIs 
loadImg = imadjust(dicomread(obj.filedata(itr,1).name)); 
 
% If image size is ok - apply mask 
if length(loadImg) == obj.sizeChk 
imgData = obj.masks(:,:,i).*loadImg; 
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% Get data 
mskLabels = bwlabel(obj.masks(:, :, i)); 
stats = regionprops(mskLabels, imgData, 'meanIntensity'); %#ok<*MRPBW> 
 
% Store data depending on the processing we are doing. 
if obj.isTR 
obj.tr_Data(itr,1).roi(i,1).signal = stats.MeanIntensity; 
obj.tr_Data(itr,1).TRval = obj.tr_range(itr); 
elseif obj.isTE 
obj.te_Data(itr,1).roi(i,1).signal = stats.MeanIntensity; 
obj.te_Data(itr,1).TEval = obj.te_range(itr); 
end 
 
else 
if obj.isTR 
obj.tr_Data(itr,1).roi(i,1).signal = NaN; 
obj.tr_Data(itr,1).TRval = obj.tr_range(itr); 
elseif obj.isTE 
obj.te_Data(itr,1).roi(i,1).signal = NaN; 
obj.te_Data(itr,1).TEval = obj.te_range(itr); 
end 
 
 
% Problem? Display message in command line, or in GUI 
if i == 1 
tmp = dicomread(obj.filedata(itr,1).name); 
errSTR = ['WARNING: missed out file '  obj.filedata(itr,1).name '. File size = ' 
num2str(size(tmp))... 
' Mask size = ' num2str(size(obj.masks(:,:,1)))]; 
clear tmp 
 
if nargin == 1 
disp(['* ' errSTR]); 
else 
varargin{2}(errSTR,varargin{3}); 
end 
end 
end 
end 
end 
 
end 
clear loadImg mskLabels imdata 
end % end applyROIs() 
 
%------- sort out fig legends 
function applyLegend(obj) 
%sort out legend 
% See “MRIdata.m” for full details 
end % end applyLegend() 
 
%------ sort out plot length for FA data only 
function FArange = opt1plotRange(obj) 
%return val depending on plot opt 
retryPlot = 1; 
disp(' '); 
disp('-----------------------------'); 
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disp(':: Choose flip angle range ::'); 
disp('-----------------------------'); 
disp('a. Plot all flip angles (NOTE:: this can produce a lot of graphs)'); 
disp('b. input my own flip angle range'); 
disp(' '); 
opt = input('plot range option:  ', 's'); 
disp(' '); 
 
while retryPlot == 1 
retryPlot = 0; 
 
if opt == 'b' 
farangeMIN = input('what is the starting flip angle to plot: '); 
farangeMAX = input('what is the ending flip angle to plot: '); 
if farangeMIN ~= farangeMAX 
farangeSTEP = input('what is the steps between each flip angle: '); 
else 
farangeSTEP = 1; 
end 
elseif opt == 'a' 
farangeMIN = obj.fa_Data(1,1).angle; 
farangeMAX = obj.fa_Data(end,1).angle; 
if length(obj.fa_Data) ~= 1 
farangeSTEP = obj.fa_Data(2,1).angle - obj.fa_Data(1,1).angle; 
else 
farangeSTEP = 1; 
end 
else % if the user selects an option which isn't present get them to retry. 
disp('*** WARNING: please select one of the options ***'); 
retryPlot = 1; 
disp('-----------------------------'); 
disp(':: Choose flip angle range ::'); 
disp('-----------------------------'); 
disp('a. Plot all flip angles (NOTE:: this can produce a lot of graphs)'); 
disp('b. input my own flip angle range'); 
disp(' '); 
opt = input('plot range option:  ', 's'); 
end 
end 
 
FArange = farangeMIN:farangeSTEP:farangeMAX; 
end % end opt1plotRange() 
 
%------ fit straight line to get gradient for T2 
function [g, c] = getGradient(obj, x, y) 
% MATLAB function for fitting to nth degree polynomial. 
% "p" contains the coefficients from the fit where p(1) 
% corresponds to the coefficient for the highest order term; 
% in this case the x term, with degree 1. 
% 
% p(1) -> m 
% p(2) -> c 
% 
% for polynomial 
%   y = m x + c 
 
if obj.isTE || obj.isTR 
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p = polyfit(x, y, 1); 
g = p(1); 
c = p(2); 
else 
err = 0; % just for safety. 
g = 0; 
c = 0; 
end 
 
%             obj.err = err; 
end %end getGradient 
end % END PROTECTED METHODS 
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Glossary of terms 
2CH Two-chamber 
4CH Four-chamber 
ADC Analogue to digital converter 
AF Atrial fibrillation 
ANOVA Analysis of variance 
AP Anterior-posterior 
ATP Adenosine triphosphate 
B0 Main magnetic field 
B1 Radio frequency pulse 
BW Bandwidth 
CAD Coronary artery disease 
CHF Congestive heart failure 
CMRI Cardiac magnetic resonance imaging 
CNR Contrast-to-noise ratio 
CO Cardiac output 
CoR Coefficient of repeatability 
CT Computed tomography 
CVD Cardiovascular disease 
DCM Dilated cardiomyopathy 
dT Duration time 
DTPA Diethylene triamine pentaacetic acid 
ECG Electrocardiogram 
Echo Echocardiography 
ED End-diastole 
EDV End-diastolic volume  
EF Ejection fraction 
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Emf Electromotive force 
EPI Echo planar imaging 
ES End-systole 
ESMRMB European Society for Magnetic Resonance in medicine and 
Biology 
ESV End-systolic volume 
FA Flip angle 
FID Free induction decay 
FIESTA Fast imaging employing steady-state acquisition 
FLASH Fast low angle shot 
FOV Field of view 
Gd Gadolinium  
GE Gradient echo 
GRAPPA Generalised autocalibrating partially parallel acquisitions 
HCM Hypertrophic cardiomyopathy 
HLA Horizontal long axis 
HNV Healthy normal volunteers 
IR-GRE Inversion recovery gradient echo 
ISMRM International Society for Magnetic Resonance in Medicine 
LA Left atrium 
LAA Left atrial appendage 
LV  Left ventricle 
LVH Left ventricular hypertrophy 
LVHD Left ventricular hypertrophy and type 2 diabetes 
LVHI Left ventricular and ischemic heart disease 
LVM Left ventricular mass 
M0 Net magnetisation vector 
MHD  Magnetohydrodynamic  
MHRA The medicines and healthcare regulatory agency 
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MI  Myocardial infarction 
MRI  Magnetic resonance imaging 
Mxy Magnetisation vector in the x-y plane 
NFE Number of frequency encoding steps 
NHS  National Health Service 
NHV Normal healthy volunteer 
NMR Nuclear magnetic resonance 
NPE Number of phase encoding steps 
NSA Number of signal averages 
PCr Phosphocreatine 
PD  Proton density 
PET Positron emission computed tomography 
PI Parallel imaging 
PPI Partial parallel imaging 
ppm Parts per million 
PQRST Five deflection waves produced by the heart 
PV Pulmonary veins 
RF Radio frequency 
ROI Region of interest 
RV  Right ventricle 
SA Short-axis 
SAR Specific absorption rate 
SD Standard deviation 
SE Spin echo 
SENSE Sensitive encoding for fast MRI 
SLE Systemic Lupus Erythematosus 
SMASH Simultaneous acquisition of parallel imaging techniques 
SNR Signal-to-noise ratio 
SPECT Single photon emission computed tomography 
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SPGR Spoiled gradient echo 
SSFP Steady-state in free precession 
SV Stroke volume 
T Tesla 
T1 Longitudinal relaxation rate 
T2 Spin-spin relaxation rate 
T2* Time constant that includes spin-spin relaxation plus 
additional dephasing effects 
TE Echo time – the time period between the excitation pulse 
and signal measurement 
TR Repetition time between successive RF pulses 
UK United Kingdom 
USA United States of America 
VECG Vector ECG 
VLA Vertical long axis 
α Angle of precession from the z-axis 
 
